"Test Directory Package ID","Assay: Assay ID","Performance Detail Submission ID","Created Date","Assay: Company/Institution Name: City","Assay: Company/Institution Name: Country","Assay: Company/Institution Name: WHO Region","Assay: Company/Institution Name: Website","Assay: Company/Institution Name: Organisation Name","Assay: Assay Name","Assay: Primary Use Case","Assay: Assay Aim","Assay: Disease Target","Assay: Disease Target Phase","Assay: Target Pathogen","Assay: Stage of Development","Assay: Regulatory Approval","Assay: Planned Market Entry","Assay: Type of Technology","Assay: Assay Target","Assay: Target Analyte(s)","Assay: Technology principle","Assay: Other Technology principle","Assay: Readout Technology","Assay: Resistance Marker","Assay: Other resistance marker","Assay: Drug Resistance Target","Assay: Other drug resistance target","Assay: Test Format","Assay: Other Test Format","Assay: Instrument requirement","Assay: Level of automation","Assay: Lab vs. POC","Assay: Self-testing/Self-Collection","Assay: Validated Sample Types","Assay: Other Validated Sample Type","Assay: Time to results (mins)","Assay: Test to be listed on FIND's web page?","Data to be published on FIND's web page","Perf Submission Title","Performance Detail Submission Number","Assay Target","Study Type","Type of data source","Drug Resistance Target","Sensitivity (%)","95% CI for Clinical Sensitivity (Lower)","95% CI for Clinical Sensitivity (Upper)","Specificity (%)","95% CI for Clinical Specificity (Lower)","95% CI for Clinical Specificity (Upper)","Target Patient Group","Sample Type","Total number of samples","Number of positive samples","Number of negative samples","Other drug resistance target","Assay: Other Regulatory Approval","Assay: Purpose of submission"
"a2v69000004gKt4","a2r69000007lbEm","a266900000B8tqf","06.07.2023","Groß-Rohrheim","Germany","European Region","globalpointofcare.abbott/en/index.html","Abbott Rapid Diagnostics","Determine TB-LAM Ag","Diagnostic/confirmatory test","ID","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","CE-IVDD; WHO recommended","Already on the market (commercialized)","Immunoassay","Antigen","Lipoarabinomannan (LAM)","Lateral Flow Assay","","Colorimetric","Not applicable","","Not applicable","","Rapid diagnostic test (strip or cassette)","","No instrumentation is required","Manual","True Point of Care","Intended for professional use only","Urine","","25.00","Yes","Yes","TB detection from urine (HIV+ patients)","PD-57851","Antigen","Independent","Other","Not applicable","42.00","31.00","55.00","91.00","85.00","95.00","Active TB","Urine","3449","1277","2172","","WHO recommended","Test Directory"
"a2v69000004gKt4","a2r69000007lbEm","a266900000B8tqg","06.07.2023","Groß-Rohrheim","Germany","European Region","globalpointofcare.abbott/en/index.html","Abbott Rapid Diagnostics","Determine TB-LAM Ag","Diagnostic/confirmatory test","ID","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","CE-IVDD; WHO recommended","Already on the market (commercialized)","Immunoassay","Antigen","Lipoarabinomannan (LAM)","Lateral Flow Assay","","Colorimetric","Not applicable","","Not applicable","","Rapid diagnostic test (strip or cassette)","","No instrumentation is required","Manual","True Point of Care","Intended for professional use only","Urine","","25.00","Yes","Yes","TB detection from urine (overall symptomatic HIV+ patients)","PD-57852","Antigen","Independent","Other","Not applicable","42.00","31.00","55.00","91.00","85.00","95.00","Active TB","Urine","3449","1277","2172","","WHO recommended","Test Directory"
"a2v69000004gKt4","a2r69000007lbEm","a266900000B8tqh","06.07.2023","Groß-Rohrheim","Germany","European Region","globalpointofcare.abbott/en/index.html","Abbott Rapid Diagnostics","Determine TB-LAM Ag","Diagnostic/confirmatory test","ID","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","CE-IVDD; WHO recommended","Already on the market (commercialized)","Immunoassay","Antigen","Lipoarabinomannan (LAM)","Lateral Flow Assay","","Colorimetric","Not applicable","","Not applicable","","Rapid diagnostic test (strip or cassette)","","No instrumentation is required","Manual","True Point of Care","Intended for professional use only","Urine","","25.00","Yes","Yes","TB detection from urine (overall unselected HIV+ patients)","PD-57853","Antigen","Independent","Other","Not applicable","35.00","22.00","50.00","95.00","89.00","98.00","Active TB","Urine","3365","432","2933","","WHO recommended","Test Directory"
"a2v69000004gKt4","a2r69000007lbEm","a266900000B8tqi","06.07.2023","Groß-Rohrheim","Germany","European Region","globalpointofcare.abbott/en/index.html","Abbott Rapid Diagnostics","Determine TB-LAM Ag","Diagnostic/confirmatory test","ID","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","CE-IVDD; WHO recommended","Already on the market (commercialized)","Immunoassay","Antigen","Lipoarabinomannan (LAM)","Lateral Flow Assay","","Colorimetric","Not applicable","","Not applicable","","Rapid diagnostic test (strip or cassette)","","No instrumentation is required","Manual","True Point of Care","Intended for professional use only","Urine","","25.00","Yes","Yes","TB detection from urine (symptomatic HIV+ inpatient)","PD-57854","Antigen","Independent","Other","Not applicable","52.00","40.00","64.00","87.00","78.00","93.00","Active TB","Urine","2253","868","1385","","WHO recommended","Test Directory"
"a2v69000004gKt4","a2r69000007lbEm","a266900000B8tqj","06.07.2023","Groß-Rohrheim","Germany","European Region","globalpointofcare.abbott/en/index.html","Abbott Rapid Diagnostics","Determine TB-LAM Ag","Diagnostic/confirmatory test","ID","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","CE-IVDD; WHO recommended","Already on the market (commercialized)","Immunoassay","Antigen","Lipoarabinomannan (LAM)","Lateral Flow Assay","","Colorimetric","Not applicable","","Not applicable","","Rapid diagnostic test (strip or cassette)","","No instrumentation is required","Manual","True Point of Care","Intended for professional use only","Urine","","25.00","Yes","Yes","TB detection from urine (symptomatic HIV+ outpatient)","PD-57855","Antigen","Independent","Other","Not applicable","29.00","17.00","47.00","96.00","91.00","99.00","Active TB","Urine","1196","409","787","","WHO recommended","Test Directory"
"a2v69000004gKt4","a2r69000007lbEm","a266900000B8tqk","06.07.2023","Groß-Rohrheim","Germany","European Region","globalpointofcare.abbott/en/index.html","Abbott Rapid Diagnostics","Determine TB-LAM Ag","Diagnostic/confirmatory test","ID","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","CE-IVDD; WHO recommended","Already on the market (commercialized)","Immunoassay","Antigen","Lipoarabinomannan (LAM)","Lateral Flow Assay","","Colorimetric","Not applicable","","Not applicable","","Rapid diagnostic test (strip or cassette)","","No instrumentation is required","Manual","True Point of Care","Intended for professional use only","Urine","","25.00","Yes","Yes","TB detection from urine (unselected HIV+ inpatient)","PD-57856","Antigen","Independent","Other","Not applicable","62.00","41.00","83.00","84.00","48.00","96.00","Active TB","Urine","537","159","378","","WHO recommended","Test Directory"
"a2v69000004gKt4","a2r69000007lbEm","a266900000B8tql","06.07.2023","Groß-Rohrheim","Germany","European Region","globalpointofcare.abbott/en/index.html","Abbott Rapid Diagnostics","Determine TB-LAM Ag","Diagnostic/confirmatory test","ID","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","CE-IVDD; WHO recommended","Already on the market (commercialized)","Immunoassay","Antigen","Lipoarabinomannan (LAM)","Lateral Flow Assay","","Colorimetric","Not applicable","","Not applicable","","Rapid diagnostic test (strip or cassette)","","No instrumentation is required","Manual","True Point of Care","Intended for professional use only","Urine","","25.00","Yes","Yes","TB detection from urine (unselected HIV+ outpatient)","PD-57857","Antigen","Independent","Other","Not applicable","31.00","18.00","47.00","95.00","87.00","99.00","Active TB","Urine","2828","273","2555","","WHO recommended","Test Directory"
"a2v69000004gLSu","a2r69000007lb91","a266900000B8ttk","06.07.2023","Darmstadt","Germany","European Region","r-biopharm.com","R-Biopharm AG","IP-10 IGRA LF","Triage/Screening","ID","Tuberculosis","Latent","Mycobacterium Tuberculosis","Late Stage Development (fully functional prototype)","None","Unspecified Market Entry","Immunoassay","Antigen","Interferon Gamma","IGRA","","Colorimetric","Not applicable","","Not applicable","","Rapid diagnostic test (strip or cassette)","","No instrumentation is required","Manual","near Point of Care","Intended for professional use only","Whole Blood","","","Yes","No","","PD-58042","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gLSt","a2r69000007lbFH","a266900000B8ttj","06.07.2023","Darmstadt","Germany","European Region","r-biopharm.com","R-Biopharm AG","IP-10 IGRA ELISA","Triage/Screening","ID","Tuberculosis","Latent","Mycobacterium Tuberculosis","Research Use Only (RUO)","None","Unspecified Market Entry","Immunoassay","Antigen","Interferon Gamma","ELISA/EIA; IGRA","","Colorimetric","Not applicable","","Not applicable","","Chemiluminescent Immunoassay (CLIA)","","Standard lab instrumentation is required","Manual","Lab-based","Intended for professional use only","Whole Blood","heprin","","Yes","No","","PD-58041","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gLUB","a2r69000007lbFL","a266900000B8ttu","06.07.2023","Suwon-si","Korea, Republic of","Western Pacific Region","sdbiosensor.com","SD Biosensor, Inc.","STANDARD E TB-Feron ELISA","Triage/Screening","ID","Tuberculosis","Latent","Mycobacterium Tuberculosis","Regulatory Achieved","CE-IVDD; Korea MFDS","Already on the market (commercialized)","Immunoassay","Antigen","Interferon Gamma","ELISA/EIA; IGRA","","Colorimetric","Not applicable","","Not applicable","","Chemiluminescent Immunoassay (CLIA)","","Standard lab instrumentation is required","Manual","Lab-based","Intended for professional use only","Plasma","","100.00","Yes","No","","PD-58052","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gKre","a2r69000007lbEo","a266900000B8tqv","06.07.2023","Carlsbad","United States","Region of the Americas","autogenomics.com/?q=node/42","Autogenomics","INFINITIMTB Assay","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Research Use Only (RUO)","None","Already on the market (commercialized)","Molecular","DNA","Unknown","qPCR","Microarray","Fluorescence","katG; pncA; rpoB","KatG315 (for INHR); RpoB511-533 (for RIFR); and PncA57","Isoniazid; Pyrazinamide; Rifampicin","","Cartridge-based processing","microarray chip based","A proprietary/new instrument is required","Automated (excluding sample preparation)","Lab-based","Intended for professional use only","Unknown","","","Yes","No","","PD-57867","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gKrR","a2r69000007lbF6","a266900000B8trE","06.07.2023","Daejeon","Korea, Republic of","Western Pacific Region","bioneer.com","Bioneer Corporation","IRON qPCR RFIA kit (preXDR-TB)","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis","Late Stage Development (fully functional prototype)","None","Unspecified Market Entry","Molecular","DNA","Unknown","qPCR","","Fluorescence","Unknown","","Amikacin; Fluoroquinolone; Isoniazid; Kanamycin; Rifampicin","","Cartridge-based processing","","A proprietary/new instrument is required","Fully automated (including sample preparation)","near Point of Care","Intended for professional use only","Sputum","","60.00","Yes","No","","PD-57886","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gKqt","a2r69000007lb94","a266900000B8trI","06.07.2023","Sunnyvale","United States","Region of the Americas","cepheid.com","Cepheid","Xpert MTB/RIF","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis","Regulatory Achieved","Brazil ANVISA; CE-IVDD; Israel Ministry of Health; US FDA 510k; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB rpoB gene","qPCR","","Fluorescence","rpoB","rpoB gene contianing the 81 base pair core region (5 probes); for mutations within the rifampicin-resistance determining region (RRDR)","Rifampicin","","Cartridge-based processing","","A proprietary/new instrument is required","Automated (excluding sample preparation)","near Point of Care","Intended for professional use only","Bronchoalveolar lavage; Sputum; Other","Sputum Sediment","90.00","Yes","No","RIF detection (against AFB smear positive subjects )","PD-57890","DNA","Company-Sponsored","Instructions for Use (IFU)","Not applicable","99.70","98.40","99.90","98.50","91.90","99.70","Active TB","Sputum","417","351","66","","","Test Directory"
"a2v69000004gKqt","a2r69000007lb94","a266900000B8trJ","06.07.2023","Sunnyvale","United States","Region of the Americas","cepheid.com","Cepheid","Xpert MTB/RIF","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis","Regulatory Achieved","Brazil ANVISA; CE-IVDD; Israel Ministry of Health; US FDA 510k; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB rpoB gene","qPCR","","Fluorescence","rpoB","rpoB gene contianing the 81 base pair core region (5 probes); for mutations within the rifampicin-resistance determining region (RRDR)","Rifampicin","","Cartridge-based processing","","A proprietary/new instrument is required","Automated (excluding sample preparation)","near Point of Care","Intended for professional use only","Bronchoalveolar lavage; Sputum; Other","Sputum Sediment","90.00","Yes","No","RIF detection (against AFB smear negative subjects )","PD-57891","DNA","Company-Sponsored","Instructions for Use (IFU)","Not applicable","76.10","67.60","82.90","98.80","97.50","99.40","Active TB","Sputum","679","117","562","","","Test Directory"
"a2v69000004gKqt","a2r69000007lb94","a266900000B8trK","06.07.2023","Sunnyvale","United States","Region of the Americas","cepheid.com","Cepheid","Xpert MTB/RIF","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis","Regulatory Achieved","Brazil ANVISA; CE-IVDD; Israel Ministry of Health; US FDA 510k; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB rpoB gene","qPCR","","Fluorescence","rpoB","rpoB gene contianing the 81 base pair core region (5 probes); for mutations within the rifampicin-resistance determining region (RRDR)","Rifampicin","","Cartridge-based processing","","A proprietary/new instrument is required","Automated (excluding sample preparation)","near Point of Care","Intended for professional use only","Bronchoalveolar lavage; Sputum; Other","Sputum Sediment","90.00","Yes","Yes","TB detection from sputum","PD-57892","DNA","Independent","Other","Not applicable","85.00","82.00","88.00","98.00","97.00","98.00","Active TB","Sputum","37237","","","","","Test Directory"
"a2v69000004gKqt","a2r69000007lb94","a266900000B8trL","06.07.2023","Sunnyvale","United States","Region of the Americas","cepheid.com","Cepheid","Xpert MTB/RIF","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis","Regulatory Achieved","Brazil ANVISA; CE-IVDD; Israel Ministry of Health; US FDA 510k; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB rpoB gene","qPCR","","Fluorescence","rpoB","rpoB gene contianing the 81 base pair core region (5 probes); for mutations within the rifampicin-resistance determining region (RRDR)","Rifampicin","","Cartridge-based processing","","A proprietary/new instrument is required","Automated (excluding sample preparation)","near Point of Care","Intended for professional use only","Bronchoalveolar lavage; Sputum; Other","Sputum Sediment","90.00","Yes","Yes","TB detection from sputum  (smear positive)","PD-57893","DNA","Independent","Other","Not applicable","98.00","97.00","98.00","","","","Active TB","Sputum","18275","","","","","Test Directory"
"a2v69000004gKqt","a2r69000007lb94","a266900000B8trM","06.07.2023","Sunnyvale","United States","Region of the Americas","cepheid.com","Cepheid","Xpert MTB/RIF","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis","Regulatory Achieved","Brazil ANVISA; CE-IVDD; Israel Ministry of Health; US FDA 510k; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB rpoB gene","qPCR","","Fluorescence","rpoB","rpoB gene contianing the 81 base pair core region (5 probes); for mutations within the rifampicin-resistance determining region (RRDR)","Rifampicin","","Cartridge-based processing","","A proprietary/new instrument is required","Automated (excluding sample preparation)","near Point of Care","Intended for professional use only","Bronchoalveolar lavage; Sputum; Other","Sputum Sediment","90.00","Yes","Yes","TB detection from sputum (smear negative)","PD-57894","DNA","Independent","Other","Not applicable","67.00","62.00","72.00","98.00","98.00","99.00","Active TB","Sputum","18962","","","","","Test Directory"
"a2v69000004gKqt","a2r69000007lb94","a266900000B8trN","06.07.2023","Sunnyvale","United States","Region of the Americas","cepheid.com","Cepheid","Xpert MTB/RIF","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis","Regulatory Achieved","Brazil ANVISA; CE-IVDD; Israel Ministry of Health; US FDA 510k; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB rpoB gene","qPCR","","Fluorescence","rpoB","rpoB gene contianing the 81 base pair core region (5 probes); for mutations within the rifampicin-resistance determining region (RRDR)","Rifampicin","","Cartridge-based processing","","A proprietary/new instrument is required","Automated (excluding sample preparation)","near Point of Care","Intended for professional use only","Bronchoalveolar lavage; Sputum; Other","Sputum Sediment","90.00","Yes","Yes","RIF detection from sputum","PD-57895","DNA","Independent","Other","Rifampicin","96.00","94.00","97.00","98.00","98.00","99.00","Active TB","Sputum","8020","","","","","Test Directory"
"a2v69000004gKqv","a2r69000007lb94","a266900000B8trU","06.07.2023","Sunnyvale","United States","Region of the Americas","cepheid.com","Cepheid","Xpert MTB/RIF","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis","Regulatory Achieved","Brazil ANVISA; CE-IVDD; Israel Ministry of Health; US FDA 510k; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB rpoB gene","qPCR","","Fluorescence","rpoB","rpoB gene contianing the 81 base pair core region (5 probes); for mutations within the rifampicin-resistance determining region (RRDR)","Rifampicin","","Cartridge-based processing","","A proprietary/new instrument is required","Automated (excluding sample preparation)","near Point of Care","Intended for professional use only","Bronchoalveolar lavage; Sputum; Other","Sputum Sediment","90.00","Yes","No","RIF detection (against AFB smear positive subjects )","PD-57902","DNA","Company-Sponsored","Instructions for Use (IFU)","Not applicable","99.70","98.40","99.90","98.50","91.90","99.70","Active TB","Sputum","417","351","66","","","Test Directory"
"a2v69000004gKqv","a2r69000007lb94","a266900000B8trV","06.07.2023","Sunnyvale","United States","Region of the Americas","cepheid.com","Cepheid","Xpert MTB/RIF","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis","Regulatory Achieved","Brazil ANVISA; CE-IVDD; Israel Ministry of Health; US FDA 510k; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB rpoB gene","qPCR","","Fluorescence","rpoB","rpoB gene contianing the 81 base pair core region (5 probes); for mutations within the rifampicin-resistance determining region (RRDR)","Rifampicin","","Cartridge-based processing","","A proprietary/new instrument is required","Automated (excluding sample preparation)","near Point of Care","Intended for professional use only","Bronchoalveolar lavage; Sputum; Other","Sputum Sediment","90.00","Yes","No","RIF detection (against AFB smear negative subjects )","PD-57903","DNA","Company-Sponsored","Instructions for Use (IFU)","Not applicable","76.10","67.60","82.90","98.80","97.50","99.40","Active TB","Sputum","679","117","562","","","Test Directory"
"a2v69000004gKqv","a2r69000007lb94","a266900000B8trW","06.07.2023","Sunnyvale","United States","Region of the Americas","cepheid.com","Cepheid","Xpert MTB/RIF","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis","Regulatory Achieved","Brazil ANVISA; CE-IVDD; Israel Ministry of Health; US FDA 510k; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB rpoB gene","qPCR","","Fluorescence","rpoB","rpoB gene contianing the 81 base pair core region (5 probes); for mutations within the rifampicin-resistance determining region (RRDR)","Rifampicin","","Cartridge-based processing","","A proprietary/new instrument is required","Automated (excluding sample preparation)","near Point of Care","Intended for professional use only","Bronchoalveolar lavage; Sputum; Other","Sputum Sediment","90.00","Yes","Yes","TB detection from sputum","PD-57904","DNA","Independent","Other","Not applicable","85.00","82.00","88.00","98.00","97.00","98.00","Active TB","Sputum","37237","","","","","Test Directory"
"a2v69000004gKqv","a2r69000007lb94","a266900000B8trX","06.07.2023","Sunnyvale","United States","Region of the Americas","cepheid.com","Cepheid","Xpert MTB/RIF","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis","Regulatory Achieved","Brazil ANVISA; CE-IVDD; Israel Ministry of Health; US FDA 510k; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB rpoB gene","qPCR","","Fluorescence","rpoB","rpoB gene contianing the 81 base pair core region (5 probes); for mutations within the rifampicin-resistance determining region (RRDR)","Rifampicin","","Cartridge-based processing","","A proprietary/new instrument is required","Automated (excluding sample preparation)","near Point of Care","Intended for professional use only","Bronchoalveolar lavage; Sputum; Other","Sputum Sediment","90.00","Yes","Yes","TB detection from sputum  (smear positive)","PD-57905","DNA","Independent","Other","Not applicable","98.00","97.00","98.00","","","","Active TB","Sputum","18275","","","","","Test Directory"
"a2v69000004gKqv","a2r69000007lb94","a266900000B8trY","06.07.2023","Sunnyvale","United States","Region of the Americas","cepheid.com","Cepheid","Xpert MTB/RIF","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis","Regulatory Achieved","Brazil ANVISA; CE-IVDD; Israel Ministry of Health; US FDA 510k; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB rpoB gene","qPCR","","Fluorescence","rpoB","rpoB gene contianing the 81 base pair core region (5 probes); for mutations within the rifampicin-resistance determining region (RRDR)","Rifampicin","","Cartridge-based processing","","A proprietary/new instrument is required","Automated (excluding sample preparation)","near Point of Care","Intended for professional use only","Bronchoalveolar lavage; Sputum; Other","Sputum Sediment","90.00","Yes","Yes","TB detection from sputum (smear negative)","PD-57906","DNA","Independent","Other","Not applicable","67.00","62.00","72.00","98.00","98.00","99.00","Active TB","Sputum","18962","","","","","Test Directory"
"a2v69000004gKqv","a2r69000007lb94","a266900000B8trZ","06.07.2023","Sunnyvale","United States","Region of the Americas","cepheid.com","Cepheid","Xpert MTB/RIF","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis","Regulatory Achieved","Brazil ANVISA; CE-IVDD; Israel Ministry of Health; US FDA 510k; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB rpoB gene","qPCR","","Fluorescence","rpoB","rpoB gene contianing the 81 base pair core region (5 probes); for mutations within the rifampicin-resistance determining region (RRDR)","Rifampicin","","Cartridge-based processing","","A proprietary/new instrument is required","Automated (excluding sample preparation)","near Point of Care","Intended for professional use only","Bronchoalveolar lavage; Sputum; Other","Sputum Sediment","90.00","Yes","Yes","RIF detection from sputum","PD-57907","DNA","Independent","Other","Rifampicin","96.00","94.00","97.00","98.00","98.00","99.00","Active TB","Sputum","8020","","","","","Test Directory"
"a2v69000004gKqu","a2r69000007lb94","a266900000B8trO","06.07.2023","Sunnyvale","United States","Region of the Americas","cepheid.com","Cepheid","Xpert MTB/RIF","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis","Regulatory Achieved","Brazil ANVISA; CE-IVDD; Israel Ministry of Health; US FDA 510k; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB rpoB gene","qPCR","","Fluorescence","rpoB","rpoB gene contianing the 81 base pair core region (5 probes); for mutations within the rifampicin-resistance determining region (RRDR)","Rifampicin","","Cartridge-based processing","","A proprietary/new instrument is required","Automated (excluding sample preparation)","near Point of Care","Intended for professional use only","Bronchoalveolar lavage; Sputum; Other","Sputum Sediment","90.00","Yes","No","RIF detection (against AFB smear positive subjects )","PD-57896","DNA","Company-Sponsored","Instructions for Use (IFU)","Not applicable","99.70","98.40","99.90","98.50","91.90","99.70","Active TB","Sputum","417","351","66","","","Test Directory"
"a2v69000004gKqu","a2r69000007lb94","a266900000B8trP","06.07.2023","Sunnyvale","United States","Region of the Americas","cepheid.com","Cepheid","Xpert MTB/RIF","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis","Regulatory Achieved","Brazil ANVISA; CE-IVDD; Israel Ministry of Health; US FDA 510k; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB rpoB gene","qPCR","","Fluorescence","rpoB","rpoB gene contianing the 81 base pair core region (5 probes); for mutations within the rifampicin-resistance determining region (RRDR)","Rifampicin","","Cartridge-based processing","","A proprietary/new instrument is required","Automated (excluding sample preparation)","near Point of Care","Intended for professional use only","Bronchoalveolar lavage; Sputum; Other","Sputum Sediment","90.00","Yes","No","RIF detection (against AFB smear negative subjects )","PD-57897","DNA","Company-Sponsored","Instructions for Use (IFU)","Not applicable","76.10","67.60","82.90","98.80","97.50","99.40","Active TB","Sputum","679","117","562","","","Test Directory"
"a2v69000004gKqu","a2r69000007lb94","a266900000B8trQ","06.07.2023","Sunnyvale","United States","Region of the Americas","cepheid.com","Cepheid","Xpert MTB/RIF","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis","Regulatory Achieved","Brazil ANVISA; CE-IVDD; Israel Ministry of Health; US FDA 510k; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB rpoB gene","qPCR","","Fluorescence","rpoB","rpoB gene contianing the 81 base pair core region (5 probes); for mutations within the rifampicin-resistance determining region (RRDR)","Rifampicin","","Cartridge-based processing","","A proprietary/new instrument is required","Automated (excluding sample preparation)","near Point of Care","Intended for professional use only","Bronchoalveolar lavage; Sputum; Other","Sputum Sediment","90.00","Yes","Yes","TB detection from sputum","PD-57898","DNA","Independent","Other","Not applicable","85.00","82.00","88.00","98.00","97.00","98.00","Active TB","Sputum","37237","","","","","Test Directory"
"a2v69000004gKqu","a2r69000007lb94","a266900000B8trR","06.07.2023","Sunnyvale","United States","Region of the Americas","cepheid.com","Cepheid","Xpert MTB/RIF","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis","Regulatory Achieved","Brazil ANVISA; CE-IVDD; Israel Ministry of Health; US FDA 510k; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB rpoB gene","qPCR","","Fluorescence","rpoB","rpoB gene contianing the 81 base pair core region (5 probes); for mutations within the rifampicin-resistance determining region (RRDR)","Rifampicin","","Cartridge-based processing","","A proprietary/new instrument is required","Automated (excluding sample preparation)","near Point of Care","Intended for professional use only","Bronchoalveolar lavage; Sputum; Other","Sputum Sediment","90.00","Yes","Yes","TB detection from sputum  (smear positive)","PD-57899","DNA","Independent","Other","Not applicable","98.00","97.00","98.00","","","","Active TB","Sputum","18275","","","","","Test Directory"
"a2v69000004gKqu","a2r69000007lb94","a266900000B8trS","06.07.2023","Sunnyvale","United States","Region of the Americas","cepheid.com","Cepheid","Xpert MTB/RIF","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis","Regulatory Achieved","Brazil ANVISA; CE-IVDD; Israel Ministry of Health; US FDA 510k; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB rpoB gene","qPCR","","Fluorescence","rpoB","rpoB gene contianing the 81 base pair core region (5 probes); for mutations within the rifampicin-resistance determining region (RRDR)","Rifampicin","","Cartridge-based processing","","A proprietary/new instrument is required","Automated (excluding sample preparation)","near Point of Care","Intended for professional use only","Bronchoalveolar lavage; Sputum; Other","Sputum Sediment","90.00","Yes","Yes","TB detection from sputum (smear negative)","PD-57900","DNA","Independent","Other","Not applicable","67.00","62.00","72.00","98.00","98.00","99.00","Active TB","Sputum","18962","","","","","Test Directory"
"a2v69000004gKqu","a2r69000007lb94","a266900000B8trT","06.07.2023","Sunnyvale","United States","Region of the Americas","cepheid.com","Cepheid","Xpert MTB/RIF","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis","Regulatory Achieved","Brazil ANVISA; CE-IVDD; Israel Ministry of Health; US FDA 510k; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB rpoB gene","qPCR","","Fluorescence","rpoB","rpoB gene contianing the 81 base pair core region (5 probes); for mutations within the rifampicin-resistance determining region (RRDR)","Rifampicin","","Cartridge-based processing","","A proprietary/new instrument is required","Automated (excluding sample preparation)","near Point of Care","Intended for professional use only","Bronchoalveolar lavage; Sputum; Other","Sputum Sediment","90.00","Yes","Yes","RIF detection from sputum","PD-57901","DNA","Independent","Other","Rifampicin","96.00","94.00","97.00","98.00","98.00","99.00","Active TB","Sputum","8020","","","","","Test Directory"
"a2v69000004gKqx","a2r69000007lb95","a266900000B8tra","06.07.2023","Sunnyvale","United States","Region of the Americas","cepheid.com","Cepheid","Xpert MTB/RIF Ultra","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis","Regulatory Achieved","Brazil ANVISA; CE-IVDD; Israel Ministry of Health; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB IS1081; MTB IS6110","qPCR","Melt-curve analysis","Fluorescence","rpoB","RRDR","Rifampicin","","Cartridge-based processing","","A proprietary/new instrument is required","Automated (excluding sample preparation)","near Point of Care","Intended for professional use only","Bronchoalveolar lavage; Sputum; Other","Sputum Sediment","60.00","Yes","Yes","TB detection from sputum","PD-57908","DNA","Independent","Other","","90.00","84.00","94.00","96.00","93.00","97.00","Active TB","Sputum","2654","","","","","Test Directory"
"a2v69000004gKqx","a2r69000007lb95","a266900000C4Gda","06.07.2023","Sunnyvale","United States","Region of the Americas","cepheid.com","Cepheid","Xpert MTB/RIF Ultra","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis","Regulatory Achieved","Brazil ANVISA; CE-IVDD; Israel Ministry of Health; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB IS1081; MTB IS6110","qPCR","Melt-curve analysis","Fluorescence","rpoB","RRDR","Rifampicin","","Cartridge-based processing","","A proprietary/new instrument is required","Automated (excluding sample preparation)","near Point of Care","Intended for professional use only","Bronchoalveolar lavage; Sputum; Other","Sputum Sediment","60.00","Yes","Yes","RIF detection from sputum","PD-69687","DNA","Independent","Other","Rifampicin","94.90","88.90","97.90","99.10","97.70","99.80","Active TB","Sputum","930","","","","","Test Directory"
"a2v69000004gKqz","a2r69000007lb96","a266900000B8trd","06.07.2023","Sunnyvale","United States","Region of the Americas","cepheid.com","Cepheid","Xpert MTB/XDR","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis","Regulatory Achieved","Brazil ANVISA; CE-IVDD; Israel Ministry of Health; WHO recommended","Already on the market (commercialized)","Molecular","DNA","Not applicable","qPCR","","Fluorescence","eis promoter; fabG1; gyrA; gyrB; inhA promoter; katG; oxyR-ahpC intergenic region; rrs","katG and fabG1 genes; oxyR-ahpC intergenic region; inhA promoter only ;gyrA and gyrB quinolone resistance determining region (QRDR) ;rrs gene and eis promoter region (SLID)","Amikacin; Capreomycin; Ethionamide; Fluoroquinolone; Isoniazid; Kanamycin","","Cartridge-based processing","","A proprietary/new instrument is required","Automated (excluding sample preparation)","near Point of Care","Intended for professional use only","Bronchoalveolar lavage; Sputum; Other","Sputum Sediment","90.00","Yes","No","INH detection from sputum","PD-57911","DNA","Company-Sponsored","Instructions for Use (IFU)","Isoniazid","95.20","92.90","96.80","95.60","90.10","98.10","Active TB","Sputum","596","464","132","","","Test Directory"
"a2v69000004gKqz","a2r69000007lb96","a266900000B8tre","06.07.2023","Sunnyvale","United States","Region of the Americas","cepheid.com","Cepheid","Xpert MTB/XDR","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis","Regulatory Achieved","Brazil ANVISA; CE-IVDD; Israel Ministry of Health; WHO recommended","Already on the market (commercialized)","Molecular","DNA","Not applicable","qPCR","","Fluorescence","eis promoter; fabG1; gyrA; gyrB; inhA promoter; katG; oxyR-ahpC intergenic region; rrs","katG and fabG1 genes; oxyR-ahpC intergenic region; inhA promoter only ;gyrA and gyrB quinolone resistance determining region (QRDR) ;rrs gene and eis promoter region (SLID)","Amikacin; Capreomycin; Ethionamide; Fluoroquinolone; Isoniazid; Kanamycin","","Cartridge-based processing","","A proprietary/new instrument is required","Automated (excluding sample preparation)","near Point of Care","Intended for professional use only","Bronchoalveolar lavage; Sputum; Other","Sputum Sediment","90.00","Yes","No","FLQ detection from sputum","PD-57912","DNA","Company-Sponsored","Instructions for Use (IFU)","Fluoroquinolone","94.50","90.70","96.90","95.20","92.50","96.90","Active TB","Sputum","594","226","368","","","Test Directory"
"a2v69000004gKqz","a2r69000007lb96","a266900000B8trf","06.07.2023","Sunnyvale","United States","Region of the Americas","cepheid.com","Cepheid","Xpert MTB/XDR","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis","Regulatory Achieved","Brazil ANVISA; CE-IVDD; Israel Ministry of Health; WHO recommended","Already on the market (commercialized)","Molecular","DNA","Not applicable","qPCR","","Fluorescence","eis promoter; fabG1; gyrA; gyrB; inhA promoter; katG; oxyR-ahpC intergenic region; rrs","katG and fabG1 genes; oxyR-ahpC intergenic region; inhA promoter only ;gyrA and gyrB quinolone resistance determining region (QRDR) ;rrs gene and eis promoter region (SLID)","Amikacin; Capreomycin; Ethionamide; Fluoroquinolone; Isoniazid; Kanamycin","","Cartridge-based processing","","A proprietary/new instrument is required","Automated (excluding sample preparation)","near Point of Care","Intended for professional use only","Bronchoalveolar lavage; Sputum; Other","Sputum Sediment","90.00","Yes","No","AMK detection from sputum","PD-57913","DNA","Company-Sponsored","Instructions for Use (IFU)","Amikacin","87.70","77.50","93.60","98.50","97.00","99.20","Active TB","Sputum","593","65","528","","","Test Directory"
"a2v69000004gKqz","a2r69000007lb96","a266900000B8trg","06.07.2023","Sunnyvale","United States","Region of the Americas","cepheid.com","Cepheid","Xpert MTB/XDR","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis","Regulatory Achieved","Brazil ANVISA; CE-IVDD; Israel Ministry of Health; WHO recommended","Already on the market (commercialized)","Molecular","DNA","Not applicable","qPCR","","Fluorescence","eis promoter; fabG1; gyrA; gyrB; inhA promoter; katG; oxyR-ahpC intergenic region; rrs","katG and fabG1 genes; oxyR-ahpC intergenic region; inhA promoter only ;gyrA and gyrB quinolone resistance determining region (QRDR) ;rrs gene and eis promoter region (SLID)","Amikacin; Capreomycin; Ethionamide; Fluoroquinolone; Isoniazid; Kanamycin","","Cartridge-based processing","","A proprietary/new instrument is required","Automated (excluding sample preparation)","near Point of Care","Intended for professional use only","Bronchoalveolar lavage; Sputum; Other","Sputum Sediment","90.00","Yes","No","KAN detection from sputum","PD-57914","DNA","Company-Sponsored","Instructions for Use (IFU)","Kanamycin","93.70","89.00","96.40","92.40","89.40","94.60","Active TB","Sputum","594","195","399","","","Test Directory"
"a2v69000004gKqz","a2r69000007lb96","a266900000B8trh","06.07.2023","Sunnyvale","United States","Region of the Americas","cepheid.com","Cepheid","Xpert MTB/XDR","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis","Regulatory Achieved","Brazil ANVISA; CE-IVDD; Israel Ministry of Health; WHO recommended","Already on the market (commercialized)","Molecular","DNA","Not applicable","qPCR","","Fluorescence","eis promoter; fabG1; gyrA; gyrB; inhA promoter; katG; oxyR-ahpC intergenic region; rrs","katG and fabG1 genes; oxyR-ahpC intergenic region; inhA promoter only ;gyrA and gyrB quinolone resistance determining region (QRDR) ;rrs gene and eis promoter region (SLID)","Amikacin; Capreomycin; Ethionamide; Fluoroquinolone; Isoniazid; Kanamycin","","Cartridge-based processing","","A proprietary/new instrument is required","Automated (excluding sample preparation)","near Point of Care","Intended for professional use only","Bronchoalveolar lavage; Sputum; Other","Sputum Sediment","90.00","Yes","No","CAP detection from sputum","PD-57915","DNA","Company-Sponsored","Instructions for Use (IFU)","Capreomycin","75.40","64.00","84.00","99.60","98.60","99.90","Active TB","Sputum","595","54","541","","","Test Directory"
"a2v69000004gKqz","a2r69000007lb96","a266900000B8tri","06.07.2023","Sunnyvale","United States","Region of the Americas","cepheid.com","Cepheid","Xpert MTB/XDR","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis","Regulatory Achieved","Brazil ANVISA; CE-IVDD; Israel Ministry of Health; WHO recommended","Already on the market (commercialized)","Molecular","DNA","Not applicable","qPCR","","Fluorescence","eis promoter; fabG1; gyrA; gyrB; inhA promoter; katG; oxyR-ahpC intergenic region; rrs","katG and fabG1 genes; oxyR-ahpC intergenic region; inhA promoter only ;gyrA and gyrB quinolone resistance determining region (QRDR) ;rrs gene and eis promoter region (SLID)","Amikacin; Capreomycin; Ethionamide; Fluoroquinolone; Isoniazid; Kanamycin","","Cartridge-based processing","","A proprietary/new instrument is required","Automated (excluding sample preparation)","near Point of Care","Intended for professional use only","Bronchoalveolar lavage; Sputum; Other","Sputum Sediment","90.00","Yes","No","ETH detection from sputum","PD-57916","DNA","Company-Sponsored","Instructions for Use (IFU)","Ethionamide","55.00","49.50","60.30","93.80","90.30","96.10","Active TB","Sputum","597","194","403","","","Test Directory"
"a2v69000004gKsB","a2r69000007lbFE","a266900000B8ttY","06.07.2023","Abingdon","United Kingdom","European Region","oxfordimmunotec.com","Oxford Immunotec Limited","T-SPOT.TB","Triage/Screening","ID","Tuberculosis","Latent","Mycobacterium Tuberculosis","Regulatory Achieved","CE-IVDD; WHO recommended","Already on the market (commercialized)","Immunoassay","Antigen","MTB CFP-10; MTB ESAT-6","ELISA/EIA; IGRA","Eli-Spot","Colorimetric","Not applicable","","Not applicable","","Unspecified","","A proprietary/new instrument is optional","Automated (excluding sample preparation)","Lab-based","Intended for professional use only","Whole Blood","","","Yes","No","","PD-58030","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gKqb","a2r69000007lbLJ","a266900000C4GdB","06.07.2023","Des Plaines","United States","Region of the Americas","abbottmolecular.com/home.html","Abbott Molecular","Abbott RealTime MTB","Diagnostic/confirmatory test","ID","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB IS6110; MTB pab gene","qPCR","","Fluorescence","Not applicable","","Not applicable","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Automated (excluding sample preparation)","Lab-based","Intended for professional use only","Bronchoalveolar lavage; Sputum; Other","NALC treated sputum and bronchialalveolar lavages","","Yes","Yes","TB detection from sputum","PD-69681","DNA","Independent","Systematic review + Meta-analysis","","96.20","90.20","98.60","97.10","93.70","98.70","Active TB","Sputum","4858","","","","WHO recommended","Test Directory"
"a2v69000004gKqa","a2r69000007lb6C","a266900000B8tqn","06.07.2023","Des Plaines","United States","Region of the Americas","abbottmolecular.com/home.html","Abbott Molecular","Abbott RealTime MTB RIF/INH","Diagnostic/confirmatory test","AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","Brazil ANVISA; CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","Not applicable","qPCR","","Fluorescence","inhA promoter; katG; rpoB","RRDR; KatG PR; INH PR","Isoniazid; Rifampicin","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Automated (excluding sample preparation)","Lab-based","Intended for professional use only","Bronchoalveolar lavage; Sputum; Other","NALC treated sputum and bronchialalveolar lavages","","Yes","No","RIF resistance from sputum","PD-57859","DNA","Company-Sponsored","Instructions for Use (IFU)","Rifampicin","94.80","88.30","98.30","100.00","97.00","100.00","Active TB","Sputum","216","91","125","","WHO recommended","Test Directory"
"a2v69000004gKqa","a2r69000007lb6C","a266900000B8tqo","06.07.2023","Des Plaines","United States","Region of the Americas","abbottmolecular.com/home.html","Abbott Molecular","Abbott RealTime MTB RIF/INH","Diagnostic/confirmatory test","AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","Brazil ANVISA; CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","Not applicable","qPCR","","Fluorescence","inhA promoter; katG; rpoB","RRDR; KatG PR; INH PR","Isoniazid; Rifampicin","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Automated (excluding sample preparation)","Lab-based","Intended for professional use only","Bronchoalveolar lavage; Sputum; Other","NALC treated sputum and bronchialalveolar lavages","","Yes","No","INH resistance from sputum","PD-57860","DNA","Company-Sponsored","Instructions for Use (IFU)","Isoniazid","88.30","80.00","94.00","94.30","88.60","97.70","Active TB","Sputum","217","90","127","","WHO recommended","Test Directory"
"a2v69000004gKqa","a2r69000007lb6C","a266900000C4GdG","06.07.2023","Des Plaines","United States","Region of the Americas","abbottmolecular.com/home.html","Abbott Molecular","Abbott RealTime MTB RIF/INH","Diagnostic/confirmatory test","AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","Brazil ANVISA; CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","Not applicable","qPCR","","Fluorescence","inhA promoter; katG; rpoB","RRDR; KatG PR; INH PR","Isoniazid; Rifampicin","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Automated (excluding sample preparation)","Lab-based","Intended for professional use only","Bronchoalveolar lavage; Sputum; Other","NALC treated sputum and bronchialalveolar lavages","","Yes","Yes","RIF resistance from sputum & culture isolates","PD-69682","DNA","Independent","Systematic review + Meta-analysis","Rifampicin","94.00","89.00","99.00","100.00","99.00","100.00","Active TB","Sputum; Sputum Culture","1008","","","","WHO recommended","Test Directory"
"a2v69000004gKqa","a2r69000007lb6C","a266900000C4GdL","06.07.2023","Des Plaines","United States","Region of the Americas","abbottmolecular.com/home.html","Abbott Molecular","Abbott RealTime MTB RIF/INH","Diagnostic/confirmatory test","AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","Brazil ANVISA; CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","Not applicable","qPCR","","Fluorescence","inhA promoter; katG; rpoB","RRDR; KatG PR; INH PR","Isoniazid; Rifampicin","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Automated (excluding sample preparation)","Lab-based","Intended for professional use only","Bronchoalveolar lavage; Sputum; Other","NALC treated sputum and bronchialalveolar lavages","","Yes","Yes","INH resistance from sputum & culture isolates","PD-69683","DNA","Independent","Systematic review + Meta-analysis","Isoniazid","89.00","86.00","92.00","99.00","98.00","100.00","Active TB","Sputum; Sputum Culture","1013","","","","WHO recommended","Test Directory"
"a2v69000004gKqe","a2r69000007lbEr","a266900000B8tqy","06.07.2023","Franklin Lakes","United States","Region of the Americas","bd.com","Becton, Dickinson and Company (BD)","BD MAX MDR-TB","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB IS1081; MTB IS6110","qPCR","","Fluorescence","inhA promoter; katG; rpoB","RDR codons 507-533 Escherichia coli nomenclature (426-452 Mtb nomenclature) of the rpoB gene; inhA promoter region; 315 codon of the katG gene","Isoniazid; Rifampicin","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Automated (excluding sample preparation)","Lab-based","Intended for professional use only","Sputum; Other","Sputum Sediment","240.00","Yes","No","TB detection","PD-57870","DNA","Company-Sponsored","Instructions for Use (IFU)","Not applicable","94.50","91.70","96.40","94.90","91.10","97.10","Active TB","Sputum","596","371","225","","WHO recommended","Test Directory"
"a2v69000004gKqe","a2r69000007lbEr","a266900000B8tqz","06.07.2023","Franklin Lakes","United States","Region of the Americas","bd.com","Becton, Dickinson and Company (BD)","BD MAX MDR-TB","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB IS1081; MTB IS6110","qPCR","","Fluorescence","inhA promoter; katG; rpoB","RDR codons 507-533 Escherichia coli nomenclature (426-452 Mtb nomenclature) of the rpoB gene; inhA promoter region; 315 codon of the katG gene","Isoniazid; Rifampicin","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Automated (excluding sample preparation)","Lab-based","Intended for professional use only","Sputum; Other","Sputum Sediment","240.00","Yes","No","RIF resistance from sputum","PD-57871","DNA","Company-Sponsored","Instructions for Use (IFU)","Rifampicin","100.00","87.10","100.00","100.00","98.20","100.00","Active TB","Sputum","232","26","206","","WHO recommended","Test Directory"
"a2v69000004gKqe","a2r69000007lbEr","a266900000B8tr0","06.07.2023","Franklin Lakes","United States","Region of the Americas","bd.com","Becton, Dickinson and Company (BD)","BD MAX MDR-TB","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB IS1081; MTB IS6110","qPCR","","Fluorescence","inhA promoter; katG; rpoB","RDR codons 507-533 Escherichia coli nomenclature (426-452 Mtb nomenclature) of the rpoB gene; inhA promoter region; 315 codon of the katG gene","Isoniazid; Rifampicin","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Automated (excluding sample preparation)","Lab-based","Intended for professional use only","Sputum; Other","Sputum Sediment","240.00","Yes","No","INH detection from sputum","PD-57872","DNA","Company-Sponsored","Instructions for Use (IFU)","Isoniazid","100.00","91.80","100.00","100.00","98.10","100.00","Active TB","Sputum","242","43","199","","WHO recommended","Test Directory"
"a2v69000004gKqe","a2r69000007lbEr","a266900000C4GdM","06.07.2023","Franklin Lakes","United States","Region of the Americas","bd.com","Becton, Dickinson and Company (BD)","BD MAX MDR-TB","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB IS1081; MTB IS6110","qPCR","","Fluorescence","inhA promoter; katG; rpoB","RDR codons 507-533 Escherichia coli nomenclature (426-452 Mtb nomenclature) of the rpoB gene; inhA promoter region; 315 codon of the katG gene","Isoniazid; Rifampicin","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Automated (excluding sample preparation)","Lab-based","Intended for professional use only","Sputum; Other","Sputum Sediment","240.00","Yes","Yes","INH detection from sputum","PD-69686","DNA","Independent","Systematic review + Meta-analysis","Isoniazid","82.00","63.00","92.00","100.00","98.00","100.00","Active TB","Sputum","232","","","","WHO recommended","Test Directory"
"a2v69000004gKqe","a2r69000007lbEr","a266900000C4GdQ","06.07.2023","Franklin Lakes","United States","Region of the Americas","bd.com","Becton, Dickinson and Company (BD)","BD MAX MDR-TB","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB IS1081; MTB IS6110","qPCR","","Fluorescence","inhA promoter; katG; rpoB","RDR codons 507-533 Escherichia coli nomenclature (426-452 Mtb nomenclature) of the rpoB gene; inhA promoter region; 315 codon of the katG gene","Isoniazid; Rifampicin","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Automated (excluding sample preparation)","Lab-based","Intended for professional use only","Sputum; Other","Sputum Sediment","240.00","Yes","Yes","TB detection from sputum","PD-69684","DNA","Independent","Systematic review + Meta-analysis","Not applicable","93.00","89.00","96.00","97.00","96.00","98.00","Active TB","Sputum","892","","","","WHO recommended","Test Directory"
"a2v69000004gKqe","a2r69000007lbEr","a266900000C4GdV","06.07.2023","Franklin Lakes","United States","Region of the Americas","bd.com","Becton, Dickinson and Company (BD)","BD MAX MDR-TB","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB IS1081; MTB IS6110","qPCR","","Fluorescence","inhA promoter; katG; rpoB","RDR codons 507-533 Escherichia coli nomenclature (426-452 Mtb nomenclature) of the rpoB gene; inhA promoter region; 315 codon of the katG gene","Isoniazid; Rifampicin","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Automated (excluding sample preparation)","Lab-based","Intended for professional use only","Sputum; Other","Sputum Sediment","240.00","Yes","Yes","RIF detection from sputum","PD-69685","DNA","Independent","Systematic review + Meta-analysis","Rifampicin","90.00","55.00","100.00","95.00","91.00","97.00","Active TB","Sputum","232","","","","WHO recommended","Test Directory"
"a2v69000004gKrM","a2r69000007lbEs","a266900000B8tr9","06.07.2023","Daejeon","Korea, Republic of","Western Pacific Region","bioneer.com","Bioneer Corporation","AccuPower TB&MDR RealTime PCR kit-A","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis","Regulatory Achieved","CE-IVDD","Already on the market (commercialized)","Molecular","DNA","MTB IS6110","qPCR","","Fluorescence","fabG1; inhA; katG; oxyR-ahpC intergenic region; rpoB","","Isoniazid; Rifampicin","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Unknown","near Point of Care","Intended for professional use only","Bronchoalveolar lavage; Sputum; Urine","","","Yes","No","","PD-57881","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gKrL","a2r69000007lbEs","a266900000B8tr8","06.07.2023","Daejeon","Korea, Republic of","Western Pacific Region","bioneer.com","Bioneer Corporation","AccuPower TB&MDR RealTime PCR kit-A","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis","Regulatory Achieved","CE-IVDD","Already on the market (commercialized)","Molecular","DNA","MTB IS6110","qPCR","","Fluorescence","fabG1; inhA; katG; oxyR-ahpC intergenic region; rpoB","","Isoniazid; Rifampicin","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Unknown","near Point of Care","Intended for professional use only","Bronchoalveolar lavage; Sputum; Urine","","","Yes","No","","PD-57880","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gKrO","a2r69000007lbF4","a266900000B8trB","06.07.2023","Daejeon","Korea, Republic of","Western Pacific Region","bioneer.com","Bioneer Corporation","AccuPower XDR-TB RealTime PCR kit-A","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis","Regulatory Achieved","CE-IVDD","Already on the market (commercialized)","Molecular","DNA","MTB IS6110","qPCR","","Fluorescence","gyrA; gyrB; rrs","","Amikacin; Fluoroquinolone; Kanamycin","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Unknown","near Point of Care","Intended for professional use only","Bronchoalveolar lavage; Sputum; Sputum Culture","","","Yes","No","","PD-57883","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gKrN","a2r69000007lbF4","a266900000B8trA","06.07.2023","Daejeon","Korea, Republic of","Western Pacific Region","bioneer.com","Bioneer Corporation","AccuPower XDR-TB RealTime PCR kit-A","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis","Regulatory Achieved","CE-IVDD","Already on the market (commercialized)","Molecular","DNA","MTB IS6110","qPCR","","Fluorescence","gyrA; gyrB; rrs","","Amikacin; Fluoroquinolone; Kanamycin","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Unknown","near Point of Care","Intended for professional use only","Bronchoalveolar lavage; Sputum; Sputum Culture","","","Yes","No","","PD-57882","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gKrQ","a2r69000007lbF5","a266900000B8trD","06.07.2023","Daejeon","Korea, Republic of","Western Pacific Region","bioneer.com","Bioneer Corporation","AccuPower XDR-TB RealTime PCR kit-B","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis","Regulatory Achieved","CE-IVDD","Already on the market (commercialized)","Molecular","DNA","MTB IS6110","qPCR","","Fluorescence","embB; rpsL","","Ethambutol; Streptomycin","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Unknown","near Point of Care","Intended for professional use only","Bronchoalveolar lavage; Sputum; Sputum Culture","","","Yes","No","","PD-57885","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gKrP","a2r69000007lbF5","a266900000B8trC","06.07.2023","Daejeon","Korea, Republic of","Western Pacific Region","bioneer.com","Bioneer Corporation","AccuPower XDR-TB RealTime PCR kit-B","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis","Regulatory Achieved","CE-IVDD","Already on the market (commercialized)","Molecular","DNA","MTB IS6110","qPCR","","Fluorescence","embB; rpsL","","Ethambutol; Streptomycin","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Unknown","near Point of Care","Intended for professional use only","Bronchoalveolar lavage; Sputum; Sputum Culture","","","Yes","No","","PD-57884","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gLVH","a2r69000007lbFM","a266900000B8tu1","06.07.2023","Pune","India","South-East Asian Region","seruminstitute.com","Serum Institute of India","Cy-Tb skin test","Triage/Screening","ID","Tuberculosis","Latent","Mycobacterium Tuberculosis","Regulatory Achieved","WHO recommended","Already on the market (commercialized)","Immunoassay","Antigen","MTB CFP-10; MTB ESAT-6","Host Immune Response","Skin test","Colorimetric","Not applicable","","Not applicable","","Other","Injectable","No instrumentation is required","Manual","True Point of Care","Intended for professional use only","Other","injection under skin","","Yes","No","","PD-58059","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gLUF","a2r69000007lbLA","a266900000B8ttv","06.07.2023","Suwon-si","Korea, Republic of","Western Pacific Region","sdbiosensor.com","SD Biosensor, Inc.","Standard F TB LAM Ag FIA","Diagnostic/confirmatory test","ID","Tuberculosis","Active","Mycobacterium Tuberculosis","Late Stage Development (fully functional prototype)","None","Unspecified Market Entry","Immunoassay","Antigen","Lipoarabinomannan (LAM)","Lateral Flow Assay","","Fluorescence","Not applicable","","Not applicable","","Rapid diagnostic test (strip or cassette)","","No instrumentation is required","Manual","True Point of Care","Intended for professional use only","Urine","","","Yes","No","","PD-58053","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gLTq","a2r69000007lbFJ","a266900000B8tts","06.07.2023","Madison","United States","Region of the Americas","salusd.com","Salus Discovery","FLOW TB Urine LAM Assay","Triage/Screening","ID","Tuberculosis","Active","Mycobacterium Tuberculosis","Late Stage Development (fully functional prototype)","None","Unspecified Market Entry","Immunoassay","Antigen","Lipoarabinomannan (LAM)","Lateral Flow Assay","","Colorimetric","Not applicable","","Not applicable","","Rapid diagnostic test (strip or cassette)","","No instrumentation is required","Manual","True Point of Care","Intended for professional use only","Urine","","","Yes","No","","PD-58050","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000003LBpe","a2r69000006Skdn","a266900000BsdtA","10.10.2023","Beijing","China","Western Pacific Region","ystwt.cn","Beijing Wantai Biological Pharmacy Enterprise Co., Ltd","Wantai TB-IGRA","Triage/Screening","ID","Tuberculosis","Latent","Mycobacterium Tuberculosis","Regulatory Achieved","China NMPA; WHO recommended","Already on the market (commercialized)","Immunoassay","Antigen","Interferon Gamma","ELISA/EIA; IGRA","","Colorimetric","Not applicable","","Not applicable","","IA Reagent Kit","","Standard lab instrumentation is required","Manual","Lab-based","Intended for professional use only","Whole Blood","","","Yes","No","","PD-69673","","","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gKxz","a2r69000007lbLH","a266900000B8tqt","06.07.2023","HeBei","China","Western Pacific Region","atlas-link.com","Atlas Link Technology Co., Ltd.","NOVA Test Tuberculosis IGG/IGM Tri-line Test","Triage/Screening","ID","Tuberculosis","Active","Mycobacterium Tuberculosis","Research Use Only (RUO)","None","Already on the market (commercialized)","Immunoassay","Antibody (serological)","MTB IgG; MTB IgM","Lateral Flow Assay","","Colorimetric","Not applicable","","Not applicable","","Rapid diagnostic test (strip or cassette)","","No instrumentation is required","Manual","True Point of Care","Intended for professional use only","Plasma; Serum; Whole Blood","","15.00","Yes","No","","PD-57865","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gKy0","a2r69000007lbLI","a266900000B8tqu","06.07.2023","HeBei","China","Western Pacific Region","atlas-link.com","Atlas Link Technology Co., Ltd.","NOVA Test Tuberculosis Antibody Test","Triage/Screening","ID","Tuberculosis","Active","Mycobacterium Tuberculosis","Research Use Only (RUO)","None","Already on the market (commercialized)","Immunoassay","Antibody (serological)","Unknown","Lateral Flow Assay","","Colorimetric","Not applicable","","Not applicable","","Rapid diagnostic test (strip or cassette)","","No instrumentation is required","Manual","True Point of Care","Intended for professional use only","Serum","","15.00","Yes","No","","PD-57866","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gKwm","a2r69000007lbLK","a266900000B8tqr","06.07.2023","Anhui","China","Western Pacific Region","zflongkema.com","Anhui Zhifei Longcom Biopharmaceutical Co. Ltd.","Recombinant mycobacterium tuberculosis fusion protein(EC)n","Triage/Screening","ID","Tuberculosis","Latent","Mycobacterium Tuberculosis","Regulatory Achieved","CE-IVDD; WHO recommended","Already on the market (commercialized)","Immunoassay","Antigen","PPD tuberculin","Host Immune Response","Skin test","Colorimetric","Not applicable","","Not applicable","","Other","Injectable","No instrumentation is required","Manual","True Point of Care","Intended for professional use only","Other","injection under skin","","Yes","No","","PD-57863","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gKwp","a2r69000007lbLL","a266900000B8tqs","06.07.2023","Cape Town","South Africa","African Region","antrumbiotech.co","Antrum Biotech","IRISA-TB","Triage/Screening","ID","Tuberculosis","Latent","Mycobacterium Tuberculosis","Late Stage Development (fully functional prototype)","None","Unspecified Market Entry","Immunoassay","Antigen","Interferon Gamma","ELISA/EIA; IGRA","","Colorimetric","Not applicable","","Not applicable","","Chemiluminescent Immunoassay (CLIA)","","Standard lab instrumentation is required","Manual","Lab-based","Intended for professional use only","Cerebrospinal fluid (CSF); Other","Pleural fluid; Pericardial fluid; Peritoneal fluid;","120.00","Yes","No","","PD-57864","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gLdD","a2r69000007lb6F","a266900000B8tu6","06.07.2023","Xiamen City","China","Western Pacific Region","zeesandx.com","Xiamen Zeesan Biotech Co., ltd.","MeltPro MTB/RIF Test Kit","Diagnostic/confirmatory test","AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","CE-IVDD; Other","Already on the market (commercialized)","Molecular","DNA","Not applicable","qPCR","Melt-curve analysis","Fluorescence","rpoB","rpoB codons 507~533","Rifampicin","","NAT reagent kit (proprietary platform)","","Standard lab instrumentation is required","Manual","Lab-based","Intended for professional use only","Sputum; Sputum Culture","","","Yes","No","","PD-58064","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","China CDFA","Test Directory"
"a2v69000004gLdC","a2r69000007lb6B","a266900000B8tu5","06.07.2023","Xiamen City","China","Western Pacific Region","zeesandx.com","Xiamen Zeesan Biotech Co., ltd.","MeltPro MTB/SL Test Kit","Diagnostic/confirmatory test","AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","CE-IVDD","Already on the market (commercialized)","Molecular","DNA","Not applicable","qPCR","Melt-curve analysis","Fluorescence","eis promoter; rrs","rrs (positions 1401; 1402 and 1484) and eis promoter region (positions -37; -14 and -10)","Amikacin; Capreomycin; Kanamycin","","NAT reagent kit (proprietary platform)","","Standard lab instrumentation is required","Manual","Lab-based","Intended for professional use only","Sputum; Sputum Culture","","","Yes","No","","PD-58063","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gLdF","a2r69000007lb6H","a266900000B8tu8","06.07.2023","Xiamen City","China","Western Pacific Region","zeesandx.com","Xiamen Zeesan Biotech Co., ltd.","MeltPro MTB/INH Test Kit","Diagnostic/confirmatory test","AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","CE-IVDD; Other","Already on the market (commercialized)","Molecular","DNA","Not applicable","qPCR","Melt-curve analysis","Fluorescence","inhA; inhA promoter; oxyR-ahpC intergenic region","ahpC promoter region (positions -44~-30 and -15~3); inhA codon 94; inhA promoter region (positions -17~-8); and katG codon 315","Isoniazid","","NAT reagent kit (proprietary platform)","","Standard lab instrumentation is required","Manual","Lab-based","Intended for professional use only","Sputum; Sputum Culture","","","Yes","No","","PD-58066","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","China CDFA","Test Directory"
"a2v69000004gLdE","a2r69000007lb6G","a266900000B8tu7","06.07.2023","Xiamen City","China","Western Pacific Region","zeesandx.com","Xiamen Zeesan Biotech Co., ltd.","MeltPro MTB/STR Test Kit","Diagnostic/confirmatory test","AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","CE-IVDD; Other","Already on the market (commercialized)","Molecular","DNA","Not applicable","qPCR","Melt-curve analysis","Fluorescence","rpsL","codon 43 and codon 88; rrs positions 513 - 517 and positions 905 - 908","Streptomycin","","NAT reagent kit (proprietary platform)","","Standard lab instrumentation is required","Manual","Lab-based","Intended for professional use only","Sputum; Sputum Culture","","","Yes","No","","PD-58065","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","China CDFA","Test Directory"
"a2v69000004gLdH","a2r69000007lb6J","a266900000B8tuA","06.07.2023","Xiamen City","China","Western Pacific Region","zeesandx.com","Xiamen Zeesan Biotech Co., ltd.","MeltPro MTB/FQ Test Kit","Diagnostic/confirmatory test","AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","CE-IVDD; Other","Already on the market (commercialized)","Molecular","DNA","Not applicable","qPCR","Melt-curve analysis","Fluorescence","gyrA","gyrA codons 88~94","Fluoroquinolone","","NAT reagent kit (proprietary platform)","","Standard lab instrumentation is required","Manual","Lab-based","Intended for professional use only","Sputum; Sputum Culture","","","Yes","No","","PD-58068","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","China CDFA","Test Directory"
"a2v69000004gLdG","a2r69000007lb6I","a266900000B8tu9","06.07.2023","Xiamen City","China","Western Pacific Region","zeesandx.com","Xiamen Zeesan Biotech Co., ltd.","MeltPro MTB/EMB Test Kit","Diagnostic/confirmatory test","AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","CE-IVDD; Other","Already on the market (commercialized)","Molecular","DNA","Not applicable","qPCR","Melt-curve analysis","Fluorescence","embB","embB codons 306; 368; 378; 380; 406; 497","Ethambutol","","NAT reagent kit (proprietary platform)","","Standard lab instrumentation is required","Manual","Lab-based","Intended for professional use only","Sputum; Sputum Culture","","","Yes","No","","PD-58067","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","China CDFA","Test Directory"
"a2v69000004gLdJ","a2r69000007lbFP","a266900000B8tuC","06.07.2023","Xiamen City","China","Western Pacific Region","zeesandx.com","Xiamen Zeesan Biotech Co., ltd.","MeltPro Mycobacteria Identification Kit","Diagnostic/confirmatory test","ID","Tuberculosis","Active","Mycobacterium Tuberculosis","Regulatory Achieved","CE-IVDD","Already on the market (commercialized)","Molecular","DNA","MTB ITS","qPCR","Melt-curve analysis","Fluorescence","Not applicable","","Not applicable","","NAT reagent kit (proprietary platform)","","Standard lab instrumentation is required","Manual","Lab-based","Intended for professional use only","Sputum; Sputum Culture","","","Yes","No","","PD-58070","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gLdI","a2r69000007lbFO","a266900000B8tuB","06.07.2023","Xiamen City","China","Western Pacific Region","zeesandx.com","Xiamen Zeesan Biotech Co., ltd.","MeltPro TB Assay","Diagnostic/confirmatory test","ID","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","Other","Already on the market (commercialized)","Molecular","DNA","MTB IS6110","qPCR","","Fluorescence","Not applicable","","Not applicable","","NAT reagent kit (proprietary platform)","","Standard lab instrumentation is required","Manual","Lab-based","Intended for professional use only","Bronchoalveolar lavage; Sputum","","","Yes","No","","PD-58069","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","China CDFA","Test Directory"
"a2v69000004gLdK","a2r69000007lbFQ","a266900000B8tuD","06.07.2023","Xiamen City","China","Western Pacific Region","zeesandx.com","Xiamen Zeesan Biotech Co., ltd.","MeltPro Mycobacterium Tuberculosis McSpoligotyping Kit","Diagnostic/confirmatory test","ID","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Research Use Only (RUO)","None","Already on the market (commercialized)","Molecular","DNA","Other","qPCR","Melt-curve analysis","Fluorescence","Not applicable","","Not applicable","","NAT reagent kit (proprietary platform)","","Standard lab instrumentation is required","Manual","Lab-based","Intended for professional use only","Sputum; Sputum Culture","","","Yes","No","","PD-58071","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gLhg","a2r69000007lb8t","a266900000B8ttD","13.07.2023","Bavaria","Germany","European Region","mikrogen.de","Mikrogen GmbH","T-Track TB part 2 - T-Track TB Quant PCR","Triage/Screening","ID","Tuberculosis","Latent","Mycobacterium Tuberculosis","Regulatory Achieved","CE-IVDD","Already on the market (commercialized)","Molecular","RNA","Interferon Gamma; Other","qPCR","","Fluorescence","Not applicable","","Not applicable","","NAT reagent kit (open source)","","A proprietary/new instrument is optional","Manual","Lab-based","Intended for professional use only","Purified RNA","","180.00","Yes","No","","PD-58009","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gLht","a2r69000007lb8w","a266900000B8ttl","13.07.2023","Borstel","Germany","European Region","fz-borstel.de/index.php/en","Research Center Borstel","TB22 signature in-house assay","Monitoring (treatment, immune status, patient)","Host Response","Tuberculosis","Active","Mycobacterium Tuberculosis","Early Stage Development (partial prototype)","None","Unspecified Market Entry","Molecular","mRNA","Unknown","qPCR","","Fluorescence","Not applicable","","Not applicable","","Unspecified","","Unknown","Unknown","Lab-based","Intended for professional use only","Whole Blood","","","Yes","No","","PD-58043","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gLhs","a2r69000007lb8z","a266900000B8tth","13.07.2023","Newcastle upon Tyne","United Kingdom","European Region","quantumdx.com","QuantuMDx Group Limited","RISK 6 host response assay","Monitoring (treatment, immune status, patient)","Host Response","Tuberculosis","Active","Mycobacterium Tuberculosis","Early Stage Development (partial prototype)","None","Unspecified Market Entry","Molecular","mRNA","Unknown","qPCR","","Fluorescence","Not applicable","","Not applicable","","Unspecified","","Unknown","Unknown","Lab-based","Intended for professional use only","Finger prick blood","","","Yes","No","","PD-58039","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gLhf","a2r69000007lbEy","a266900000B8ttC","13.07.2023","Bavaria","Germany","European Region","mikrogen.de","Mikrogen GmbH","T-Track TB part 1 - T-Track TB Stimulation","Triage/Screening","ID","Tuberculosis","Latent","Mycobacterium Tuberculosis","Regulatory Achieved","CE-IVDD","Already on the market (commercialized)","Immunoassay","Antigen","MTB CFP-10; MTB ESAT-6","Other","part 1 of 2 test kit; activation and incubation","Fluorescence","Not applicable","","Not applicable","","Other","Stimulation/incubation","A proprietary/new instrument is optional","Manual","Lab-based","Intended for professional use only","Whole Blood","Blood stimulation tubes","1440.00","Yes","No","","PD-58008","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gLAd","a2r69000007lbL8","a266900000B8ts8","06.07.2023","Pleasanton","United States","Region of the Americas","Genendeavor.com","GenEndeavor llc","RidTB","Triage/Screening","ID","Tuberculosis","Active","Mycobacterium Tuberculosis","Late Stage Development (fully functional prototype)","None","Unspecified Market Entry","Molecular","DNA","MTB IS6110","Other","lateral flow nucleic acid Assay","Colorimetric","Not applicable","","Not applicable","","Rapid diagnostic test (strip or cassette)","","Standard lab instrumentation is required","Manual","near Point of Care","Intended for professional use only","Saliva; Urine","","","Yes","No","","PD-57942","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gL8w","a2r69000007lb8p","a266900000B8ts7","06.07.2023","Yangzhou","China","Western Pacific Region","http://www.genenexus.com/","Erythra Inc.","Erythra-TB-KIT","Triage/Screening","ID","Tuberculosis","Active","Mycobacterium Tuberculosis","Research Use Only (RUO)","None","Already on the market (commercialized)","Immunoassay","Antigen","Other","Lateral Flow Assay","","Colorimetric","Not applicable","","Not applicable","","Rapid diagnostic test (strip or cassette)","","No instrumentation is required","Manual","near Point of Care","Intended for professional use only","Other","Heamolysate","5.00","Yes","No","","PD-57941","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gL8a","a2r69000007lb8j","a266900000B8trz","06.07.2023","Otawara","Japan","Western Pacific Region","eiken.co.jp","Eiken Chemical Co., Ltd.","Loopamp MTBC Detection Kit","Diagnostic/confirmatory test","ID","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","CE-IVDR; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB gyrB Gene; Other","Isothermal LAMP","","Fluorescence","Not applicable","","Not applicable","","NAT reagent kit (open source)","","Standard lab instrumentation is required","Manual","near Point of Care","Intended for professional use only","Sputum","","40.00","Yes","No","","PD-57933","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","WHO recommended","Test Directory"
"a2v69000004gKl5","a2r69000007lbEz","a266900000B8ttN","06.07.2023","Pune","India","South-East Asian Region","mylabglobal.com","Mylab Discovery Solutions Pvt. Ltd.","PathoDetect MTB Detection kit","Diagnostic/confirmatory test","ID","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Research Use Only (RUO)","None","Already on the market (commercialized)","Molecular","DNA","MTB IS6110","qPCR","","Fluorescence","Not applicable","","Not applicable","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Unknown","near Point of Care","Intended for professional use only","Sputum; Sputum Culture; Other","EPTB specimen","80.00","Yes","No","","PD-58019","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gKl6","a2r69000007lbF0","a266900000B8ttO","06.07.2023","Pune","India","South-East Asian Region","mylabglobal.com","Mylab Discovery Solutions Pvt. Ltd.","PathoDetect MTB RIF and INH resistance detection kit","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Research Use Only (RUO)","None","Already on the market (commercialized)","Molecular","DNA","MTB IS6110","qPCR","","Fluorescence","Unknown","","Isoniazid; Rifampicin","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Unknown","near Point of Care","Intended for professional use only","Sputum; Sputum Culture; Other","EPTB specimen","80.00","Yes","No","","PD-58020","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gKl9","a2r69000007lb68","a266900000B8ttG","06.07.2023","Verna Industrial Estate, Verna,","India","South-East Asian Region","molbiodiagnostics.com","Molbio Diagnostics Pvt. Ltd.","Truenat MTB-BDQ","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis","Late Stage Development (fully functional prototype)","None","Unspecified Market Entry","Molecular","DNA","Not applicable","qPCR","","Fluorescence","atpE","","Bedaquiline","","Cartridge-based processing","chip based","A proprietary/new instrument is required","Automated (excluding sample preparation)","near Point of Care","Intended for professional use only","Purified DNA","Sputum or EPTB specimen","","Yes","No","","PD-58012","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gKl8","a2r69000007lb67","a266900000B8ttF","06.07.2023","Verna Industrial Estate, Verna,","India","South-East Asian Region","molbiodiagnostics.com","Molbio Diagnostics Pvt. Ltd.","Truenat MTB-FQ","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis","Late Stage Development (fully functional prototype)","None","Unspecified Market Entry","Molecular","DNA","Not applicable","qPCR","","Fluorescence","gyrA","","Fluoroquinolone","","Cartridge-based processing","chip based","A proprietary/new instrument is required","Automated (excluding sample preparation)","near Point of Care","Intended for professional use only","Purified DNA","Sputum or EPTB specimen","","Yes","No","","PD-58011","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gKjO","a2r69000007lbL5","a266900000B8tr2","06.07.2023","Pasadena","United States","Region of the Americas","beckmancoulter.com","Beckman Coulter Inc.","T cell activation marker (TAM-TB) assay","Monitoring (treatment, immune status, patient)","ID","Tuberculosis","Active","Mycobacterium Tuberculosis","Early Stage Development (partial prototype)","None","Unspecified Market Entry","Immunoassay","Antigen","Other","Flow Cytometry","","Fluorescence","Not applicable","","Not applicable","","Other","Flow cytometry","A proprietary/new instrument is required","Unknown","Lab-based","Intended for professional use only","Whole Blood","","","Yes","No","","PD-57874","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gKjN","a2r69000007lbL5","a266900000B8tr1","06.07.2023","Pasadena","United States","Region of the Americas","beckmancoulter.com","Beckman Coulter Inc.","T cell activation marker (TAM-TB) assay","Monitoring (treatment, immune status, patient)","ID","Tuberculosis","Active","Mycobacterium Tuberculosis","Early Stage Development (partial prototype)","None","Unspecified Market Entry","Immunoassay","Antigen","Other","Flow Cytometry","","Fluorescence","Not applicable","","Not applicable","","Other","Flow cytometry","A proprietary/new instrument is required","Unknown","Lab-based","Intended for professional use only","Whole Blood","","","Yes","No","","PD-57873","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gLKB","a2r69000007lbL9","a266900000B8tt9","06.07.2023","Minato-ku","Japan","Western Pacific Region","medience.co.jp","LSI Medience Corporation","PATHFAST-LAM","Triage/Screening; Monitoring (treatment, immune status, patient)","ID","Tuberculosis","Active","Mycobacterium Tuberculosis","Late Stage Development (fully functional prototype)","None","Unspecified Market Entry","Immunoassay","Antigen","Lipoarabinomannan (LAM)","Lateral Flow Assay","","Colorimetric","Not applicable","","Not applicable","","Rapid diagnostic test (strip or cassette)","","No instrumentation is required","Manual","True Point of Care","Intended for professional use only","Sputum","","","Yes","No","","PD-58005","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gLMr","a2r69000007lbLE","a266900000B8ttM","06.07.2023","Thurleigh","United Kingdom","European Region","mologic.co.uk","Mologic Ltd.","gLAMexpress","Triage/Screening","ID","Tuberculosis","Active","Mycobacterium Tuberculosis","Late Stage Development (fully functional prototype)","None","Unspecified Market Entry","Immunoassay","Antigen","Lipoarabinomannan (LAM)","Lateral Flow Assay","","Colorimetric","Not applicable","","Not applicable","","Rapid diagnostic test (strip or cassette)","","No instrumentation is required","Manual","True Point of Care","Intended for professional use only","Urine","","","Yes","No","","PD-58018","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gKkn","a2r69000007lbEn","a266900000B8tqq","06.07.2023","Frederick","United States","Region of the Americas","akonni.com","Akonni Biosystems, Inc.","TruArray MDR-TB","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Research Use Only (RUO)","None","Already on the market (commercialized)","Molecular","DNA","MTB IS1245; MTB IS6110","Hybridization","Microarray","Colorimetric","inhA; katG; rpoB","","Isoniazid; Rifampicin","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Automated (excluding sample preparation)","Lab-based","Intended for professional use only","Sputum","","","Yes","No","","PD-57862","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gKlA","a2r69000007lb6D","a266900000B8ttH","06.07.2023","Verna Industrial Estate, Verna,","India","South-East Asian Region","molbiodiagnostics.com","Molbio Diagnostics Pvt. Ltd.","Truenat MTB-RIF Dx","Diagnostic/confirmatory test","AMR","Tuberculosis","Active","Mycobacterium Tuberculosis","Regulatory Achieved","CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","Not applicable","qPCR","","Fluorescence","rpoB","RRDR region","Rifampicin","","Cartridge-based processing","chip based","A proprietary/new instrument is required","Automated (excluding sample preparation)","near Point of Care","Intended for professional use only","Purified DNA","Sputum or EPTB specimen","","Yes","No","RIF detection from sputum","PD-58013","DNA","Company-Sponsored","Instructions for Use (IFU)","Rifampicin","84.20","62.40","94.50","95.20","90.80","97.50","Active TB","Sputum","0","0","0","","WHO recommended","Test Directory"
"a2v69000004gKlA","a2r69000007lb6D","a266900000C4Gdf","06.07.2023","Verna Industrial Estate, Verna,","India","South-East Asian Region","molbiodiagnostics.com","Molbio Diagnostics Pvt. Ltd.","Truenat MTB-RIF Dx","Diagnostic/confirmatory test","AMR","Tuberculosis","Active","Mycobacterium Tuberculosis","Regulatory Achieved","CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","Not applicable","qPCR","","Fluorescence","rpoB","RRDR region","Rifampicin","","Cartridge-based processing","chip based","A proprietary/new instrument is required","Automated (excluding sample preparation)","near Point of Care","Intended for professional use only","Purified DNA","Sputum or EPTB specimen","","Yes","Yes","RIF detection from sputum","PD-69688","DNA","Independent","Other","Rifampicin","84.00","62.00","95.00","95.00","91.00","98.00","Active TB","Sputum","186","19","167","","WHO recommended","Test Directory"
"a2v69000004gKlC","a2r69000007lb8k","a266900000B8ttK","06.07.2023","Verna Industrial Estate, Verna,","India","South-East Asian Region","molbiodiagnostics.com","Molbio Diagnostics Pvt. Ltd.","Truenat MTB","Diagnostic/confirmatory test","ID","Tuberculosis","Active","Mycobacterium Tuberculosis","Regulatory Achieved","CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB nrdB gene","qPCR","","Fluorescence","Not applicable","","Not applicable","","Cartridge-based processing","chip based","A proprietary/new instrument is required","Automated (excluding sample preparation)","near Point of Care","Intended for professional use only","Purified DNA","Sputum or EPTB specimen","","Yes","No","TB detection from pulmonary and EPTB specimen","PD-58016","DNA","Company-Sponsored","Instructions for Use (IFU)","Not applicable","91.10","0.00","0.00","100.00","0.00","0.00","Active TB","Sputum","226","191","35","","WHO recommended","Test Directory"
"a2v69000004gKlC","a2r69000007lb8k","a266900000C4Gdg","06.07.2023","Verna Industrial Estate, Verna,","India","South-East Asian Region","molbiodiagnostics.com","Molbio Diagnostics Pvt. Ltd.","Truenat MTB","Diagnostic/confirmatory test","ID","Tuberculosis","Active","Mycobacterium Tuberculosis","Regulatory Achieved","CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB nrdB gene","qPCR","","Fluorescence","Not applicable","","Not applicable","","Cartridge-based processing","chip based","A proprietary/new instrument is required","Automated (excluding sample preparation)","near Point of Care","Intended for professional use only","Purified DNA","Sputum or EPTB specimen","","Yes","Yes","TB detection from sputum","PD-69689","DNA","Independent","Other","Not applicable","73.00","68.00","78.00","98.00","97.00","99.00","Active TB","Sputum","1336","258","1078","","WHO recommended","Test Directory"
"a2v69000004gKlC","a2r69000007lb8k","a266900000C4Gdk","06.07.2023","Verna Industrial Estate, Verna,","India","South-East Asian Region","molbiodiagnostics.com","Molbio Diagnostics Pvt. Ltd.","Truenat MTB","Diagnostic/confirmatory test","ID","Tuberculosis","Active","Mycobacterium Tuberculosis","Regulatory Achieved","CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB nrdB gene","qPCR","","Fluorescence","Not applicable","","Not applicable","","Cartridge-based processing","chip based","A proprietary/new instrument is required","Automated (excluding sample preparation)","near Point of Care","Intended for professional use only","Purified DNA","Sputum or EPTB specimen","","Yes","Yes","TB detection from sputum (smear positive)","PD-69690","DNA","Independent","Other","Not applicable","91.00","86.00","94.00","","","","Active TB","Sputum","174","174","0","","WHO recommended","Test Directory"
"a2v69000004gKlC","a2r69000007lb8k","a266900000C4Gdp","06.07.2023","Verna Industrial Estate, Verna,","India","South-East Asian Region","molbiodiagnostics.com","Molbio Diagnostics Pvt. Ltd.","Truenat MTB","Diagnostic/confirmatory test","ID","Tuberculosis","Active","Mycobacterium Tuberculosis","Regulatory Achieved","CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB nrdB gene","qPCR","","Fluorescence","Not applicable","","Not applicable","","Cartridge-based processing","chip based","A proprietary/new instrument is required","Automated (excluding sample preparation)","near Point of Care","Intended for professional use only","Purified DNA","Sputum or EPTB specimen","","Yes","Yes","TB detection  from sputum (smear negative)","PD-69691","DNA","Independent","Other","Not applicable","37.00","27.00","48.00","98.00","97.00","99.00","Active TB","Sputum","1162","84","1078","","WHO recommended","Test Directory"
"a2v69000004gKlB","a2r69000007lb6E","a266900000B8ttJ","06.07.2023","Verna Industrial Estate, Verna,","India","South-East Asian Region","molbiodiagnostics.com","Molbio Diagnostics Pvt. Ltd.","Truenat MTB-INH","Diagnostic/confirmatory test","AMR","Tuberculosis","Active","Mycobacterium Tuberculosis","Late Stage Development (fully functional prototype)","None","Unspecified Market Entry","Molecular","DNA","Not applicable","qPCR","","Fluorescence","inhA; katG","","Isoniazid","","Cartridge-based processing","chip based","A proprietary/new instrument is required","Automated (excluding sample preparation)","near Point of Care","Intended for professional use only","Purified DNA","Sputum or EPTB specimen","","Yes","No","INH detection from sputum","PD-58015","DNA","Company-Sponsored","Instructions for Use (IFU)","Isoniazid","100.00","0.00","0.00","96.15","0.00","0.00","Active TB","Sputum","50","0","0","","","Test Directory"
"a2v69000004gKlD","a2r69000007lb8l","a266900000B8ttL","06.07.2023","Verna Industrial Estate, Verna,","India","South-East Asian Region","molbiodiagnostics.com","Molbio Diagnostics Pvt. Ltd.","Truenat MTB Plus","Diagnostic/confirmatory test","ID","Tuberculosis","Active","Mycobacterium Tuberculosis","Regulatory Achieved","CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB IS6110; MTB nrdz gene","qPCR","","Fluorescence","Not applicable","","Not applicable","","Cartridge-based processing","chip based","A proprietary/new instrument is required","Automated (excluding sample preparation)","near Point of Care","Intended for professional use only","Purified DNA","Sputum or EPTB specimen","","Yes","No","TB detection from sputum","PD-58017","DNA","Company-Sponsored","Instructions for Use (IFU)","Not applicable","79.80","74.50","84.30","96.50","95.20","97.40","Active TB","Sputum","1654","0","0","","WHO recommended","Test Directory"
"a2v69000004gKlD","a2r69000007lb8l","a266900000C4Gdu","06.07.2023","Verna Industrial Estate, Verna,","India","South-East Asian Region","molbiodiagnostics.com","Molbio Diagnostics Pvt. Ltd.","Truenat MTB Plus","Diagnostic/confirmatory test","ID","Tuberculosis","Active","Mycobacterium Tuberculosis","Regulatory Achieved","CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB IS6110; MTB nrdz gene","qPCR","","Fluorescence","Not applicable","","Not applicable","","Cartridge-based processing","chip based","A proprietary/new instrument is required","Automated (excluding sample preparation)","near Point of Care","Intended for professional use only","Purified DNA","Sputum or EPTB specimen","","Yes","Yes","TB detection from sputum","PD-69692","DNA","Independent","Other","Not applicable","80.00","75.00","84.00","96.00","95.00","97.00","Active TB","Sputum","1336","258","1078","","WHO recommended","Test Directory"
"a2v69000004gKlD","a2r69000007lb8l","a266900000C4Gdz","06.07.2023","Verna Industrial Estate, Verna,","India","South-East Asian Region","molbiodiagnostics.com","Molbio Diagnostics Pvt. Ltd.","Truenat MTB Plus","Diagnostic/confirmatory test","ID","Tuberculosis","Active","Mycobacterium Tuberculosis","Regulatory Achieved","CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB IS6110; MTB nrdz gene","qPCR","","Fluorescence","Not applicable","","Not applicable","","Cartridge-based processing","chip based","A proprietary/new instrument is required","Automated (excluding sample preparation)","near Point of Care","Intended for professional use only","Purified DNA","Sputum or EPTB specimen","","Yes","Yes","TB detection from sputum (smear positive)","PD-69693","DNA","Independent","Other","Not applicable","96.00","92.00","98.00","","","","Active TB","Sputum","174","174","0","","WHO recommended","Test Directory"
"a2v69000004gKlD","a2r69000007lb8l","a266900000C4Ge4","06.07.2023","Verna Industrial Estate, Verna,","India","South-East Asian Region","molbiodiagnostics.com","Molbio Diagnostics Pvt. Ltd.","Truenat MTB Plus","Diagnostic/confirmatory test","ID","Tuberculosis","Active","Mycobacterium Tuberculosis","Regulatory Achieved","CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB IS6110; MTB nrdz gene","qPCR","","Fluorescence","Not applicable","","Not applicable","","Cartridge-based processing","chip based","A proprietary/new instrument is required","Automated (excluding sample preparation)","near Point of Care","Intended for professional use only","Purified DNA","Sputum or EPTB specimen","","Yes","Yes","TB detection from sputum (smear negative)","PD-69694","DNA","Independent","Other","Not applicable","46.00","36.00","57.00","97.00","95.00","97.00","Active TB","Sputum","1162","84","1078","","WHO recommended","Test Directory"
"a2v69000004gKkh","a2r69000007lbF9","a266900000B8ts1","06.07.2023","Puteaux","France","European Region","elitechgroup.com","ELITechGroup","MDR/MTB ELITe MGB Kit for InGenius platform","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","Brazil ANVISA; CE-IVDD","Already on the market (commercialized)","Molecular","DNA","MTB IS6110","qPCR","","Fluorescence","inhA; katG; rpoB","","Isoniazid; Rifampicin","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Automated (excluding sample preparation)","Lab-based","Intended for professional use only","Bronchoalveolar lavage; Sputum; Urine; Other","Cavitary Fluid; Biopsies/Tissue Bronchial Aspirate (BA); Gastric Aspirates","","Yes","No","","PD-57935","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gKkg","a2r69000007lbF9","a266900000B8ts0","06.07.2023","Puteaux","France","European Region","elitechgroup.com","ELITechGroup","MDR/MTB ELITe MGB Kit for InGenius platform","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","Brazil ANVISA; CE-IVDD","Already on the market (commercialized)","Molecular","DNA","MTB IS6110","qPCR","","Fluorescence","inhA; katG; rpoB","","Isoniazid; Rifampicin","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Automated (excluding sample preparation)","Lab-based","Intended for professional use only","Bronchoalveolar lavage; Sputum; Urine; Other","Cavitary Fluid; Biopsies/Tissue Bronchial Aspirate (BA); Gastric Aspirates","","Yes","No","","PD-57934","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gKkj","a2r69000007lbFA","a266900000B8ts3","06.07.2023","Puteaux","France","European Region","elitechgroup.com","ELITechGroup","MTB EXTRA ELITe MGB Kit for InGenius platform","Diagnostic/confirmatory test","ID","Tuberculosis","Active","Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","Brazil ANVISA; CE-IVDD","Already on the market (commercialized)","Molecular","DNA","MTB IS6110","qPCR","","Fluorescence","Not applicable","","Not applicable","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Automated (excluding sample preparation)","Lab-based","Intended for professional use only","Bronchoalveolar lavage; Sputum; Urine; Other","Cavitary Fluid; Biopsies/Tissue Bronchial Aspirate (BA); Gastric Aspirates","","Yes","No","","PD-57937","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gKki","a2r69000007lbFA","a266900000B8ts2","06.07.2023","Puteaux","France","European Region","elitechgroup.com","ELITechGroup","MTB EXTRA ELITe MGB Kit for InGenius platform","Diagnostic/confirmatory test","ID","Tuberculosis","Active","Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","Brazil ANVISA; CE-IVDD","Already on the market (commercialized)","Molecular","DNA","MTB IS6110","qPCR","","Fluorescence","Not applicable","","Not applicable","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Automated (excluding sample preparation)","Lab-based","Intended for professional use only","Bronchoalveolar lavage; Sputum; Urine; Other","Cavitary Fluid; Biopsies/Tissue Bronchial Aspirate (BA); Gastric Aspirates","","Yes","No","","PD-57936","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gKp3","a2r69000007lb69","a266900000B8ttQ","06.07.2023","3-9-3, Honjo-Nishi, Kita-ku,","Japan","Western Pacific Region","nipro.co.jp","Nipro Corporation","Genoscholar PZA-TB II","Diagnostic/confirmatory test","AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","Not applicable","Hybridization","","Colorimetric","pncA","700 pair (bp) fragment covering the entire pncA gene and promoter region up to nucleotide -18 of the wild type H34Rv reference strain","Pyrazinamide","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Manual","Lab-based","Intended for professional use only","Sputum; Other","Culture","1440.00","Yes","Yes","PZA detection from sputum culture","PD-58022","DNA","Independent","Other","Pyrazinamide","81.20","75.40","85.80","97.80","96.50","98.60","Active TB","Sputum Culture","964","","","","WHO recommended","Test Directory"
"a2v69000004gKp3","a2r69000007lb69","a266900000B8ttR","06.07.2023","3-9-3, Honjo-Nishi, Kita-ku,","Japan","Western Pacific Region","nipro.co.jp","Nipro Corporation","Genoscholar PZA-TB II","Diagnostic/confirmatory test","AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","Not applicable","Hybridization","","Colorimetric","pncA","700 pair (bp) fragment covering the entire pncA gene and promoter region up to nucleotide -18 of the wild type H34Rv reference strain","Pyrazinamide","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Manual","Lab-based","Intended for professional use only","Sputum; Other","Culture","1440.00","Yes","Yes","PZA detection from sputum culture","PD-58023","DNA","Independent","Other","Pyrazinamide","96.40","93.30","98.40","100.00","99.40","100.00","Active TB","Sputum Culture","","","","","WHO recommended","Test Directory"
"a2v69000004gKp3","a2r69000007lb69","a266900000B8ttS","06.07.2023","3-9-3, Honjo-Nishi, Kita-ku,","Japan","Western Pacific Region","nipro.co.jp","Nipro Corporation","Genoscholar PZA-TB II","Diagnostic/confirmatory test","AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","Not applicable","Hybridization","","Colorimetric","pncA","700 pair (bp) fragment covering the entire pncA gene and promoter region up to nucleotide -18 of the wild type H34Rv reference strain","Pyrazinamide","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Manual","Lab-based","Intended for professional use only","Sputum; Other","Culture","1440.00","Yes","Yes","PZA detection from sputum culture","PD-58024","DNA","Independent","Other","Pyrazinamide","95.70","93.50","97.20","98.60","97.40","99.20","Active TB","Sputum Culture","","","","","WHO recommended","Test Directory"
"a2v69000004gKp5","a2r69000007lbll","a266900000B8ttX","06.07.2023","3-9-3, Honjo-Nishi, Kita-ku,","Japan","Western Pacific Region","nipro.co.jp","Nipro Corporation","Genoscholar FQ+KM-TB II","Diagnostic/confirmatory test","AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Research Use Only (RUO)","Unknown","Already on the market (commercialized)","Molecular","DNA","Not applicable","qPCR","","Colorimetric","gyrA; gyrB; rrs","700 pair (bp) fragment covering the entire pncA gene and promoter region up to nucleotide -18 of the wild type H34Rv reference strain","Fluoroquinolone; Kanamycin","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Manual","Lab-based","Intended for professional use only","Sputum; Other","Culture","1440.00","Yes","No","","PD-58029","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gKp4","a2r69000007lbFD","a266900000B8ttT","06.07.2023","3-9-3, Honjo-Nishi, Kita-ku,","Japan","Western Pacific Region","nipro.co.jp","Nipro Corporation","Genoscholar NTM+MDRTB II","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB IS6110","Hybridization","","Colorimetric","inhA promoter; katG; rpoB","rpoB probes; katG S315N mutation; inhA promoter probes;","Isoniazid; Rifampicin","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Manual","Lab-based","Intended for professional use only","Sputum; Other","Culture","1440.00","Yes","Yes","RIF detection from sputum","PD-58025","DNA","Independent","Other","Rifampicin","","75.00","100.00","","96.50","100.00","Active TB","Sputum","","","","","WHO recommended","Test Directory"
"a2v69000004gKp4","a2r69000007lbFD","a266900000B8ttU","06.07.2023","3-9-3, Honjo-Nishi, Kita-ku,","Japan","Western Pacific Region","nipro.co.jp","Nipro Corporation","Genoscholar NTM+MDRTB II","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB IS6110","Hybridization","","Colorimetric","inhA promoter; katG; rpoB","rpoB probes; katG S315N mutation; inhA promoter probes;","Isoniazid; Rifampicin","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Manual","Lab-based","Intended for professional use only","Sputum; Other","Culture","1440.00","Yes","Yes","INH detection from sputum","PD-58026","DNA","Independent","Other","Isoniazid","","50.00","94.90","","96.50","97.80","Active TB","Sputum","","","","","WHO recommended","Test Directory"
"a2v69000004gKp4","a2r69000007lbFD","a266900000B8ttV","06.07.2023","3-9-3, Honjo-Nishi, Kita-ku,","Japan","Western Pacific Region","nipro.co.jp","Nipro Corporation","Genoscholar NTM+MDRTB II","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB IS6110","Hybridization","","Colorimetric","inhA promoter; katG; rpoB","rpoB probes; katG S315N mutation; inhA promoter probes;","Isoniazid; Rifampicin","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Manual","Lab-based","Intended for professional use only","Sputum; Other","Culture","1440.00","Yes","Yes","RIF detection from culture isolates","PD-58027","DNA","Independent","Other","Rifampicin","","92.80","98.90","","97.30","98.20","Active TB","Sputum Culture","","","","","WHO recommended","Test Directory"
"a2v69000004gKp4","a2r69000007lbFD","a266900000B8ttW","06.07.2023","3-9-3, Honjo-Nishi, Kita-ku,","Japan","Western Pacific Region","nipro.co.jp","Nipro Corporation","Genoscholar NTM+MDRTB II","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB IS6110","Hybridization","","Colorimetric","inhA promoter; katG; rpoB","rpoB probes; katG S315N mutation; inhA promoter probes;","Isoniazid; Rifampicin","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Manual","Lab-based","Intended for professional use only","Sputum; Other","Culture","1440.00","Yes","Yes","INH detection from culture isolates","PD-58028","DNA","Independent","Other","Isoniazid","","61.60","91.60","","99.40","100.00","Active TB","Sputum Culture","","","","","WHO recommended","Test Directory"
"a2v69000004gKp7","a2r69000007lb6A","a266900000B8tto","06.07.2023","Rotkreuz","Switzerland","European Region","molecular.roche.com","Roche Diagnostics International AG","cobas MTB-RIF/INH","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","Brazil ANVISA; CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","Not applicable","qPCR","","Fluorescence","inhA promoter; katG; rpoB","RRDR; inhA promoter region; katG gene","Isoniazid; Rifampicin","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Manual","Lab-based","Intended for professional use only","Bronchoalveolar lavage; Sputum; Other","Sputum Sediment","","Yes","Yes","RIF detection from sputum","PD-58046","DNA","Company-Sponsored","Instructions for Use (IFU)","Rifampicin","96.70","91.70","99.10","97.90","95.80","99.20","Active TB","Sputum","","","","","WHO recommended","Test Directory"
"a2v69000004gKp7","a2r69000007lb6A","a266900000B8ttp","06.07.2023","Rotkreuz","Switzerland","European Region","molecular.roche.com","Roche Diagnostics International AG","cobas MTB-RIF/INH","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","Brazil ANVISA; CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","Not applicable","qPCR","","Fluorescence","inhA promoter; katG; rpoB","RRDR; inhA promoter region; katG gene","Isoniazid; Rifampicin","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Manual","Lab-based","Intended for professional use only","Bronchoalveolar lavage; Sputum; Other","Sputum Sediment","","Yes","Yes","INH detection from sputum","PD-58047","DNA","Company-Sponsored","Instructions for Use (IFU)","Isoniazid","97.40","93.50","99.30","99.30","97.60","99.90","Active TB","Sputum","","","","","WHO recommended","Test Directory"
"a2v69000004gKp6","a2r69000007lb6A","a266900000B8ttm","06.07.2023","Rotkreuz","Switzerland","European Region","molecular.roche.com","Roche Diagnostics International AG","cobas MTB-RIF/INH","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","Brazil ANVISA; CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","Not applicable","qPCR","","Fluorescence","inhA promoter; katG; rpoB","RRDR; inhA promoter region; katG gene","Isoniazid; Rifampicin","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Manual","Lab-based","Intended for professional use only","Bronchoalveolar lavage; Sputum; Other","Sputum Sediment","","Yes","Yes","RIF detection from sputum","PD-58044","DNA","Company-Sponsored","Instructions for Use (IFU)","Rifampicin","96.70","91.70","99.10","97.90","95.80","99.20","Active TB","Sputum","","","","","WHO recommended","Test Directory"
"a2v69000004gKp6","a2r69000007lb6A","a266900000B8ttn","06.07.2023","Rotkreuz","Switzerland","European Region","molecular.roche.com","Roche Diagnostics International AG","cobas MTB-RIF/INH","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","Brazil ANVISA; CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","Not applicable","qPCR","","Fluorescence","inhA promoter; katG; rpoB","RRDR; inhA promoter region; katG gene","Isoniazid; Rifampicin","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Manual","Lab-based","Intended for professional use only","Bronchoalveolar lavage; Sputum; Other","Sputum Sediment","","Yes","Yes","INH detection from sputum","PD-58045","DNA","Company-Sponsored","Instructions for Use (IFU)","Isoniazid","97.40","93.50","99.30","99.30","97.60","99.90","Active TB","Sputum","","","","","WHO recommended","Test Directory"
"a2v69000004gKnz","a2r69000007lb93","a266900000B8trG","06.07.2023","Chuncheon-s","Korea, Republic of","Western Pacific Region","boditech.co.kr/en","Boditech Med Inc.","ichroma IGRA-TB 25","Triage/Screening","ID","Tuberculosis","Latent","Mycobacterium Tuberculosis","Regulatory Achieved","CE-IVDD","Already on the market (commercialized)","Immunoassay","Antigen","Interferon Gamma","Lateral Flow Assay; IGRA","","Fluorescence","Not applicable","","Not applicable","","Cartridge-based processing","","A proprietary/new instrument is required","Automated (excluding sample preparation)","near Point of Care","Intended for professional use only","Plasma","Li-Heprin","","Yes","No","","PD-57888","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gKna","a2r69000007lbFK","a266900000B8ttt","06.07.2023","Suwon-si","Korea, Republic of","Western Pacific Region","sdbiosensor.com","SD Biosensor, Inc.","STANDARD M10 MDR-TB","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis","Regulatory Achieved","CE-IVDD","Already on the market (commercialized)","Molecular","DNA","MTB IS1081; MTB IS6110","qPCR","","Fluorescence","inhA; katG; rpoB","","Isoniazid; Rifampicin","","Cartridge-based processing","","A proprietary/new instrument is required","Fully automated (including sample preparation)","near Point of Care","Intended for professional use only","Sputum; Sputum Sediment","","80.00","Yes","No","","PD-58051","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gKnc","a2r69000007lbLC","a266900000B8ttx","06.07.2023","Suwon-si","Korea, Republic of","Western Pacific Region","sdbiosensor.com","SD Biosensor, Inc.","STANDARD F TB-Feron FIA","Triage/Screening","ID","Tuberculosis","Latent","Mycobacterium Tuberculosis","Regulatory Achieved","CE-IVDD","Already on the market (commercialized)","Immunoassay","Antigen","Interferon Gamma","Lateral Flow Assay; IGRA","","Fluorescence","Not applicable","","Not applicable","","Rapid diagnostic test (strip or cassette)","","A proprietary/new instrument is required","Manual","near Point of Care","Intended for professional use only","Plasma","sensitized whole blood in TB-Feron Tubes","15.00","Yes","No","","PD-58055","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gKnb","a2r69000007lbLB","a266900000B8ttw","06.07.2023","Suwon-si","Korea, Republic of","Western Pacific Region","sdbiosensor.com","SD Biosensor, Inc.","STANDARD M10 MTB/NTM","Diagnostic/confirmatory test","ID","Tuberculosis","Active","Mycobacterium Tuberculosis","Regulatory Achieved","CE-IVDD","Already on the market (commercialized)","Molecular","DNA","MTB IS1081; MTB IS6110","qPCR","","Fluorescence","Not applicable","","Not applicable","","Cartridge-based processing","","A proprietary/new instrument is required","Fully automated (including sample preparation)","near Point of Care","Intended for professional use only","Sputum; Sputum Sediment","","72.00","Yes","No","","PD-58054","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gKne","a2r69000007lbLC","a266900000B8ttz","06.07.2023","Suwon-si","Korea, Republic of","Western Pacific Region","sdbiosensor.com","SD Biosensor, Inc.","STANDARD F TB-Feron FIA","Triage/Screening","ID","Tuberculosis","Latent","Mycobacterium Tuberculosis","Regulatory Achieved","CE-IVDD","Already on the market (commercialized)","Immunoassay","Antigen","Interferon Gamma","Lateral Flow Assay; IGRA","","Fluorescence","Not applicable","","Not applicable","","Rapid diagnostic test (strip or cassette)","","A proprietary/new instrument is required","Manual","near Point of Care","Intended for professional use only","Plasma","sensitized whole blood in TB-Feron Tubes","15.00","Yes","No","","PD-58057","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gKnd","a2r69000007lbLC","a266900000B8tty","06.07.2023","Suwon-si","Korea, Republic of","Western Pacific Region","sdbiosensor.com","SD Biosensor, Inc.","STANDARD F TB-Feron FIA","Triage/Screening","ID","Tuberculosis","Latent","Mycobacterium Tuberculosis","Regulatory Achieved","CE-IVDD","Already on the market (commercialized)","Immunoassay","Antigen","Interferon Gamma","Lateral Flow Assay; IGRA","","Fluorescence","Not applicable","","Not applicable","","Rapid diagnostic test (strip or cassette)","","A proprietary/new instrument is required","Manual","near Point of Care","Intended for professional use only","Plasma","sensitized whole blood in TB-Feron Tubes","15.00","Yes","No","","PD-58056","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gKnk","a2r69000007lb8x","a266900000B8tu0","06.07.2023","Suwon-si","Korea, Republic of","Western Pacific Region","sdbiosensor.com","SD Biosensor, Inc.","STANDARD M10 XDR-TB","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis","Late Stage Development (fully functional prototype)","None","Unspecified Market Entry","Molecular","DNA","Unknown","qPCR","","Fluorescence","Unknown","","Amikacin; Capreomycin; Fluoroquinolone; Kanamycin","","Cartridge-based processing","","A proprietary/new instrument is required","Automated (excluding sample preparation)","near Point of Care","Intended for professional use only","Unknown","","","Yes","No","","PD-58058","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gKmn","a2r69000007lbL6","a266900000B8tr3","06.07.2023","Marcy l'Etoile","France","European Region","biomerieux-diagnostics.com","bioMérieux","VIDAS TB-IGRA","Triage/Screening","ID","Tuberculosis","Latent","Mycobacterium Tuberculosis","Regulatory Achieved","CE-IVDD","Already on the market (commercialized)","Immunoassay","Antigen","Interferon Gamma","ELISA/EIA; IGRA","","Fluorescence","Not applicable","","Not applicable","","Other","Reagent strip","A proprietary/new instrument is required","Automated (excluding sample preparation)","Lab-based","Intended for professional use only","Whole Blood","","1020.00","Yes","No","","PD-57875","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gKmp","a2r69000007lbL7","a266900000B8tr5","06.07.2023","Marcy l'Etoile","France","European Region","biomerieux-diagnostics.com","bioMérieux","ISIT-TB","Monitoring (treatment, immune status, patient)","Host Response","Tuberculosis","Latent","Mycobacterium Tuberculosis","Late Stage Development (fully functional prototype)","None","Unspecified Market Entry","Molecular","mRNA","Other","qPCR","transcriptomic blood signature","Fluorescence","Not applicable","","Not applicable","","Cartridge-based processing","","A proprietary/new instrument is required","Unknown","Lab-based","Intended for professional use only","Whole Blood","","60.00","Yes","No","","PD-57877","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gKmo","a2r69000007lbL6","a266900000B8tr4","06.07.2023","Marcy l'Etoile","France","European Region","biomerieux-diagnostics.com","bioMérieux","VIDAS TB-IGRA","Triage/Screening","ID","Tuberculosis","Latent","Mycobacterium Tuberculosis","Regulatory Achieved","CE-IVDD","Already on the market (commercialized)","Immunoassay","Antigen","Interferon Gamma","ELISA/EIA; IGRA","","Fluorescence","Not applicable","","Not applicable","","Other","Reagent strip","A proprietary/new instrument is required","Automated (excluding sample preparation)","Lab-based","Intended for professional use only","Whole Blood","","1020.00","Yes","No","","PD-57876","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gKmr","a2r69000007lbL7","a266900000B8tr7","06.07.2023","Marcy l'Etoile","France","European Region","biomerieux-diagnostics.com","bioMérieux","ISIT-TB","Monitoring (treatment, immune status, patient)","Host Response","Tuberculosis","Latent","Mycobacterium Tuberculosis","Late Stage Development (fully functional prototype)","None","Unspecified Market Entry","Molecular","mRNA","Other","qPCR","transcriptomic blood signature","Fluorescence","Not applicable","","Not applicable","","Cartridge-based processing","","A proprietary/new instrument is required","Unknown","Lab-based","Intended for professional use only","Whole Blood","","60.00","Yes","No","","PD-57879","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gKmq","a2r69000007lbL7","a266900000B8tr6","06.07.2023","Marcy l'Etoile","France","European Region","biomerieux-diagnostics.com","bioMérieux","ISIT-TB","Monitoring (treatment, immune status, patient)","Host Response","Tuberculosis","Latent","Mycobacterium Tuberculosis","Late Stage Development (fully functional prototype)","None","Unspecified Market Entry","Molecular","mRNA","Other","qPCR","transcriptomic blood signature","Fluorescence","Not applicable","","Not applicable","","Cartridge-based processing","","A proprietary/new instrument is required","Unknown","Lab-based","Intended for professional use only","Whole Blood","","60.00","Yes","No","","PD-57878","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gLOB","a2r69000007lbFC","a266900000B8ttP","06.07.2023","NEW ORLEANS","United States","Region of the Americas","nanopintech.com","NanoPin Technologies","NanoDetect-TB test","Diagnostic/confirmatory test","ID","Tuberculosis","Active","Mycobacterium Tuberculosis","Regulatory Status Unknown","None","Already on the market (commercialized)","Immunoassay","Antigen","MTB CFP-10","Mass spectrometry","Liquid chromatography-tandem mass spectrometry-based assay","Other","Not applicable","","Not applicable","","Laboratory-developed test (LDT)","","Standard lab instrumentation is required","Manual","Lab-based","Intended for professional use only","Plasma; Serum","","","Yes","No","","PD-58021","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gKnI","a2r69000007lbAY","a266900000B8ttA","06.07.2023","London","United Kingdom","European Region","lumiradx.com/us-en/what-we-do/diagnostics/fast-lab-solutions","LumiraDx Limited","LumiraDx MTB qSTAR Test","Triage/Screening","ID","Tuberculosis","Active","Mycobacterium Tuberculosis","Late Stage Development (fully functional prototype)","None","Unspecified Market Entry","Molecular","DNA","Unknown","qPCR","","Electrochemical","Not applicable","","Not applicable","","Cartridge-based processing","chip based","A proprietary/new instrument is required","Automated (excluding sample preparation)","near Point of Care","Intended for professional use only","Other","tongue","15.00","Yes","No","","PD-58006","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gKr3","a2r69000007lb97","a266900000B8trw","06.07.2023","Sunnyvale","United States","Region of the Americas","cepheid.com","Cepheid","Xpert MTB Host Response assay","Monitoring (treatment, immune status, patient)","Host Response","Tuberculosis","Active","Mycobacterium Tuberculosis","Late Stage Development (fully functional prototype)","None","Unspecified Market Entry","Molecular","mRNA","MTB DUSP3; MTB GBP5; MTB KLF2","qPCR","","Fluorescence","Not applicable","","Not applicable","","Cartridge-based processing","","A proprietary/new instrument is required","Automated (excluding sample preparation)","near Point of Care","Intended for professional use only","Whole Blood","","","Yes","No","","PD-57930","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gKpq","a2r69000007lbLG","a266900000B8ttg","06.07.2023","Lexington","United States","Region of the Americas","quanterix.com","Quanterix","Simoa SR-X","Triage/Screening","ID","Tuberculosis","Active","Mycobacterium Tuberculosis","Early Stage Development (partial prototype)","Unknown","Unspecified Market Entry","Immunoassay","Antigen","Other","Other","POC-amenable single-molecule array","Fluorescence","Not applicable","","Not applicable","","Unspecified","","A proprietary/new instrument is required","Automated (excluding sample preparation)","Lab-based","Intended for professional use only","Whole Blood","","","Yes","No","","PD-58038","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gKr2","a2r69000007lb97","a266900000B8trv","06.07.2023","Sunnyvale","United States","Region of the Americas","cepheid.com","Cepheid","Xpert MTB Host Response assay","Monitoring (treatment, immune status, patient)","Host Response","Tuberculosis","Active","Mycobacterium Tuberculosis","Late Stage Development (fully functional prototype)","None","Unspecified Market Entry","Molecular","mRNA","MTB DUSP3; MTB GBP5; MTB KLF2","qPCR","","Fluorescence","Not applicable","","Not applicable","","Cartridge-based processing","","A proprietary/new instrument is required","Automated (excluding sample preparation)","near Point of Care","Intended for professional use only","Whole Blood","","","Yes","No","","PD-57929","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gKpp","a2r69000007lbLG","a266900000B8ttf","06.07.2023","Lexington","United States","Region of the Americas","quanterix.com","Quanterix","Simoa SR-X","Triage/Screening","ID","Tuberculosis","Active","Mycobacterium Tuberculosis","Early Stage Development (partial prototype)","Unknown","Unspecified Market Entry","Immunoassay","Antigen","Other","Other","POC-amenable single-molecule array","Fluorescence","Not applicable","","Not applicable","","Unspecified","","A proprietary/new instrument is required","Automated (excluding sample preparation)","Lab-based","Intended for professional use only","Whole Blood","","","Yes","No","","PD-58037","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gKr4","a2r69000007lb97","a266900000B8trx","06.07.2023","Sunnyvale","United States","Region of the Americas","cepheid.com","Cepheid","Xpert MTB Host Response assay","Monitoring (treatment, immune status, patient)","Host Response","Tuberculosis","Active","Mycobacterium Tuberculosis","Late Stage Development (fully functional prototype)","None","Unspecified Market Entry","Molecular","mRNA","MTB DUSP3; MTB GBP5; MTB KLF2","qPCR","","Fluorescence","Not applicable","","Not applicable","","Cartridge-based processing","","A proprietary/new instrument is required","Automated (excluding sample preparation)","near Point of Care","Intended for professional use only","Whole Blood","","","Yes","No","","PD-57931","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gLS9","a2r69000007lbFF","a266900000B8ttZ","06.07.2023","Germantown","United States","Region of the Americas","www.qiagen.com","QIAGEN GmbH","QuantiFERON-TB Gold Plus (QFT-Plus)","Triage/Screening","ID","Tuberculosis","Latent","Mycobacterium Tuberculosis","Regulatory Achieved","Brazil ANVISA; CE-IVDD; China NMPA; US FDA PMA; WHO recommended","Already on the market (commercialized)","Immunoassay","Antigen","Interferon Gamma","ELISA/EIA; IGRA","","Colorimetric","Not applicable","","Not applicable","","Chemiluminescent Immunoassay (CLIA)","","Standard lab instrumentation is required","Manual","Lab-based","Intended for professional use only","Whole Blood","Blood stimulation tubes","","Yes","No","","PD-58031","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gKpv","a2r69000007lb8u","a266900000B8ttB","06.07.2023","Pretoria","South Africa","African Region","martidiagnostic.com","MARTI TB Diagnostics (Pty) Ltd","MARTI point-of-care TB diagnostic test","Triage/Screening","ID","Tuberculosis","Active","Mycobacterium Tuberculosis","Late Stage Development (fully functional prototype)","None","Unspecified Market Entry","Immunoassay","Antibody (serological)","Unknown","Other","Electrochemical impedance spectroscopy","Electrochemical","Not applicable","","Not applicable","","Cartridge-based processing","","A proprietary/new instrument is required","Automated (excluding sample preparation)","near Point of Care","Intended for professional use only","Whole Blood","","","Yes","No","","PD-58007","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gKpd","a2r69000007lb90","a266900000B8tti","06.07.2023","Newcastle upon Tyne","United Kingdom","European Region","quantumdx.com","QuantuMDx Group Limited","Q-POC - TB Assay","Diagnostic/confirmatory test","ID","Tuberculosis","Active","Mycobacterium Tuberculosis","Early Stage Development (partial prototype)","None","Unspecified Market Entry","Molecular","DNA","Unknown","qPCR","","Fluorescence","Not applicable","","Not applicable","","Cartridge-based processing","","A proprietary/new instrument is required","Automated (excluding sample preparation)","near Point of Care","Intended for professional use only","Unknown","","","Yes","No","","PD-58040","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gKr1","a2r69000007lb96","a266900000B8trp","06.07.2023","Sunnyvale","United States","Region of the Americas","cepheid.com","Cepheid","Xpert MTB/XDR","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis","Regulatory Achieved","Brazil ANVISA; CE-IVDD; Israel Ministry of Health; WHO recommended","Already on the market (commercialized)","Molecular","DNA","Not applicable","qPCR","","Fluorescence","eis promoter; fabG1; gyrA; gyrB; inhA promoter; katG; oxyR-ahpC intergenic region; rrs","katG and fabG1 genes; oxyR-ahpC intergenic region; inhA promoter only ;gyrA and gyrB quinolone resistance determining region (QRDR) ;rrs gene and eis promoter region (SLID)","Amikacin; Capreomycin; Ethionamide; Fluoroquinolone; Isoniazid; Kanamycin","","Cartridge-based processing","","A proprietary/new instrument is required","Automated (excluding sample preparation)","near Point of Care","Intended for professional use only","Bronchoalveolar lavage; Sputum; Other","Sputum Sediment","90.00","Yes","No","INH detection from sputum","PD-57923","DNA","Company-Sponsored","Instructions for Use (IFU)","Isoniazid","95.20","92.90","96.80","95.60","90.10","98.10","Active TB","Sputum","596","464","132","","","Test Directory"
"a2v69000004gKr1","a2r69000007lb96","a266900000B8trq","06.07.2023","Sunnyvale","United States","Region of the Americas","cepheid.com","Cepheid","Xpert MTB/XDR","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis","Regulatory Achieved","Brazil ANVISA; CE-IVDD; Israel Ministry of Health; WHO recommended","Already on the market (commercialized)","Molecular","DNA","Not applicable","qPCR","","Fluorescence","eis promoter; fabG1; gyrA; gyrB; inhA promoter; katG; oxyR-ahpC intergenic region; rrs","katG and fabG1 genes; oxyR-ahpC intergenic region; inhA promoter only ;gyrA and gyrB quinolone resistance determining region (QRDR) ;rrs gene and eis promoter region (SLID)","Amikacin; Capreomycin; Ethionamide; Fluoroquinolone; Isoniazid; Kanamycin","","Cartridge-based processing","","A proprietary/new instrument is required","Automated (excluding sample preparation)","near Point of Care","Intended for professional use only","Bronchoalveolar lavage; Sputum; Other","Sputum Sediment","90.00","Yes","No","FLQ detection from sputum","PD-57924","DNA","Company-Sponsored","Instructions for Use (IFU)","Fluoroquinolone","94.50","90.70","96.90","95.20","92.50","96.90","Active TB","Sputum","594","226","368","","","Test Directory"
"a2v69000004gKr1","a2r69000007lb96","a266900000B8trr","06.07.2023","Sunnyvale","United States","Region of the Americas","cepheid.com","Cepheid","Xpert MTB/XDR","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis","Regulatory Achieved","Brazil ANVISA; CE-IVDD; Israel Ministry of Health; WHO recommended","Already on the market (commercialized)","Molecular","DNA","Not applicable","qPCR","","Fluorescence","eis promoter; fabG1; gyrA; gyrB; inhA promoter; katG; oxyR-ahpC intergenic region; rrs","katG and fabG1 genes; oxyR-ahpC intergenic region; inhA promoter only ;gyrA and gyrB quinolone resistance determining region (QRDR) ;rrs gene and eis promoter region (SLID)","Amikacin; Capreomycin; Ethionamide; Fluoroquinolone; Isoniazid; Kanamycin","","Cartridge-based processing","","A proprietary/new instrument is required","Automated (excluding sample preparation)","near Point of Care","Intended for professional use only","Bronchoalveolar lavage; Sputum; Other","Sputum Sediment","90.00","Yes","No","AMK detection from sputum","PD-57925","DNA","Company-Sponsored","Instructions for Use (IFU)","Amikacin","87.70","77.50","93.60","98.50","97.00","99.20","Active TB","Sputum","593","65","528","","","Test Directory"
"a2v69000004gKr1","a2r69000007lb96","a266900000B8trs","06.07.2023","Sunnyvale","United States","Region of the Americas","cepheid.com","Cepheid","Xpert MTB/XDR","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis","Regulatory Achieved","Brazil ANVISA; CE-IVDD; Israel Ministry of Health; WHO recommended","Already on the market (commercialized)","Molecular","DNA","Not applicable","qPCR","","Fluorescence","eis promoter; fabG1; gyrA; gyrB; inhA promoter; katG; oxyR-ahpC intergenic region; rrs","katG and fabG1 genes; oxyR-ahpC intergenic region; inhA promoter only ;gyrA and gyrB quinolone resistance determining region (QRDR) ;rrs gene and eis promoter region (SLID)","Amikacin; Capreomycin; Ethionamide; Fluoroquinolone; Isoniazid; Kanamycin","","Cartridge-based processing","","A proprietary/new instrument is required","Automated (excluding sample preparation)","near Point of Care","Intended for professional use only","Bronchoalveolar lavage; Sputum; Other","Sputum Sediment","90.00","Yes","No","KAN detection from sputum","PD-57926","DNA","Company-Sponsored","Instructions for Use (IFU)","Kanamycin","93.70","89.00","96.40","92.40","89.40","94.60","Active TB","Sputum","594","195","399","","","Test Directory"
"a2v69000004gKr1","a2r69000007lb96","a266900000B8trt","06.07.2023","Sunnyvale","United States","Region of the Americas","cepheid.com","Cepheid","Xpert MTB/XDR","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis","Regulatory Achieved","Brazil ANVISA; CE-IVDD; Israel Ministry of Health; WHO recommended","Already on the market (commercialized)","Molecular","DNA","Not applicable","qPCR","","Fluorescence","eis promoter; fabG1; gyrA; gyrB; inhA promoter; katG; oxyR-ahpC intergenic region; rrs","katG and fabG1 genes; oxyR-ahpC intergenic region; inhA promoter only ;gyrA and gyrB quinolone resistance determining region (QRDR) ;rrs gene and eis promoter region (SLID)","Amikacin; Capreomycin; Ethionamide; Fluoroquinolone; Isoniazid; Kanamycin","","Cartridge-based processing","","A proprietary/new instrument is required","Automated (excluding sample preparation)","near Point of Care","Intended for professional use only","Bronchoalveolar lavage; Sputum; Other","Sputum Sediment","90.00","Yes","No","CAP detection from sputum","PD-57927","DNA","Company-Sponsored","Instructions for Use (IFU)","Capreomycin","75.40","64.00","84.00","99.60","98.60","99.90","Active TB","Sputum","595","54","541","","","Test Directory"
"a2v69000004gKr1","a2r69000007lb96","a266900000B8tru","06.07.2023","Sunnyvale","United States","Region of the Americas","cepheid.com","Cepheid","Xpert MTB/XDR","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis","Regulatory Achieved","Brazil ANVISA; CE-IVDD; Israel Ministry of Health; WHO recommended","Already on the market (commercialized)","Molecular","DNA","Not applicable","qPCR","","Fluorescence","eis promoter; fabG1; gyrA; gyrB; inhA promoter; katG; oxyR-ahpC intergenic region; rrs","katG and fabG1 genes; oxyR-ahpC intergenic region; inhA promoter only ;gyrA and gyrB quinolone resistance determining region (QRDR) ;rrs gene and eis promoter region (SLID)","Amikacin; Capreomycin; Ethionamide; Fluoroquinolone; Isoniazid; Kanamycin","","Cartridge-based processing","","A proprietary/new instrument is required","Automated (excluding sample preparation)","near Point of Care","Intended for professional use only","Bronchoalveolar lavage; Sputum; Other","Sputum Sediment","90.00","Yes","No","ETH detection from sputum","PD-57928","DNA","Company-Sponsored","Instructions for Use (IFU)","Ethionamide","55.00","49.50","60.30","93.80","90.30","96.10","Active TB","Sputum","597","194","403","","","Test Directory"
"a2v69000004gKpo","a2r69000007lbLG","a266900000B8tte","06.07.2023","Lexington","United States","Region of the Americas","quanterix.com","Quanterix","Simoa SR-X","Triage/Screening","ID","Tuberculosis","Active","Mycobacterium Tuberculosis","Early Stage Development (partial prototype)","Unknown","Unspecified Market Entry","Immunoassay","Antigen","Other","Other","POC-amenable single-molecule array","Fluorescence","Not applicable","","Not applicable","","Unspecified","","A proprietary/new instrument is required","Automated (excluding sample preparation)","Lab-based","Intended for professional use only","Whole Blood","","","Yes","No","","PD-58036","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gKr0","a2r69000007lb96","a266900000B8trj","06.07.2023","Sunnyvale","United States","Region of the Americas","cepheid.com","Cepheid","Xpert MTB/XDR","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis","Regulatory Achieved","Brazil ANVISA; CE-IVDD; Israel Ministry of Health; WHO recommended","Already on the market (commercialized)","Molecular","DNA","Not applicable","qPCR","","Fluorescence","eis promoter; fabG1; gyrA; gyrB; inhA promoter; katG; oxyR-ahpC intergenic region; rrs","katG and fabG1 genes; oxyR-ahpC intergenic region; inhA promoter only ;gyrA and gyrB quinolone resistance determining region (QRDR) ;rrs gene and eis promoter region (SLID)","Amikacin; Capreomycin; Ethionamide; Fluoroquinolone; Isoniazid; Kanamycin","","Cartridge-based processing","","A proprietary/new instrument is required","Automated (excluding sample preparation)","near Point of Care","Intended for professional use only","Bronchoalveolar lavage; Sputum; Other","Sputum Sediment","90.00","Yes","No","INH detection from sputum","PD-57917","DNA","Company-Sponsored","Instructions for Use (IFU)","Isoniazid","95.20","92.90","96.80","95.60","90.10","98.10","Active TB","Sputum","596","464","132","","","Test Directory"
"a2v69000004gKr0","a2r69000007lb96","a266900000B8trk","06.07.2023","Sunnyvale","United States","Region of the Americas","cepheid.com","Cepheid","Xpert MTB/XDR","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis","Regulatory Achieved","Brazil ANVISA; CE-IVDD; Israel Ministry of Health; WHO recommended","Already on the market (commercialized)","Molecular","DNA","Not applicable","qPCR","","Fluorescence","eis promoter; fabG1; gyrA; gyrB; inhA promoter; katG; oxyR-ahpC intergenic region; rrs","katG and fabG1 genes; oxyR-ahpC intergenic region; inhA promoter only ;gyrA and gyrB quinolone resistance determining region (QRDR) ;rrs gene and eis promoter region (SLID)","Amikacin; Capreomycin; Ethionamide; Fluoroquinolone; Isoniazid; Kanamycin","","Cartridge-based processing","","A proprietary/new instrument is required","Automated (excluding sample preparation)","near Point of Care","Intended for professional use only","Bronchoalveolar lavage; Sputum; Other","Sputum Sediment","90.00","Yes","No","FLQ detection from sputum","PD-57918","DNA","Company-Sponsored","Instructions for Use (IFU)","Fluoroquinolone","94.50","90.70","96.90","95.20","92.50","96.90","Active TB","Sputum","594","226","368","","","Test Directory"
"a2v69000004gKr0","a2r69000007lb96","a266900000B8trl","06.07.2023","Sunnyvale","United States","Region of the Americas","cepheid.com","Cepheid","Xpert MTB/XDR","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis","Regulatory Achieved","Brazil ANVISA; CE-IVDD; Israel Ministry of Health; WHO recommended","Already on the market (commercialized)","Molecular","DNA","Not applicable","qPCR","","Fluorescence","eis promoter; fabG1; gyrA; gyrB; inhA promoter; katG; oxyR-ahpC intergenic region; rrs","katG and fabG1 genes; oxyR-ahpC intergenic region; inhA promoter only ;gyrA and gyrB quinolone resistance determining region (QRDR) ;rrs gene and eis promoter region (SLID)","Amikacin; Capreomycin; Ethionamide; Fluoroquinolone; Isoniazid; Kanamycin","","Cartridge-based processing","","A proprietary/new instrument is required","Automated (excluding sample preparation)","near Point of Care","Intended for professional use only","Bronchoalveolar lavage; Sputum; Other","Sputum Sediment","90.00","Yes","No","AMK detection from sputum","PD-57919","DNA","Company-Sponsored","Instructions for Use (IFU)","Amikacin","87.70","77.50","93.60","98.50","97.00","99.20","Active TB","Sputum","593","65","528","","","Test Directory"
"a2v69000004gKr0","a2r69000007lb96","a266900000B8trm","06.07.2023","Sunnyvale","United States","Region of the Americas","cepheid.com","Cepheid","Xpert MTB/XDR","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis","Regulatory Achieved","Brazil ANVISA; CE-IVDD; Israel Ministry of Health; WHO recommended","Already on the market (commercialized)","Molecular","DNA","Not applicable","qPCR","","Fluorescence","eis promoter; fabG1; gyrA; gyrB; inhA promoter; katG; oxyR-ahpC intergenic region; rrs","katG and fabG1 genes; oxyR-ahpC intergenic region; inhA promoter only ;gyrA and gyrB quinolone resistance determining region (QRDR) ;rrs gene and eis promoter region (SLID)","Amikacin; Capreomycin; Ethionamide; Fluoroquinolone; Isoniazid; Kanamycin","","Cartridge-based processing","","A proprietary/new instrument is required","Automated (excluding sample preparation)","near Point of Care","Intended for professional use only","Bronchoalveolar lavage; Sputum; Other","Sputum Sediment","90.00","Yes","No","KAN detection from sputum","PD-57920","DNA","Company-Sponsored","Instructions for Use (IFU)","Kanamycin","93.70","89.00","96.40","92.40","89.40","94.60","Active TB","Sputum","594","195","399","","","Test Directory"
"a2v69000004gKr0","a2r69000007lb96","a266900000B8trn","06.07.2023","Sunnyvale","United States","Region of the Americas","cepheid.com","Cepheid","Xpert MTB/XDR","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis","Regulatory Achieved","Brazil ANVISA; CE-IVDD; Israel Ministry of Health; WHO recommended","Already on the market (commercialized)","Molecular","DNA","Not applicable","qPCR","","Fluorescence","eis promoter; fabG1; gyrA; gyrB; inhA promoter; katG; oxyR-ahpC intergenic region; rrs","katG and fabG1 genes; oxyR-ahpC intergenic region; inhA promoter only ;gyrA and gyrB quinolone resistance determining region (QRDR) ;rrs gene and eis promoter region (SLID)","Amikacin; Capreomycin; Ethionamide; Fluoroquinolone; Isoniazid; Kanamycin","","Cartridge-based processing","","A proprietary/new instrument is required","Automated (excluding sample preparation)","near Point of Care","Intended for professional use only","Bronchoalveolar lavage; Sputum; Other","Sputum Sediment","90.00","Yes","No","CAP detection from sputum","PD-57921","DNA","Company-Sponsored","Instructions for Use (IFU)","Capreomycin","75.40","64.00","84.00","99.60","98.60","99.90","Active TB","Sputum","595","54","541","","","Test Directory"
"a2v69000004gKr0","a2r69000007lb96","a266900000B8tro","06.07.2023","Sunnyvale","United States","Region of the Americas","cepheid.com","Cepheid","Xpert MTB/XDR","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis","Regulatory Achieved","Brazil ANVISA; CE-IVDD; Israel Ministry of Health; WHO recommended","Already on the market (commercialized)","Molecular","DNA","Not applicable","qPCR","","Fluorescence","eis promoter; fabG1; gyrA; gyrB; inhA promoter; katG; oxyR-ahpC intergenic region; rrs","katG and fabG1 genes; oxyR-ahpC intergenic region; inhA promoter only ;gyrA and gyrB quinolone resistance determining region (QRDR) ;rrs gene and eis promoter region (SLID)","Amikacin; Capreomycin; Ethionamide; Fluoroquinolone; Isoniazid; Kanamycin","","Cartridge-based processing","","A proprietary/new instrument is required","Automated (excluding sample preparation)","near Point of Care","Intended for professional use only","Bronchoalveolar lavage; Sputum; Other","Sputum Sediment","90.00","Yes","No","ETH detection from sputum","PD-57922","DNA","Company-Sponsored","Instructions for Use (IFU)","Ethionamide","55.00","49.50","60.30","93.80","90.30","96.10","Active TB","Sputum","597","194","403","","","Test Directory"
"a2v69000004gKop","a2r69000007lb8m","a266900000B8tse","06.07.2023","Nehren","Germany","European Region","hain-lifescience.de/en/","Hain Lifescience GmbH","GenoType MTBDRsl VER 1.0","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","Brazil ANVISA; CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB 23S rRNA","Hybridization","","Colorimetric","embB; gyrA; rrs","","Ethambutol; Fluoroquinolone","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Manual","Lab-based","Intended for professional use only","Sputum; Sputum Culture","Sputum Culture isolates","300.00","Yes","Yes","SLID detection from  culture (indirect)","PD-57974","DNA","Independent","Other","Other","76.50","63.30","86.00","99.10","97.30","99.70","Active TB","Sputum Culture","1921","","","SLID resistance","WHO recommended","Test Directory"
"a2v69000004gKop","a2r69000007lb8m","a266900000B8tsf","06.07.2023","Nehren","Germany","European Region","hain-lifescience.de/en/","Hain Lifescience GmbH","GenoType MTBDRsl VER 1.0","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","Brazil ANVISA; CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB 23S rRNA","Hybridization","","Colorimetric","embB; gyrA; rrs","","Ethambutol; Fluoroquinolone","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Manual","Lab-based","Intended for professional use only","Sputum; Sputum Culture","Sputum Culture isolates","300.00","Yes","Yes","SLID detection from sputum (direct)","PD-57975","DNA","Independent","Other","Other","87.00","38.10","98.60","99.50","93.60","100.00","Active TB","Sputum","1639","","","SLID resistance","WHO recommended","Test Directory"
"a2v69000004gKop","a2r69000007lb8m","a266900000B8tsg","06.07.2023","Nehren","Germany","European Region","hain-lifescience.de/en/","Hain Lifescience GmbH","GenoType MTBDRsl VER 1.0","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","Brazil ANVISA; CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB 23S rRNA","Hybridization","","Colorimetric","embB; gyrA; rrs","","Ethambutol; Fluoroquinolone","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Manual","Lab-based","Intended for professional use only","Sputum; Sputum Culture","Sputum Culture isolates","300.00","Yes","Yes","FLQ detection from culture (indirect)","PD-57976","DNA","Independent","Other","Fluoroquinolone","85.60","79.20","90.40","98.50","95.70","99.50","Active TB","Sputum Culture","2233","","","","WHO recommended","Test Directory"
"a2v69000004gKop","a2r69000007lb8m","a266900000B8tsh","06.07.2023","Nehren","Germany","European Region","hain-lifescience.de/en/","Hain Lifescience GmbH","GenoType MTBDRsl VER 1.0","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","Brazil ANVISA; CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB 23S rRNA","Hybridization","","Colorimetric","embB; gyrA; rrs","","Ethambutol; Fluoroquinolone","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Manual","Lab-based","Intended for professional use only","Sputum; Sputum Culture","Sputum Culture isolates","300.00","Yes","Yes","FLQ detection from sputum (direct)","PD-57977","DNA","Independent","Other","Fluoroquinolone","86.20","74.60","93.00","98.60","96.90","99.40","Active TB","Sputum","1771","","","","WHO recommended","Test Directory"
"a2v69000004gKop","a2r69000007lb8m","a266900000B8tsi","06.07.2023","Nehren","Germany","European Region","hain-lifescience.de/en/","Hain Lifescience GmbH","GenoType MTBDRsl VER 1.0","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","Brazil ANVISA; CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB 23S rRNA","Hybridization","","Colorimetric","embB; gyrA; rrs","","Ethambutol; Fluoroquinolone","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Manual","Lab-based","Intended for professional use only","Sputum; Sputum Culture","Sputum Culture isolates","300.00","Yes","Yes","SLID detection from  culture (indirect)","PD-57978","DNA","Independent","Other","Other","76.50","63.30","86.00","99.10","97.30","99.70","Active TB","Sputum Culture","1921","","","SLID resistance","WHO recommended","Test Directory"
"a2v69000004gKop","a2r69000007lb8m","a266900000B8tsj","06.07.2023","Nehren","Germany","European Region","hain-lifescience.de/en/","Hain Lifescience GmbH","GenoType MTBDRsl VER 1.0","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","Brazil ANVISA; CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB 23S rRNA","Hybridization","","Colorimetric","embB; gyrA; rrs","","Ethambutol; Fluoroquinolone","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Manual","Lab-based","Intended for professional use only","Sputum; Sputum Culture","Sputum Culture isolates","300.00","Yes","Yes","SLID detection from sputum (direct)","PD-57979","DNA","Independent","Other","Other","87.00","38.10","98.60","99.50","93.60","100.00","Active TB","Sputum","1639","","","SLID resistance","WHO recommended","Test Directory"
"a2v69000004gKop","a2r69000007lb8m","a266900000B8tsk","06.07.2023","Nehren","Germany","European Region","hain-lifescience.de/en/","Hain Lifescience GmbH","GenoType MTBDRsl VER 1.0","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","Brazil ANVISA; CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB 23S rRNA","Hybridization","","Colorimetric","embB; gyrA; rrs","","Ethambutol; Fluoroquinolone","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Manual","Lab-based","Intended for professional use only","Sputum; Sputum Culture","Sputum Culture isolates","300.00","Yes","Yes","XDR-TB detection from culture (indirect)","PD-57980","DNA","Independent","Other","Other","70.90","42.90","88.80","98.80","96.10","99.60","Active TB","Sputum Culture","880","","","XDR-TB resistance","WHO recommended","Test Directory"
"a2v69000004gKop","a2r69000007lb8m","a266900000B8tsl","06.07.2023","Nehren","Germany","European Region","hain-lifescience.de/en/","Hain Lifescience GmbH","GenoType MTBDRsl VER 1.0","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","Brazil ANVISA; CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB 23S rRNA","Hybridization","","Colorimetric","embB; gyrA; rrs","","Ethambutol; Fluoroquinolone","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Manual","Lab-based","Intended for professional use only","Sputum; Sputum Culture","Sputum Culture isolates","300.00","Yes","Yes","XDR-TB detection from sputum (direct)","PD-57981","DNA","Independent","Other","Other","69.40","38.80","89.00","99.40","95.00","99.30","Active TB","Sputum","1420","","","XDR-TB resistance","WHO recommended","Test Directory"
"a2v69000004gKoo","a2r69000007lb8m","a266900000B8tsW","06.07.2023","Nehren","Germany","European Region","hain-lifescience.de/en/","Hain Lifescience GmbH","GenoType MTBDRsl VER 1.0","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","Brazil ANVISA; CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB 23S rRNA","Hybridization","","Colorimetric","embB; gyrA; rrs","","Ethambutol; Fluoroquinolone","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Manual","Lab-based","Intended for professional use only","Sputum; Sputum Culture","Sputum Culture isolates","300.00","Yes","Yes","SLID detection from  culture (indirect)","PD-57966","DNA","Independent","Other","Other","76.50","63.30","86.00","99.10","97.30","99.70","Active TB","Sputum Culture","1921","","","SLID resistance","WHO recommended","Test Directory"
"a2v69000004gKoo","a2r69000007lb8m","a266900000B8tsX","06.07.2023","Nehren","Germany","European Region","hain-lifescience.de/en/","Hain Lifescience GmbH","GenoType MTBDRsl VER 1.0","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","Brazil ANVISA; CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB 23S rRNA","Hybridization","","Colorimetric","embB; gyrA; rrs","","Ethambutol; Fluoroquinolone","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Manual","Lab-based","Intended for professional use only","Sputum; Sputum Culture","Sputum Culture isolates","300.00","Yes","Yes","SLID detection from sputum (direct)","PD-57967","DNA","Independent","Other","Other","87.00","38.10","98.60","99.50","93.60","100.00","Active TB","Sputum","1639","","","SLID resistance","WHO recommended","Test Directory"
"a2v69000004gKoo","a2r69000007lb8m","a266900000B8tsY","06.07.2023","Nehren","Germany","European Region","hain-lifescience.de/en/","Hain Lifescience GmbH","GenoType MTBDRsl VER 1.0","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","Brazil ANVISA; CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB 23S rRNA","Hybridization","","Colorimetric","embB; gyrA; rrs","","Ethambutol; Fluoroquinolone","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Manual","Lab-based","Intended for professional use only","Sputum; Sputum Culture","Sputum Culture isolates","300.00","Yes","Yes","FLQ detection from culture (indirect)","PD-57968","DNA","Independent","Other","Fluoroquinolone","85.60","79.20","90.40","98.50","95.70","99.50","Active TB","Sputum Culture","2233","","","","WHO recommended","Test Directory"
"a2v69000004gKoo","a2r69000007lb8m","a266900000B8tsZ","06.07.2023","Nehren","Germany","European Region","hain-lifescience.de/en/","Hain Lifescience GmbH","GenoType MTBDRsl VER 1.0","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","Brazil ANVISA; CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB 23S rRNA","Hybridization","","Colorimetric","embB; gyrA; rrs","","Ethambutol; Fluoroquinolone","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Manual","Lab-based","Intended for professional use only","Sputum; Sputum Culture","Sputum Culture isolates","300.00","Yes","Yes","FLQ detection from sputum (direct)","PD-57969","DNA","Independent","Other","Fluoroquinolone","86.20","74.60","93.00","98.60","96.90","99.40","Active TB","Sputum","1771","","","","WHO recommended","Test Directory"
"a2v69000004gKoo","a2r69000007lb8m","a266900000B8tsa","06.07.2023","Nehren","Germany","European Region","hain-lifescience.de/en/","Hain Lifescience GmbH","GenoType MTBDRsl VER 1.0","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","Brazil ANVISA; CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB 23S rRNA","Hybridization","","Colorimetric","embB; gyrA; rrs","","Ethambutol; Fluoroquinolone","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Manual","Lab-based","Intended for professional use only","Sputum; Sputum Culture","Sputum Culture isolates","300.00","Yes","Yes","SLID detection from  culture (indirect)","PD-57970","DNA","Independent","Other","Other","76.50","63.30","86.00","99.10","97.30","99.70","Active TB","Sputum Culture","1921","","","SLID resistance","WHO recommended","Test Directory"
"a2v69000004gKoo","a2r69000007lb8m","a266900000B8tsb","06.07.2023","Nehren","Germany","European Region","hain-lifescience.de/en/","Hain Lifescience GmbH","GenoType MTBDRsl VER 1.0","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","Brazil ANVISA; CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB 23S rRNA","Hybridization","","Colorimetric","embB; gyrA; rrs","","Ethambutol; Fluoroquinolone","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Manual","Lab-based","Intended for professional use only","Sputum; Sputum Culture","Sputum Culture isolates","300.00","Yes","Yes","SLID detection from sputum (direct)","PD-57971","DNA","Independent","Other","Other","87.00","38.10","98.60","99.50","93.60","100.00","Active TB","Sputum","1639","","","SLID resistance","WHO recommended","Test Directory"
"a2v69000004gKoo","a2r69000007lb8m","a266900000B8tsc","06.07.2023","Nehren","Germany","European Region","hain-lifescience.de/en/","Hain Lifescience GmbH","GenoType MTBDRsl VER 1.0","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","Brazil ANVISA; CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB 23S rRNA","Hybridization","","Colorimetric","embB; gyrA; rrs","","Ethambutol; Fluoroquinolone","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Manual","Lab-based","Intended for professional use only","Sputum; Sputum Culture","Sputum Culture isolates","300.00","Yes","Yes","XDR-TB detection from culture (indirect)","PD-57972","DNA","Independent","Other","Other","70.90","42.90","88.80","98.80","96.10","99.60","Active TB","Sputum Culture","880","","","XDR-TB resistance","WHO recommended","Test Directory"
"a2v69000004gKoo","a2r69000007lb8m","a266900000B8tsd","06.07.2023","Nehren","Germany","European Region","hain-lifescience.de/en/","Hain Lifescience GmbH","GenoType MTBDRsl VER 1.0","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","Brazil ANVISA; CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB 23S rRNA","Hybridization","","Colorimetric","embB; gyrA; rrs","","Ethambutol; Fluoroquinolone","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Manual","Lab-based","Intended for professional use only","Sputum; Sputum Culture","Sputum Culture isolates","300.00","Yes","Yes","XDR-TB detection from sputum (direct)","PD-57973","DNA","Independent","Other","Other","69.40","38.80","89.00","99.40","95.00","99.30","Active TB","Sputum","1420","","","XDR-TB resistance","WHO recommended","Test Directory"
"a2v69000004gKor","a2r69000007lb8n","a266900000B8tsu","06.07.2023","Nehren","Germany","European Region","hain-lifescience.de/en/","Hain Lifescience GmbH","GenoType MTBDRsl VER 2.0","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB 23S rRNA","Hybridization","","Colorimetric","eis promoter; gyrA; gyrB; rrs","","Ethambutol; Fluoroquinolone; Kanamycin","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Manual","Lab-based","Intended for professional use only","Sputum; Sputum Culture","Sputum Culture isolates","300.00","Yes","No","TB Detection","PD-57990","DNA","Independent","Other","Not applicable","0.00","0.00","0.00","0.00","0.00","0.00","Active TB","Sputum","0","0","0","","WHO recommended","Test Directory"
"a2v69000004gKor","a2r69000007lb8n","a266900000B8tsv","06.07.2023","Nehren","Germany","European Region","hain-lifescience.de/en/","Hain Lifescience GmbH","GenoType MTBDRsl VER 2.0","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB 23S rRNA","Hybridization","","Colorimetric","eis promoter; gyrA; gyrB; rrs","","Ethambutol; Fluoroquinolone; Kanamycin","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Manual","Lab-based","Intended for professional use only","Sputum; Sputum Culture","Sputum Culture isolates","300.00","Yes","No","Fluoroquinolone resistance","PD-57991","DNA","Independent","Other","Fluoroquinolone","0.00","0.00","0.00","0.00","0.00","0.00","Active TB","Sputum","0","0","0","","WHO recommended","Test Directory"
"a2v69000004gKor","a2r69000007lb8n","a266900000B8tsw","06.07.2023","Nehren","Germany","European Region","hain-lifescience.de/en/","Hain Lifescience GmbH","GenoType MTBDRsl VER 2.0","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB 23S rRNA","Hybridization","","Colorimetric","eis promoter; gyrA; gyrB; rrs","","Ethambutol; Fluoroquinolone; Kanamycin","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Manual","Lab-based","Intended for professional use only","Sputum; Sputum Culture","Sputum Culture isolates","300.00","Yes","No","SLID resistance","PD-57992","DNA","Independent","Other","Other","0.00","0.00","0.00","0.00","0.00","0.00","Active TB","Sputum","0","0","0","SLID resistance","WHO recommended","Test Directory"
"a2v69000004gKor","a2r69000007lb8n","a266900000B8tsx","06.07.2023","Nehren","Germany","European Region","hain-lifescience.de/en/","Hain Lifescience GmbH","GenoType MTBDRsl VER 2.0","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB 23S rRNA","Hybridization","","Colorimetric","eis promoter; gyrA; gyrB; rrs","","Ethambutol; Fluoroquinolone; Kanamycin","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Manual","Lab-based","Intended for professional use only","Sputum; Sputum Culture","Sputum Culture isolates","300.00","Yes","No","TB detection from sputum","PD-57993","DNA","Company-Sponsored","Instructions for Use (IFU)","Not applicable","98.80","0.00","0.00","89.60","0.00","0.00","Active TB","Sputum","331","259","72","","WHO recommended","Test Directory"
"a2v69000004gKor","a2r69000007lb8n","a266900000B8tsy","06.07.2023","Nehren","Germany","European Region","hain-lifescience.de/en/","Hain Lifescience GmbH","GenoType MTBDRsl VER 2.0","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB 23S rRNA","Hybridization","","Colorimetric","eis promoter; gyrA; gyrB; rrs","","Ethambutol; Fluoroquinolone; Kanamycin","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Manual","Lab-based","Intended for professional use only","Sputum; Sputum Culture","Sputum Culture isolates","300.00","Yes","No","FLQ detection from sputum","PD-57994","DNA","Company-Sponsored","Instructions for Use (IFU)","Fluoroquinolone","93.10","0.00","0.00","100.00","0.00","0.00","Active TB","Sputum","251","54","197","","WHO recommended","Test Directory"
"a2v69000004gKor","a2r69000007lb8n","a266900000B8tsz","06.07.2023","Nehren","Germany","European Region","hain-lifescience.de/en/","Hain Lifescience GmbH","GenoType MTBDRsl VER 2.0","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB 23S rRNA","Hybridization","","Colorimetric","eis promoter; gyrA; gyrB; rrs","","Ethambutol; Fluoroquinolone; Kanamycin","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Manual","Lab-based","Intended for professional use only","Sputum; Sputum Culture","Sputum Culture isolates","300.00","Yes","No","AMK detection from sputum","PD-57995","DNA","Company-Sponsored","Instructions for Use (IFU)","Amikacin","94.70","0.00","0.00","98.10","0.00","0.00","Active TB","Sputum","251","40","211","","WHO recommended","Test Directory"
"a2v69000004gKor","a2r69000007lb8n","a266900000B8tt0","06.07.2023","Nehren","Germany","European Region","hain-lifescience.de/en/","Hain Lifescience GmbH","GenoType MTBDRsl VER 2.0","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB 23S rRNA","Hybridization","","Colorimetric","eis promoter; gyrA; gyrB; rrs","","Ethambutol; Fluoroquinolone; Kanamycin","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Manual","Lab-based","Intended for professional use only","Sputum; Sputum Culture","Sputum Culture isolates","300.00","Yes","No","CAP detection from sputum","PD-57996","DNA","Company-Sponsored","Instructions for Use (IFU)","Capreomycin","90.00","0.00","0.00","98.10","0.00","0.00","Active TB","Sputum","251","40","211","","WHO recommended","Test Directory"
"a2v69000004gKor","a2r69000007lb8n","a266900000B8tt1","06.07.2023","Nehren","Germany","European Region","hain-lifescience.de/en/","Hain Lifescience GmbH","GenoType MTBDRsl VER 2.0","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB 23S rRNA","Hybridization","","Colorimetric","eis promoter; gyrA; gyrB; rrs","","Ethambutol; Fluoroquinolone; Kanamycin","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Manual","Lab-based","Intended for professional use only","Sputum; Sputum Culture","Sputum Culture isolates","300.00","Yes","No","KAN detection from sputum","PD-57997","DNA","Company-Sponsored","Instructions for Use (IFU)","Kanamycin","94.80","0.00","0.00","96.60","0.00","0.00","Active TB","Sputum","251","79","172","","WHO recommended","Test Directory"
"a2v69000004gKoq","a2r69000007lb8n","a266900000B8tsm","06.07.2023","Nehren","Germany","European Region","hain-lifescience.de/en/","Hain Lifescience GmbH","GenoType MTBDRsl VER 2.0","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB 23S rRNA","Hybridization","","Colorimetric","eis promoter; gyrA; gyrB; rrs","","Ethambutol; Fluoroquinolone; Kanamycin","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Manual","Lab-based","Intended for professional use only","Sputum; Sputum Culture","Sputum Culture isolates","300.00","Yes","No","TB Detection","PD-57982","DNA","Independent","Other","Not applicable","0.00","0.00","0.00","0.00","0.00","0.00","Active TB","Sputum","0","0","0","","WHO recommended","Test Directory"
"a2v69000004gKoq","a2r69000007lb8n","a266900000B8tsn","06.07.2023","Nehren","Germany","European Region","hain-lifescience.de/en/","Hain Lifescience GmbH","GenoType MTBDRsl VER 2.0","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB 23S rRNA","Hybridization","","Colorimetric","eis promoter; gyrA; gyrB; rrs","","Ethambutol; Fluoroquinolone; Kanamycin","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Manual","Lab-based","Intended for professional use only","Sputum; Sputum Culture","Sputum Culture isolates","300.00","Yes","No","Fluoroquinolone resistance","PD-57983","DNA","Independent","Other","Fluoroquinolone","0.00","0.00","0.00","0.00","0.00","0.00","Active TB","Sputum","0","0","0","","WHO recommended","Test Directory"
"a2v69000004gKoq","a2r69000007lb8n","a266900000B8tso","06.07.2023","Nehren","Germany","European Region","hain-lifescience.de/en/","Hain Lifescience GmbH","GenoType MTBDRsl VER 2.0","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB 23S rRNA","Hybridization","","Colorimetric","eis promoter; gyrA; gyrB; rrs","","Ethambutol; Fluoroquinolone; Kanamycin","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Manual","Lab-based","Intended for professional use only","Sputum; Sputum Culture","Sputum Culture isolates","300.00","Yes","No","SLID resistance","PD-57984","DNA","Independent","Other","Other","0.00","0.00","0.00","0.00","0.00","0.00","Active TB","Sputum","0","0","0","SLID resistance","WHO recommended","Test Directory"
"a2v69000004gKoq","a2r69000007lb8n","a266900000B8tsp","06.07.2023","Nehren","Germany","European Region","hain-lifescience.de/en/","Hain Lifescience GmbH","GenoType MTBDRsl VER 2.0","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB 23S rRNA","Hybridization","","Colorimetric","eis promoter; gyrA; gyrB; rrs","","Ethambutol; Fluoroquinolone; Kanamycin","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Manual","Lab-based","Intended for professional use only","Sputum; Sputum Culture","Sputum Culture isolates","300.00","Yes","No","TB detection from sputum","PD-57985","DNA","Company-Sponsored","Instructions for Use (IFU)","Not applicable","98.80","0.00","0.00","89.60","0.00","0.00","Active TB","Sputum","331","259","72","","WHO recommended","Test Directory"
"a2v69000004gKoq","a2r69000007lb8n","a266900000B8tsq","06.07.2023","Nehren","Germany","European Region","hain-lifescience.de/en/","Hain Lifescience GmbH","GenoType MTBDRsl VER 2.0","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB 23S rRNA","Hybridization","","Colorimetric","eis promoter; gyrA; gyrB; rrs","","Ethambutol; Fluoroquinolone; Kanamycin","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Manual","Lab-based","Intended for professional use only","Sputum; Sputum Culture","Sputum Culture isolates","300.00","Yes","No","FLQ detection from sputum","PD-57986","DNA","Company-Sponsored","Instructions for Use (IFU)","Fluoroquinolone","93.10","0.00","0.00","100.00","0.00","0.00","Active TB","Sputum","251","54","197","","WHO recommended","Test Directory"
"a2v69000004gKoq","a2r69000007lb8n","a266900000B8tsr","06.07.2023","Nehren","Germany","European Region","hain-lifescience.de/en/","Hain Lifescience GmbH","GenoType MTBDRsl VER 2.0","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB 23S rRNA","Hybridization","","Colorimetric","eis promoter; gyrA; gyrB; rrs","","Ethambutol; Fluoroquinolone; Kanamycin","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Manual","Lab-based","Intended for professional use only","Sputum; Sputum Culture","Sputum Culture isolates","300.00","Yes","No","AMK detection from sputum","PD-57987","DNA","Company-Sponsored","Instructions for Use (IFU)","Amikacin","94.70","0.00","0.00","98.10","0.00","0.00","Active TB","Sputum","251","40","211","","WHO recommended","Test Directory"
"a2v69000004gKoq","a2r69000007lb8n","a266900000B8tss","06.07.2023","Nehren","Germany","European Region","hain-lifescience.de/en/","Hain Lifescience GmbH","GenoType MTBDRsl VER 2.0","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB 23S rRNA","Hybridization","","Colorimetric","eis promoter; gyrA; gyrB; rrs","","Ethambutol; Fluoroquinolone; Kanamycin","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Manual","Lab-based","Intended for professional use only","Sputum; Sputum Culture","Sputum Culture isolates","300.00","Yes","No","CAP detection from sputum","PD-57988","DNA","Company-Sponsored","Instructions for Use (IFU)","Capreomycin","90.00","0.00","0.00","98.10","0.00","0.00","Active TB","Sputum","251","40","211","","WHO recommended","Test Directory"
"a2v69000004gKoq","a2r69000007lb8n","a266900000B8tst","06.07.2023","Nehren","Germany","European Region","hain-lifescience.de/en/","Hain Lifescience GmbH","GenoType MTBDRsl VER 2.0","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB 23S rRNA","Hybridization","","Colorimetric","eis promoter; gyrA; gyrB; rrs","","Ethambutol; Fluoroquinolone; Kanamycin","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Manual","Lab-based","Intended for professional use only","Sputum; Sputum Culture","Sputum Culture isolates","300.00","Yes","No","KAN detection from sputum","PD-57989","DNA","Company-Sponsored","Instructions for Use (IFU)","Kanamycin","94.80","0.00","0.00","96.60","0.00","0.00","Active TB","Sputum","251","79","172","","WHO recommended","Test Directory"
"a2v69000004gKot","a2r69000007lb8q","a266900000B8tt3","06.07.2023","Nehren","Germany","European Region","hain-lifescience.de/en/","Hain Lifescience GmbH","LiquidArray MTB-XDR VER 1.0","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","CE-IVDD","Already on the market (commercialized)","Molecular","DNA","MTB IS6110","qPCR","","Fluorescence","embB; gyrA; gyrB; rplC; rrl; rrs","","Amikacin; Ethambutol; Fluoroquinolone; Linezolid","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Automated (excluding sample preparation)","Lab-based","Intended for professional use only","Sputum; Sputum Culture","liquid Sputum Culture from Mgit","180.00","Yes","No","","PD-57999","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gKos","a2r69000007lb8q","a266900000B8tt2","06.07.2023","Nehren","Germany","European Region","hain-lifescience.de/en/","Hain Lifescience GmbH","LiquidArray MTB-XDR VER 1.0","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","CE-IVDD","Already on the market (commercialized)","Molecular","DNA","MTB IS6110","qPCR","","Fluorescence","embB; gyrA; gyrB; rplC; rrl; rrs","","Amikacin; Ethambutol; Fluoroquinolone; Linezolid","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Automated (excluding sample preparation)","Lab-based","Intended for professional use only","Sputum; Sputum Culture","liquid Sputum Culture from Mgit","180.00","Yes","No","","PD-57998","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gKou","a2r69000007lb8q","a266900000B8tt4","06.07.2023","Nehren","Germany","European Region","hain-lifescience.de/en/","Hain Lifescience GmbH","LiquidArray MTB-XDR VER 1.0","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","CE-IVDD","Already on the market (commercialized)","Molecular","DNA","MTB IS6110","qPCR","","Fluorescence","embB; gyrA; gyrB; rplC; rrl; rrs","","Amikacin; Ethambutol; Fluoroquinolone; Linezolid","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Automated (excluding sample preparation)","Lab-based","Intended for professional use only","Sputum; Sputum Culture","liquid Sputum Culture from Mgit","180.00","Yes","No","","PD-58000","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gKox","a2r69000007lbFG","a266900000B8ttb","06.07.2023","Germantown","United States","Region of the Americas","www.qiagen.com","QIAGEN GmbH","LIAISON QuantiFERON-TB Gold Plus assay","Triage/Screening","ID","Tuberculosis","Latent","Mycobacterium Tuberculosis","Regulatory Achieved","CE-IVDD; US FDA PMA","Already on the market (commercialized)","Immunoassay","Antigen","MTB CFP-10; MTB ESAT-6","ELISA/EIA; IGRA","","Colorimetric","Not applicable","","Not applicable","","Chemiluminescent Immunoassay (CLIA)","","A proprietary/new instrument is required","Automated (excluding sample preparation)","Lab-based","Intended for professional use only","Whole Blood","","","Yes","No","","PD-58033","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gKow","a2r69000007lbFG","a266900000B8tta","06.07.2023","Germantown","United States","Region of the Americas","www.qiagen.com","QIAGEN GmbH","LIAISON QuantiFERON-TB Gold Plus assay","Triage/Screening","ID","Tuberculosis","Latent","Mycobacterium Tuberculosis","Regulatory Achieved","CE-IVDD; US FDA PMA","Already on the market (commercialized)","Immunoassay","Antigen","MTB CFP-10; MTB ESAT-6","ELISA/EIA; IGRA","","Colorimetric","Not applicable","","Not applicable","","Chemiluminescent Immunoassay (CLIA)","","A proprietary/new instrument is required","Automated (excluding sample preparation)","Lab-based","Intended for professional use only","Whole Blood","","","Yes","No","","PD-58032","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gKoz","a2r69000007lbLF","a266900000B8ttd","06.07.2023","Germantown","United States","Region of the Americas","www.qiagen.com","QIAGEN GmbH","QIAReach QuantiFERON-TB","Triage/Screening","ID","Tuberculosis","Latent","Mycobacterium Tuberculosis","Regulatory Achieved","CE-IVDD","Already on the market (commercialized)","Immunoassay","Antigen","Interferon Gamma","Lateral Flow Assay; IGRA","","Fluorescence","Not applicable","","Not applicable","","Cartridge-based processing","","A proprietary/new instrument is required","Automated (excluding sample preparation)","near Point of Care","Intended for professional use only","Whole Blood","","1440.00","Yes","No","","PD-58035","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gKoy","a2r69000007lbFG","a266900000B8ttc","06.07.2023","Germantown","United States","Region of the Americas","www.qiagen.com","QIAGEN GmbH","LIAISON QuantiFERON-TB Gold Plus assay","Triage/Screening","ID","Tuberculosis","Latent","Mycobacterium Tuberculosis","Regulatory Achieved","CE-IVDD; US FDA PMA","Already on the market (commercialized)","Immunoassay","Antigen","MTB CFP-10; MTB ESAT-6","ELISA/EIA; IGRA","","Colorimetric","Not applicable","","Not applicable","","Chemiluminescent Immunoassay (CLIA)","","A proprietary/new instrument is required","Automated (excluding sample preparation)","Lab-based","Intended for professional use only","Whole Blood","","","Yes","No","","PD-58034","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gKpC","a2r69000007lbFI","a266900000B8ttq","06.07.2023","Rotkreuz","Switzerland","European Region","molecular.roche.com","Roche Diagnostics International AG","cobas MTB","Diagnostic/confirmatory test","ID","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","Brazil ANVISA; CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB 16S rRNA; Other","qPCR","","Fluorescence","Not applicable","","Not applicable","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Manual","Lab-based","Intended for professional use only","Bronchoalveolar lavage; Sputum; Other","Sputum Sediment","","Yes","Yes","TB detection from sputum","PD-58048","DNA","Company-Sponsored","Instructions for Use (IFU)","Not applicable","98.90","96.90","99.70","98.20","96.10","99.30","Active TB","Sputum","","","","","WHO recommended","Test Directory"
"a2v69000004gKpD","a2r69000007lbFI","a266900000B8ttr","06.07.2023","Rotkreuz","Switzerland","European Region","molecular.roche.com","Roche Diagnostics International AG","cobas MTB","Diagnostic/confirmatory test","ID","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","Brazil ANVISA; CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB 16S rRNA; Other","qPCR","","Fluorescence","Not applicable","","Not applicable","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Manual","Lab-based","Intended for professional use only","Bronchoalveolar lavage; Sputum; Other","Sputum Sediment","","Yes","No","TB detection from sputum","PD-58049","DNA","Company-Sponsored","Instructions for Use (IFU)","Not applicable","98.90","96.90","99.70","98.20","96.10","99.30","Active TB","Sputum","0","0","0","","WHO recommended","Test Directory"
"a2v69000004gKoj","a2r69000007lbEv","a266900000B8tsL","06.07.2023","Nehren","Germany","European Region","hain-lifescience.de/en/","Hain Lifescience GmbH","GenoType MTBDRplus VER 2.0","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","Brazil ANVISA; CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB 23S rRNA","Hybridization","","Colorimetric","inhA promoter; katG; rpoB","inhA promoter","Isoniazid; Rifampicin","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Manual","Lab-based","Intended for professional use only","Sputum; Sputum Culture; Other","bronchial material; Aspirates","300.00","Yes","Yes","RIF detection from sputum","PD-57955","DNA","Independent","Other","Rifampicin","95.80","92.60","97.60","98.40","96.90","99.20","Active TB","Sputum","","","","","WHO recommended","Test Directory"
"a2v69000004gKoj","a2r69000007lbEv","a266900000B8tsM","06.07.2023","Nehren","Germany","European Region","hain-lifescience.de/en/","Hain Lifescience GmbH","GenoType MTBDRplus VER 2.0","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","Brazil ANVISA; CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB 23S rRNA","Hybridization","","Colorimetric","inhA promoter; katG; rpoB","inhA promoter","Isoniazid; Rifampicin","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Manual","Lab-based","Intended for professional use only","Sputum; Sputum Culture; Other","bronchial material; Aspirates","300.00","Yes","Yes","INH detection from sputum","PD-57956","DNA","Independent","Other","Isoniazid","94.50","91.40","96.50","99.30","92.60","100.00","Active TB","Sputum","","","","","WHO recommended","Test Directory"
"a2v69000004gKoj","a2r69000007lbEv","a266900000B8tsN","06.07.2023","Nehren","Germany","European Region","hain-lifescience.de/en/","Hain Lifescience GmbH","GenoType MTBDRplus VER 2.0","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","Brazil ANVISA; CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB 23S rRNA","Hybridization","","Colorimetric","inhA promoter; katG; rpoB","inhA promoter","Isoniazid; Rifampicin","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Manual","Lab-based","Intended for professional use only","Sputum; Sputum Culture; Other","bronchial material; Aspirates","300.00","Yes","Yes","RIF detection from culture isolates","PD-57957","DNA","Independent","Other","Rifampicin","91.30","86.00","95.00","98.00","94.30","98.70","Active TB","Sputum Culture","","","","","WHO recommended","Test Directory"
"a2v69000004gKoj","a2r69000007lbEv","a266900000B8tsO","06.07.2023","Nehren","Germany","European Region","hain-lifescience.de/en/","Hain Lifescience GmbH","GenoType MTBDRplus VER 2.0","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","Brazil ANVISA; CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB 23S rRNA","Hybridization","","Colorimetric","inhA promoter; katG; rpoB","inhA promoter","Isoniazid; Rifampicin","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Manual","Lab-based","Intended for professional use only","Sputum; Sputum Culture; Other","bronchial material; Aspirates","300.00","Yes","Yes","INH detection from culture isolates","PD-57958","DNA","Independent","Other","Isoniazid","89.40","84.30","93.30","98.90","96.00","99.90","Active TB","Sputum Culture","","","","","WHO recommended","Test Directory"
"a2v69000004gKol","a2r69000007lbF1","a266900000B8tsT","06.07.2023","Nehren","Germany","European Region","hain-lifescience.de/en/","Hain Lifescience GmbH","FluoroType Mycobacteria VER 1.0 PCR Kit","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","CE-IVDD","Already on the market (commercialized)","Molecular","DNA","MTB IS6110","qPCR","","Fluorescence","Not applicable","","Not applicable","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Automated (excluding sample preparation)","Lab-based","Intended for professional use only","Sputum; Sputum Culture","liquid Sputum Culture from Mgit","180.00","Yes","No","","PD-57963","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gKok","a2r69000007lbEv","a266900000B8tsP","06.07.2023","Nehren","Germany","European Region","hain-lifescience.de/en/","Hain Lifescience GmbH","GenoType MTBDRplus VER 2.0","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","Brazil ANVISA; CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB 23S rRNA","Hybridization","","Colorimetric","inhA promoter; katG; rpoB","inhA promoter","Isoniazid; Rifampicin","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Manual","Lab-based","Intended for professional use only","Sputum; Sputum Culture; Other","bronchial material; Aspirates","300.00","Yes","Yes","RIF detection from sputum","PD-57959","DNA","Independent","Other","Rifampicin","95.80","92.60","97.60","98.40","96.90","99.20","Active TB","Sputum","","","","","WHO recommended","Test Directory"
"a2v69000004gKok","a2r69000007lbEv","a266900000B8tsQ","06.07.2023","Nehren","Germany","European Region","hain-lifescience.de/en/","Hain Lifescience GmbH","GenoType MTBDRplus VER 2.0","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","Brazil ANVISA; CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB 23S rRNA","Hybridization","","Colorimetric","inhA promoter; katG; rpoB","inhA promoter","Isoniazid; Rifampicin","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Manual","Lab-based","Intended for professional use only","Sputum; Sputum Culture; Other","bronchial material; Aspirates","300.00","Yes","Yes","INH detection from sputum","PD-57960","DNA","Independent","Other","Isoniazid","94.50","91.40","96.50","99.30","92.60","100.00","Active TB","Sputum","","","","","WHO recommended","Test Directory"
"a2v69000004gKok","a2r69000007lbEv","a266900000B8tsR","06.07.2023","Nehren","Germany","European Region","hain-lifescience.de/en/","Hain Lifescience GmbH","GenoType MTBDRplus VER 2.0","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","Brazil ANVISA; CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB 23S rRNA","Hybridization","","Colorimetric","inhA promoter; katG; rpoB","inhA promoter","Isoniazid; Rifampicin","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Manual","Lab-based","Intended for professional use only","Sputum; Sputum Culture; Other","bronchial material; Aspirates","300.00","Yes","Yes","RIF detection from culture isolates","PD-57961","DNA","Independent","Other","Rifampicin","91.30","86.00","95.00","98.00","94.30","98.70","Active TB","Sputum Culture","","","","","WHO recommended","Test Directory"
"a2v69000004gKok","a2r69000007lbEv","a266900000B8tsS","06.07.2023","Nehren","Germany","European Region","hain-lifescience.de/en/","Hain Lifescience GmbH","GenoType MTBDRplus VER 2.0","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","Brazil ANVISA; CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB 23S rRNA","Hybridization","","Colorimetric","inhA promoter; katG; rpoB","inhA promoter","Isoniazid; Rifampicin","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Manual","Lab-based","Intended for professional use only","Sputum; Sputum Culture; Other","bronchial material; Aspirates","300.00","Yes","Yes","INH detection from culture isolates","PD-57962","DNA","Independent","Other","Isoniazid","89.40","84.30","93.30","98.90","96.00","99.90","Active TB","Sputum Culture","","","","","WHO recommended","Test Directory"
"a2v69000004gKon","a2r69000007lbF1","a266900000B8tsV","06.07.2023","Nehren","Germany","European Region","hain-lifescience.de/en/","Hain Lifescience GmbH","FluoroType Mycobacteria VER 1.0 PCR Kit","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","CE-IVDD","Already on the market (commercialized)","Molecular","DNA","MTB IS6110","qPCR","","Fluorescence","Not applicable","","Not applicable","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Automated (excluding sample preparation)","Lab-based","Intended for professional use only","Sputum; Sputum Culture","liquid Sputum Culture from Mgit","180.00","Yes","No","","PD-57965","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gKom","a2r69000007lbF1","a266900000B8tsU","06.07.2023","Nehren","Germany","European Region","hain-lifescience.de/en/","Hain Lifescience GmbH","FluoroType Mycobacteria VER 1.0 PCR Kit","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","CE-IVDD","Already on the market (commercialized)","Molecular","DNA","MTB IS6110","qPCR","","Fluorescence","Not applicable","","Not applicable","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Automated (excluding sample preparation)","Lab-based","Intended for professional use only","Sputum; Sputum Culture","liquid Sputum Culture from Mgit","180.00","Yes","No","","PD-57964","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gLAu","a2r69000007lbF3","a266900000B8ts9","06.07.2023","Moscow","Russian Federation","European Region","generium.ru/en","Generium","Diaskintest","Triage/Screening","ID","Tuberculosis","Latent","Mycobacterium Tuberculosis","Regulatory Achieved","WHO recommended","Already on the market (commercialized)","Immunoassay","Antigen","MTB CFP-10; MTB ESAT-6","Host Immune Response","Skin test","Colorimetric","Not applicable","","Not applicable","","Other","Injectable","No instrumentation is required","Manual","True Point of Care","Intended for professional use only","Other","injection under skin","","Yes","No","","PD-57943","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gLJP","a2r69000007lbEw","a266900000B8tt5","06.07.2023","Leiden","Netherlands","European Region","lumc.nl","Leiden Unversity Medical Center","TB Triage multiplex LFA","Triage/Screening","ID","Tuberculosis","Active","Mycobacterium Tuberculosis","Early Stage Development (partial prototype)","None","Unspecified Market Entry","Immunoassay","Antigen","Unknown","Lateral Flow Assay","","Colorimetric","Not applicable","","Not applicable","","Rapid diagnostic test (strip or cassette)","","No instrumentation is required","Manual","near Point of Care","Intended for professional use only","Finger prick blood","","","Yes","No","","PD-58001","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gLK1","a2r69000007lbEx","a266900000B8tt8","06.07.2023","Braunschweig","Germany","European Region","lionex.de","LIONEX Diagnostics & Therapeutics GmbH","LIOFeron TB/LTBI IGRA; HUMAN IFN-g ELISA KIT","Triage/Screening","ID","Tuberculosis","Latent","Mycobacterium Tuberculosis","Regulatory Achieved","CE-IVDD","Already on the market (commercialized)","Immunoassay","Antigen","Interferon Gamma","ELISA/EIA; IGRA","","Colorimetric","Not applicable","","Not applicable","","Chemiluminescent Immunoassay (CLIA)","","Standard lab instrumentation is required","Manual","Lab-based","Intended for professional use only","Whole Blood","Blood stimulation tubes","1440.00","Yes","No","","PD-58004","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gLJU","a2r69000007lb8v","a266900000B8tt6","06.07.2023","Cambridge","United States","Region of the Americas","innovation.lgchem.com","LG Chem Life Sciences Company","AdvanSure TB-IGRA ELISA","Triage/Screening","ID","Tuberculosis","Latent","Mycobacterium Tuberculosis","Research Use Only (RUO)","None","Already on the market (commercialized)","Immunoassay","Antigen","Interferon Gamma","ELISA/EIA; IGRA","","Colorimetric","Not applicable","","Not applicable","","Chemiluminescent Immunoassay (CLIA)","","Standard lab instrumentation is required","Manual","Lab-based","Intended for professional use only","Whole Blood","heprin","","Yes","No","","PD-58002","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gLJW","a2r69000007lb8s","a266900000B8tt7","06.07.2023","London","United Kingdom","European Region","lifearc.org","LifeArc","TB-MBLA","Monitoring (treatment, immune status, patient)","ID","Tuberculosis","Active","Mycobacterium Tuberculosis","Late Stage Development (fully functional prototype)","None","Unspecified Market Entry","Molecular","RNA","MTB 23S rRNA","qPCR","","Fluorescence","Not applicable","","Not applicable","","NAT reagent kit (open source)","","Standard lab instrumentation is required","Manual","Lab-based","Intended for professional use only","Sputum","","300.00","Yes","No","","PD-58003","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gKiF","a2r69000007lbF7","a266900000B8trH","06.07.2023","Beijing","China","Western Pacific Region","capitalbiotechnology.com","CapitalBio Technology Co., Ltd.","Genechip MDR kit","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis","Late Stage Development (fully functional prototype)","None","Unspecified Market Entry","Molecular","DNA","Unknown","Other","Microarray","Fluorescence","inhA; katG; rpoB","","Isoniazid; Rifampicin","","Cartridge-based processing","microarray chip based","A proprietary/new instrument is required","Unknown","Lab-based","Intended for professional use only","Sputum","","","Yes","No","","PD-57889","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000004gKgk","a2r69000007lbEp","a266900000B8tqw","06.07.2023","Beijing","China","Western Pacific Region","abiores.com","Bao Ruiyuan Biotech(Beijing) Co.,ltd.","Mycobacterium Tuberculosis and Drug Resistance Gene Rapid NAT Test Kit","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis","Late Stage Development (fully functional prototype)","None","Unspecified Market Entry","Molecular","DNA","MTB H37Rv gene","qPCR","POC NAT","Fluorescence","embB; gyrA; gyrB; inhA; katG; rpoB; rpsL","","Ethambutol; Fluoroquinolone; Isoniazid; Rifampicin; Streptomycin","","Cartridge-based processing","","A proprietary/new instrument is required","Automated (excluding sample preparation)","near Point of Care","Intended for professional use only","Sputum","","60.00","Yes","No","","PD-57868","","Company-Sponsored","","","0.00","0.00","0.00","0.00","0.00","0.00","","","0","0","0","","","Test Directory"
"a2v69000002xsOh","a2r69000009kS4Z","a266900000C4Gd1","21.10.2023","Nehren","Germany","European Region","hain-lifescience.de/en/","Hain Lifescience GmbH","FluoroType MTB VER 1.0","Diagnostic/confirmatory test","ID","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB IS6110","qPCR","","Fluorescence","Not applicable","","","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Automated (excluding sample preparation)","Lab-based","Intended for professional use only","Sputum","","180.00","Yes","Yes","TB detection from sputum","PD-69678","DNA","Independent","Systematic review + Meta-analysis","","92.10","87.60","93.30","98.90","64.00","99.90","Active TB","Sputum","2660","","","","WHO recommended","Test Directory"
"a2v69000002xsOc","a2r69000009kS4e","a266900000B8tsJ","21.10.2023","Nehren","Germany","European Region","hain-lifescience.de/en/","Hain Lifescience GmbH","FluoroType MTBDR VER 1.0","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","Brazil ANVISA; CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB rpoB gene","qPCR","","Fluorescence","inhA promoter; katG; rpoB","","Isoniazid; Rifampicin","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Automated (excluding sample preparation)","Lab-based","Intended for professional use only","Sputum","","180.00","Yes","Yes","TB detection from sputum","PD-57953","DNA","Independent","Systematic review + Meta-analysis","","","91.00","96.00","100.00","97.00","100.00","Active TB","Sputum","782","","","","WHO recommended","Test Directory"
"a2v69000002xsOc","a2r69000009kS4e","a266900000C4Gd6","21.10.2023","Nehren","Germany","European Region","hain-lifescience.de/en/","Hain Lifescience GmbH","FluoroType MTBDR VER 1.0","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","Brazil ANVISA; CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB rpoB gene","qPCR","","Fluorescence","inhA promoter; katG; rpoB","","Isoniazid; Rifampicin","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Automated (excluding sample preparation)","Lab-based","Intended for professional use only","Sputum","","180.00","Yes","Yes","RIF detection from sputum & culture isolates","PD-69679","DNA","Independent","Systematic review + Meta-analysis","Rifampicin","","97.00","99.00","100.00","85.00","100.00","Active TB","Sputum; Sputum Culture","231","","","","WHO recommended","Test Directory"
"a2v69000002xsOc","a2r69000009kS4e","a266900000C4Gd7","21.10.2023","Nehren","Germany","European Region","hain-lifescience.de/en/","Hain Lifescience GmbH","FluoroType MTBDR VER 1.0","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","Brazil ANVISA; CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB rpoB gene","qPCR","","Fluorescence","inhA promoter; katG; rpoB","","Isoniazid; Rifampicin","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Automated (excluding sample preparation)","Lab-based","Intended for professional use only","Sputum","","180.00","Yes","Yes","INH detection from sputum & culture isolates","PD-69680","DNA","Independent","Systematic review + Meta-analysis","Isoniazid","","70.00","92.00","100.00","84.00","100.00","Active TB","Sputum; Sputum Culture","207","","","","WHO recommended","Test Directory"
"a2vVj000000JSDV","a2rVj0000002CrV","","30.01.2024","Neuried","Germany","European Region","frizbiochem.de","FRIZ Biochem GmbH","TB Assay","Diagnostic/confirmatory test","ID","Tuberculosis","Active","Mycobacterium Tuberculosis","Early Stage Development (partial prototype)","None","Unspecified Market Entry","Molecular","DNA","","","","","Not applicable","","Not applicable","","Cartridge-based processing","","A proprietary/new instrument is required","Automated (excluding sample preparation)","near Point of Care","Intended for professional use only","Other","Tongue swab","","Yes","","","","","","","","","","","","","","","","","","","","","Test Directory"
"a2vVj000000JRir","a2rVj0000002Cmf","","30.01.2024","Chuncheon-s","Korea, Republic of","Western Pacific Region","boditech.co.kr/en","Boditech Med Inc.","ichroma LAM Ag","Diagnostic/confirmatory test","ID","Tuberculosis","Active","Mycobacterium Tuberculosis","Late Stage Development (fully functional prototype)","None","Unspecified Market Entry","Immunoassay","Antigen","Lipoarabinomannan (LAM)","Lateral Flow Assay","","Fluorescence","Not applicable","","Not applicable","","Cartridge-based processing","","A proprietary/new instrument is required","Fully automated (including sample preparation)","near Point of Care","Intended for professional use only","Urine","","","Yes","","","","","","","","","","","","","","","","","","","","","Test Directory"
"a2vVj000000JRhF","a2rVj0000002CoH","","30.01.2024","Philadelphia","United States","Region of the Americas","biomeme.com","Biomeme Inc","Biomeme TB assay","Diagnostic/confirmatory test","ID","Tuberculosis","Active","Mycobacterium Tuberculosis","Early Stage Development (partial prototype)","None","Unspecified Market Entry","Molecular","DNA","","qPCR","","Fluorescence","Not applicable","","Not applicable","","Cartridge-based processing","","A proprietary/new instrument is required","Automated (excluding sample preparation)","near Point of Care","Intended for professional use only","Other","Tongue swab","","Yes","","","","","","","","","","","","","","","","","","","","","Test Directory"
"a2vVj000000JSev","a2rVj0000002Cuj","","30.01.2024","NEW ORLEANS","United States","Region of the Americas","","IntelliGenome, LLC","CHALET CRISPR-TB Point of Care","Diagnostic/confirmatory test","ID","Tuberculosis","Active","Mycobacterium Tuberculosis","Early Stage Development (partial prototype)","None","Unspecified Market Entry","Molecular","cDNA","MTB IS6110","PCR (conventional); Nucleic Acid Lateral Flow Assay (NA-LFA); CRISPR","","Fluorescence","Not applicable","","Not applicable","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","","True Point of Care","Intended for professional use only","Plasma; Serum","","","Yes","","","","","","","","","","","","","","","","","","","","","Test Directory"
"a2vVj000000JSVF","a2rVj0000002Ct7","","30.01.2024","Suzhou","China","Western Pacific Region","microdiag.com","Jiangsu MicroDiag Biomedical Technology Co., Ltd.","NuRapid TB","Diagnostic/confirmatory test","ID","Tuberculosis","Active","Mycobacterium Tuberculosis","Research Use Only (RUO)","Unknown","Already on the market (commercialized)","Molecular","DNA","","Isothermal Other; Nucleic Acid Lateral Flow Assay (NA-LFA); CRISPR","","Colorimetric","Not applicable","","Not applicable","","Cartridge-based processing","","A proprietary/new instrument is required","Manual","True Point of Care","Intended for professional use only","Other","Tongue swab","","Yes","","","","","","","","","","","","","","","","","","","","","Test Directory"
"a2vVj000000JRxN","a2rVj0000002Cpt","","30.01.2024","Austin","United States","Region of the Americas","nuclein.com","Nuclein, LLC","DASH TB","Diagnostic/confirmatory test","ID","Tuberculosis","Active","Mycobacterium Tuberculosis","Early Stage Development (partial prototype)","None","Unspecified Market Entry","Molecular","DNA","Unknown","qPCR","","Fluorescence","Not applicable","","Not applicable","","Cartridge-based processing","","A proprietary/new instrument is required","Automated (excluding sample preparation)","near Point of Care","","Other","Tongue swab","","Yes","","","","","","","","","","","","","","","","","","","","","Test Directory"
"a2v69000004gKqw","a2r69000007lb95","","06.07.2023","Sunnyvale","United States","Region of the Americas","cepheid.com","Cepheid","Xpert MTB/RIF Ultra","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis","Regulatory Achieved","Brazil ANVISA; CE-IVDD; Israel Ministry of Health; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB IS1081; MTB IS6110","qPCR","Melt-curve analysis","Fluorescence","rpoB","RRDR","Rifampicin","","Cartridge-based processing","","A proprietary/new instrument is required","Automated (excluding sample preparation)","near Point of Care","Intended for professional use only","Bronchoalveolar lavage; Sputum; Other","Sputum Sediment","60.00","Yes","","","","","","","","","","","","","","","","","","","","","Test Directory"
"a2v69000004gKqy","a2r69000007lb95","","06.07.2023","Sunnyvale","United States","Region of the Americas","cepheid.com","Cepheid","Xpert MTB/RIF Ultra","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis","Regulatory Achieved","Brazil ANVISA; CE-IVDD; Israel Ministry of Health; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB IS1081; MTB IS6110","qPCR","Melt-curve analysis","Fluorescence","rpoB","RRDR","Rifampicin","","Cartridge-based processing","","A proprietary/new instrument is required","Automated (excluding sample preparation)","near Point of Care","Intended for professional use only","Bronchoalveolar lavage; Sputum; Other","Sputum Sediment","60.00","Yes","","","","","","","","","","","","","","","","","","","","","Test Directory"
"a2v69000004gKoh","a2r69000007lbEu","","06.07.2023","Nehren","Germany","European Region","hain-lifescience.de/en/","Hain Lifescience GmbH","FluoroType MTBDR VER 2.0","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","Brazil ANVISA; CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB rpoB gene","qPCR","","Fluorescence","inhA promoter; katG; rpoB","","Isoniazid; Rifampicin","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Automated (excluding sample preparation)","Lab-based","Intended for professional use only","Sputum; Sputum Culture","liquid Sputum Culture from Mgit","180.00","Yes","","","","","","","","","","","","","","","","","","","","","Test Directory"
"a2v69000004gKog","a2r69000007lbEu","","06.07.2023","Nehren","Germany","European Region","hain-lifescience.de/en/","Hain Lifescience GmbH","FluoroType MTBDR VER 2.0","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","Brazil ANVISA; CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB rpoB gene","qPCR","","Fluorescence","inhA promoter; katG; rpoB","","Isoniazid; Rifampicin","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Automated (excluding sample preparation)","Lab-based","Intended for professional use only","Sputum; Sputum Culture","liquid Sputum Culture from Mgit","180.00","Yes","","","","","","","","","","","","","","","","","","","","","Test Directory"
"a2v69000004gKoi","a2r69000007lbEu","","06.07.2023","Nehren","Germany","European Region","hain-lifescience.de/en/","Hain Lifescience GmbH","FluoroType MTBDR VER 2.0","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","Brazil ANVISA; CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB rpoB gene","qPCR","","Fluorescence","inhA promoter; katG; rpoB","","Isoniazid; Rifampicin","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Automated (excluding sample preparation)","Lab-based","Intended for professional use only","Sputum; Sputum Culture","liquid Sputum Culture from Mgit","180.00","Yes","","","","","","","","","","","","","","","","","","","","","Test Directory"
"a2vVj000000pDT3","a2rVj0000004cgD","","10.04.2024","Ahmedabad","India","South-East Asian Region","ampligeneindia.com","AmpliGene India Biotech Pvt. Ltd.","AmpEZ MTB","Diagnostic/confirmatory test","ID","Tuberculosis","Active","Mycobacterium Tuberculosis","Research Use Only (RUO)","None","Already on the market (commercialized)","Molecular","DNA","Unknown","Isothermal LAMP","","Fluorescence","Not applicable","","Not applicable","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Manual","Lab-based","Intended for professional use only","Sputum","","45.00","Yes","","","","","","","","","","","","","","","","","","","","","Test Directory"
"a2vVj000000JVZa","a2rVj0000002DE5","","30.01.2024","Gurgaon","India","South-East Asian Region","genes2me.com","Genes2Me Pvt Ltd","TBfind (TB Comprehensive)","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis","Research Use Only (RUO)","None","Already on the market (commercialized)","Molecular","DNA","MTB IS6110; Other","qPCR","","Fluorescence","inhA; katG; rpoB","","Isoniazid; Rifampicin","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Automated (excluding sample preparation)","near Point of Care","Intended for professional use only","Sputum","","50.00","Yes","","","","","","","","","","","","","","","","","","","","","Test Directory"
"a2vVj000000JXMr","a2rVj0000002DIv","","30.01.2024","Changsha","China","Western Pacific Region","sansureglobal.com","Sansure Biotech Inc","TB & RIF Resistance Fluorescence Diagnostic Kit","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis","Regulatory Achieved","Indonesia MDR","Already on the market (commercialized)","Molecular","DNA","MTB IS1081; MTB IS6110","qPCR","","Fluorescence","rpoB","","Rifampicin","","NAT reagent kit (proprietary platform)","one tube/pot process - detection has 4 channels","A proprietary/new instrument is required","Automated (excluding sample preparation)","near Point of Care","Intended for professional use only","Sputum; Other","Tongue swab","50.00","Yes","","","","","","","","","","","","","","","","","","","","","Test Directory"
"a2vVj000000JULm","a2rVj0000002DCT","","30.01.2024","Gurgaon","India","South-East Asian Region","genes2me.com","Genes2Me Pvt Ltd","TBdtect (MTC-Q)","Diagnostic/confirmatory test","ID","Tuberculosis","Active","Mycobacterium Tuberculosis","Regulatory Achieved","CE-IVDD","Already on the market (commercialized)","Molecular","DNA","MTB IS6110; Other","qPCR","","Fluorescence","Not applicable","","Not applicable","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Automated (excluding sample preparation)","near Point of Care","","Sputum","","50.00","Yes","","","","","","","","","","","","","","","","","","","","","Test Directory"
"a2vVj000000JSrp","a2rVj0000002CwL","","30.01.2024","Delhi","India","South-East Asian Region","crisprbits.com","CrisprBits","PathCrisp TB Assay","Diagnostic/confirmatory test","ID","Tuberculosis","Active","Mycobacterium Tuberculosis","Early Stage Development (partial prototype)","None","Unspecified Market Entry","Molecular","DNA","","PCR (conventional); CRISPR","","","Not applicable","","Not applicable","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","","True Point of Care","Intended for professional use only","Nasal swab; Saliva","","","Yes","","","","","","","","","","","","","","","","","","","","","Test Directory"
"a2vVj0000002vqD","a2rVj0000000N33","","13.12.2023","Overland","United States","Region of the Americas","auragentbio.com","Auragent Bioscience LLC","Ultrasensitive lateral-flow assay platform for TB LAM test","Diagnostic/confirmatory test","ID","Tuberculosis","Active","Mycobacterium Tuberculosis","Early Stage Development (partial prototype)","None","Unspecified Market Entry","Immunoassay","Antigen","Lipoarabinomannan (LAM)","Lateral Flow Assay","","Fluorescence","Not applicable","","Not applicable","","Rapid diagnostic test (strip or cassette)","","A proprietary/new instrument is required","Manual","True Point of Care","Intended for professional use only","Urine","","","Yes","","","","","","","","","","","","","","","","","","","","","Test Directory"
"a2vVj000001jAnR","a2rVj0000009105","","20.08.2024","Shanghai","China","Western Pacific Region","igenesisbioglobal.com","IGENESIS (SHANGHAI) CO., LTD.","Diagnostic Kit for MTB complex DNA and Rifampicin resistance","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","Other","Already on the market (commercialized)","Molecular","DNA","MTB IS6110","qPCR","","Fluorescence","rpoB","","Rifampicin","","Cartridge-based processing","","A proprietary/new instrument is required","","near Point of Care","Intended for professional use only","Sputum","","120.00","Yes","","","","","","","","","","","","","","","","","","","","Thai Food and Drug Administration (TFDA)","Test Directory"
"a2vVj000001jBDF","a2rVj000000913J","","20.08.2024","Xiamen City","China","Western Pacific Region","zeesandx.com","Xiamen Zeesan Biotech Co., ltd.","MTB/MDR Test Kit (Sanity 2.0)","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","CE-IVDD","Already on the market (commercialized)","Molecular","DNA","MTB IS6110","qPCR","","Fluorescence","inhA; katG; Other; rpoB","ahpC","Isoniazid; Rifampicin","","Cartridge-based processing","","A proprietary/new instrument is required","Fully automated (including sample preparation)","near Point of Care","Intended for professional use only","Sputum; Sputum Culture","","180.00","Yes","","","","","","","","","","","","","","","","","","","","","Test Directory"
"a2v69000003QzLR","a2r6900000859rG","","14.11.2023","Guangzhou","China","Western Pacific Region","pluslife.com","Guangzhou Pluslife Biotech Co., ltd.","Pluslife MTB Card","Diagnostic/confirmatory test","ID","Tuberculosis","Active","Mycobacterium Tuberculosis","Research Use Only (RUO)","None","Unspecified Market Entry","Molecular","DNA","MTB gyrB Gene; MTB IS6110","Isothermal Other","","Fluorescence","Not applicable","","","","Cartridge-based processing","","A proprietary/new instrument is required","Fully automated (including sample preparation)","near Point of Care","Intended for professional use only","Other","Tongue swab","30.00","Yes","","","","","","","","","","","","","","","","","","","","","Test Directory"
"a2v69000003QzLW","a2r6900000859rL","","14.11.2023","Salt Lake City","United States","Region of the Americas","co-dx.com","Co-Diagnostics Inc.","Co-Dx PCR Mycobacterium Tuberculosis Test Kit","Diagnostic/confirmatory test","ID","Tuberculosis","Active","Mycobacterium Tuberculosis Complex Species","Late Stage Development (fully functional prototype)","None","Unspecified Market Entry","Molecular","DNA","MTB IS1081; MTB IS6110","qPCR","","Fluorescence","Not applicable","","Not applicable","","Cartridge-based processing","","A proprietary/new instrument is required","Automated (excluding sample preparation)","near Point of Care","Intended for professional use only","Sputum; Other","Tongue swab","30.00","Yes","","","","","","","","","","","","","","","","","","","","","Test Directory"
"a2v69000003QzLb","a2r6900000859tM","","14.11.2023","Burnaby","Canada","Region of the Americas","geminalabs.com","Gemina Laboratories","LEGIO TB","Triage/Screening","ID","Tuberculosis","Active","Mycobacterium Tuberculosis Complex Species","Early Stage Development (partial prototype)","None","Unspecified Market Entry","Molecular","DNA","","Isothermal Other","","","Not applicable","","Not applicable","","Cartridge-based processing","","A proprietary/new instrument is required","","near Point of Care","Intended for professional use only","Other","Tongue swab","30.00","Yes","","","","","","","","","","","","","","","","","","","","","Test Directory"
"a2vVj000000JXmf","a2rVj0000002DKX","","30.01.2024","Beijing","China","Western Pacific Region","coyotebio.com","Coyote Bioscience Co., Ltd.","FlashDetect LyocartE MTB Assay","Diagnostic/confirmatory test","ID","Tuberculosis","Active","Mycobacterium Tuberculosis","Regulatory Achieved","CE-IVDD","Already on the market (commercialized)","Molecular","DNA","MTB IS1081; MTB IS6110","qPCR","","Fluorescence","Not applicable","","Not applicable","","Cartridge-based processing","","A proprietary/new instrument is required","Automated (excluding sample preparation)","near Point of Care","Intended for professional use only","Sputum; Other","Tongue swab","30.00","Yes","","","","","","","","","","","","","","","","","","","","","Test Directory"
"a2v69000002xsNy","a2r69000009kS45","","20.10.2023","Nehren","Germany","European Region","hain-lifescience.de/en/","Hain Lifescience GmbH","FluoroType MTB VER 2.0","Diagnostic/confirmatory test","ID","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","CE-IVDD; WHO recommended","Already on the market (commercialized)","Molecular","DNA","MTB IS6110","qPCR","","Fluorescence","Not applicable","","","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Automated (excluding sample preparation)","Lab-based","Intended for professional use only","Sputum","","180.00","Yes","","","","","","","","","","","","","","","","","","","","WHO recommended","Test Directory"
"a2vVj000001jPo5","a2rVj00000091Cz","","21.08.2024","Seongnam-si","Korea, Republic of","Western Pacific Region","wizbiosolution.com","Wizbiosolutions Inc.","WizDx CrystalMix MTB/MDR","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","CE-IVDD; Korea MFDS","Already on the market (commercialized)","Molecular","DNA","MTB IS6110; Other","qPCR","","Fluorescence","inhA; katG; rpoB","","Isoniazid; Rifampicin","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Automated (excluding sample preparation)","near Point of Care","Intended for professional use only","Bronchoalveolar lavage; Sputum","","110.00","Yes","","","","","","","","","","","","","","","","","","","","","Test Directory"
"a2vVj000001x8FV","a2rVj000000ABa5","","25.09.2024","hyderabad","India","South-East Asian Region","huwellifesciences.in","Huwel Lifesciences Pvt. ltd.","UniAMP Mycobacterium Tuberculosis Nucleic Acid Test Card","Diagnostic/confirmatory test","ID","Tuberculosis","Active","Mycobacterium Tuberculosis Complex Species","Regulatory Status Unknown","","Already on the market (commercialized)","Molecular","DNA","","Isothermal Other","","Fluorescence","Not applicable","","Not applicable","","Cartridge-based processing","","A proprietary/new instrument is required","Automated (excluding sample preparation)","True Point of Care","Intended for professional use only","Sputum; Other","Tongue swab","30.00","Yes","","","","","","","","","","","","","","","","","","","","","Test Directory"
"a2v69000002xsZ1","a2r69000009kSiA","","03.11.2023","Groß-Rohrheim","Germany","European Region","globalpointofcare.abbott/en/index.html","Abbott Rapid Diagnostics","High sensitive LAM","Diagnostic/confirmatory test","ID","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Late Stage Development (fully functional prototype)","None","Unspecified Market Entry","Immunoassay","Antigen","Lipoarabinomannan (LAM)","Lateral Flow Assay","","Unspecified","Not applicable","","Not applicable","","Rapid diagnostic test (strip or cassette)","","No instrumentation is required","Manual","True Point of Care","Intended for professional use only","Urine","","","Yes","","","","","","","","","","","","","","","","","","","","","Test Directory"
"a2v69000002xsYI","a2r69000009kSec","","02.11.2023","Solna","Sweden","European Region","biopromic.com","Biopromic AB","TB LAM urine LFA","Diagnostic/confirmatory test","ID","Tuberculosis","Active","Mycobacterium Tuberculosis","Late Stage Development (fully functional prototype)","None","Unspecified Market Entry","Immunoassay","Antigen","Lipoarabinomannan (LAM)","Lateral Flow Assay","","Colorimetric","Not applicable","","Not applicable","","Rapid diagnostic test (strip or cassette)","","No instrumentation is required","Manual","True Point of Care","Intended for professional use only","Urine","","","Yes","","","","","","","","","","","","","","","","","","","","","Test Directory"
"a2v69000002xsYD","a2r69000009kSeX","","02.11.2023","Kanagawa","Japan","Western Pacific Region","fujifilm.com","FUJIFILM Corporation","Fujifilm SILVAMP TB LAM","Diagnostic/confirmatory test","ID","Tuberculosis","Active","Mycobacterium Tuberculosis","Validation","","Already on the market (commercialized)","Immunoassay","Antigen","Lipoarabinomannan (LAM)","Lateral Flow Assay","","Colorimetric","Not applicable","","Not applicable","","Rapid diagnostic test (strip or cassette)","","No instrumentation is required","Manual","True Point of Care","Intended for professional use only","Urine","","","Yes","","","","","","","","","","","","","","","","","","","","","Test Directory"
"a2v69000002xsXe","a2r69000009kSdZ","","02.11.2023","Solna","Sweden","European Region","empediagnostics.com","EMPE Diagnostics","mfloDx MDR-TB kit","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis","Regulatory Status Unknown","None","Already on the market (commercialized)","Molecular","DNA","MTB ITS","PCR (conventional); Nucleic Acid Lateral Flow Assay (NA-LFA)","lateral flow nucleic acid Assay","Colorimetric","inhA; katG; rpoB","","Isoniazid; Rifampicin","","Rapid diagnostic test (strip or cassette)","","Standard lab instrumentation is required","Manual","near Point of Care","Intended for professional use only","Sputum","","180.00","Yes","","","","","","","","","","","","","","","","","","","","","Test Directory"
"a2v69000002xsYr","a2r69000009kShb","","03.11.2023","Verna Industrial Estate, Verna,","India","South-East Asian Region","molbiodiagnostics.com","Molbio Diagnostics Pvt. Ltd.","Truenat Ultima","Diagnostic/confirmatory test","ID","Tuberculosis","Active","Mycobacterium Tuberculosis","Late Stage Development (fully functional prototype)","None","Unspecified Market Entry","Molecular","DNA","","qPCR","","Fluorescence","Not applicable","","Not applicable","","Cartridge-based processing","chip based","A proprietary/new instrument is required","Automated (excluding sample preparation)","near Point of Care","Intended for professional use only","Purified DNA","Sputum or EPTB specimen","","Yes","","","","","","","","","","","","","","","","","","","","","Test Directory"
"a2v69000002xsYm","a2r69000009kShW","","03.11.2023","Guangzhou","China","Western Pacific Region","leidebio.com","Leide Biosciences Co. , Ltd.","AIMLAM","Diagnostic/confirmatory test","ID","Tuberculosis","Active","Mycobacterium Tuberculosis","Regulatory Status Unknown","None","Already on the market (commercialized)","Immunoassay","Antigen","Lipoarabinomannan (LAM)","Lateral Flow Assay","","Fluorescence","Not applicable","","Not applicable","","Rapid diagnostic test (strip or cassette)","","A proprietary/new instrument is required","Manual","near Point of Care","Intended for professional use only","Urine","","","Yes","","","","","","","","","","","","","","","","","","","","","Test Directory"
"a2v69000002xsZ6","a2r69000009kSiF","","03.11.2023","Hangzhou","China","Western Pacific Region","en.bioustar.com","Ustar Biotechnologies (Hangzhou) Ltd.","MultNAT MTB/RIF","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Late Stage Development (fully functional prototype)","None","Unspecified Market Entry","Molecular","DNA","Unknown","qPCR","","Fluorescence","rpoB","","Rifampicin","","Cartridge-based processing","","A proprietary/new instrument is required","Automated (excluding sample preparation)","near Point of Care","Intended for professional use only","Sputum","","","Yes","","","","","","","","","","","","","","","","","","","","","Test Directory"
"a2v69000002xsZ7","a2r69000009kSiB","","03.11.2023","Hangzhou","China","Western Pacific Region","en.bioustar.com","Ustar Biotechnologies (Hangzhou) Ltd.","PortNAT MTB","Diagnostic/confirmatory test","ID","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Late Stage Development (fully functional prototype)","None","Unspecified Market Entry","Molecular","DNA","Unknown","Isothermal Other; Nucleic Acid Lateral Flow Assay (NA-LFA)","Cross priming amplification (CPA)","Unspecified","Not applicable","","Not applicable","","Cartridge-based processing","","No instrumentation is required","Manual","True Point of Care","Intended for professional use only","Other","Tongue swab","30.00","Yes","","","","","","","","","","","","","","","","","","","","","Test Directory"
"a2v69000002xsYw","a2r69000009kSi0","","03.11.2023","Hangzhou","China","Western Pacific Region","en.bioustar.com","Ustar Biotechnologies (Hangzhou) Ltd.","EasyNAT MTC","Diagnostic/confirmatory test","ID","Tuberculosis","Active","Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species","Regulatory Achieved","Brazil ANVISA; CE-IVDR","Already on the market (commercialized)","Molecular","DNA","MTB IS6110","Isothermal Other","Cross priming amplification (CPA)","Fluorescence","Not applicable","","Not applicable","","Cartridge-based processing","","A proprietary/new instrument is required","Automated (excluding sample preparation)","near Point of Care","Intended for professional use only","Bronchoalveolar lavage; Sputum; Urine","","65.00","Yes","","","","","","","","","","","","","","","","","","","","","Test Directory"
"a2vVj0000018Byb","a2rVj0000006edt","","24.05.2024","Oxford","United Kingdom","European Region","nanoporetech.com","Oxford Nanopore Technologies plc.","Ampore-TB","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis Complex Species","Late Stage Development (fully functional prototype)","None","Unspecified Market Entry","Sequencing","DNA","","Sequencing Biological Nanopore","","Electric signal","Unknown","","Amikacin; Fluoroquinolone; Isoniazid; Linezolid; Rifampicin; Streptomycin","","Other","","","","Lab-based","Intended for professional use only","Sputum","","360.00","Yes","","","","","","","","","","","","","","","","","","","","","Test Directory"
"a2vVj000001jBbR","a2rVj000000916X","","20.08.2024","New Delhi","India","South-East Asian Region","genetixbiotech.com","Genetix Biotech Asia Pvt Ltd","Smart Sure MDR TB Detection Kit, for RIF+INH resistance","Diagnostic/confirmatory test","ID-AMR","Tuberculosis","Active","Mycobacterium Tuberculosis Complex Species","Research Use Only (RUO)","None","Already on the market (commercialized)","Molecular","DNA","MTB IS6110; Other","qPCR","","Fluorescence","inhA; katG; rpoB","","Isoniazid; Rifampicin","","NAT reagent kit (proprietary platform)","","A proprietary/new instrument is required","Automated (excluding sample preparation)","near Point of Care","Intended for professional use only","Sputum","","","Yes","","","","","","","","","","","","","","","","","","","","","Test Directory"
"a2vVj000001xMS9","a2rVj000000AC37","","26.09.2024","Guangzhou","China","Western Pacific Region","leidebio.com","Leide Biosciences Co. , Ltd.","AIMTB","Triage/Screening","ID","Tuberculosis","Latent","Mycobacterium Tuberculosis","Regulatory Achieved","CE-IVDD; China NMPA","Already on the market (commercialized)","Immunoassay","Antigen","Interferon Gamma","ELISA/EIA; IGRA","","Fluorescence","Not applicable","","Not applicable","","IA Reagent Kit","","A proprietary/new instrument is required","Manual","Lab-based","Intended for professional use only","Whole Blood","","","Yes","","","","","","","","","","","","","","","","","","","","","Test Directory"
"a2vVj000001xMAP","a2rVj000000AC1V","","26.09.2024","Watertown","United States","Region of the Americas","sherlock.bio","Sherlock Biosciences Inc.","Sherlock TB assay","Diagnostic/confirmatory test","ID","Tuberculosis","Active","Mycobacterium Tuberculosis Complex Species","Early Stage Development (partial prototype)","None","Unspecified Market Entry","Molecular","DNA","Unknown","CRISPR","","Unspecified","Not applicable","","Not applicable","","Cartridge-based processing","","","","True Point of Care","Intended for professional use only","Other","Tongue swab","","Yes","","","","","","","","","","","","","","","","","","","","","Test Directory"
